CN115612114B - Copolymer membrane and method for enzymatic self-assembly synthesis and application thereof - Google Patents
Copolymer membrane and method for enzymatic self-assembly synthesis and application thereof Download PDFInfo
- Publication number
- CN115612114B CN115612114B CN202110797790.0A CN202110797790A CN115612114B CN 115612114 B CN115612114 B CN 115612114B CN 202110797790 A CN202110797790 A CN 202110797790A CN 115612114 B CN115612114 B CN 115612114B
- Authority
- CN
- China
- Prior art keywords
- film
- cas
- acid
- forming monomer
- aqueous phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920001577 copolymer Polymers 0.000 title claims abstract description 201
- 238000000034 method Methods 0.000 title claims abstract description 43
- 230000002255 enzymatic effect Effects 0.000 title abstract description 9
- 238000001338 self-assembly Methods 0.000 title abstract description 5
- 239000012528 membrane Substances 0.000 title description 53
- 230000015572 biosynthetic process Effects 0.000 title description 7
- 238000003786 synthesis reaction Methods 0.000 title description 6
- 239000000178 monomer Substances 0.000 claims abstract description 99
- 238000006243 chemical reaction Methods 0.000 claims abstract description 80
- 239000003054 catalyst Substances 0.000 claims abstract description 44
- 239000007791 liquid phase Substances 0.000 claims abstract description 37
- 125000003277 amino group Chemical group 0.000 claims abstract description 34
- 238000006911 enzymatic reaction Methods 0.000 claims abstract description 14
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 6
- 239000008346 aqueous phase Substances 0.000 claims description 156
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 151
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 147
- -1 C 3-10 Cycloalkynyl Chemical group 0.000 claims description 112
- 239000007788 liquid Substances 0.000 claims description 109
- 239000012071 phase Substances 0.000 claims description 105
- 230000003197 catalytic effect Effects 0.000 claims description 70
- 239000007853 buffer solution Substances 0.000 claims description 68
- 108010029541 Laccase Proteins 0.000 claims description 67
- 102000004190 Enzymes Human genes 0.000 claims description 57
- 108090000790 Enzymes Proteins 0.000 claims description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 55
- 102000003992 Peroxidases Human genes 0.000 claims description 54
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 53
- 150000001875 compounds Chemical class 0.000 claims description 52
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 52
- 239000000126 substance Substances 0.000 claims description 40
- 239000000243 solution Substances 0.000 claims description 39
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 34
- 125000003118 aryl group Chemical group 0.000 claims description 33
- 230000000694 effects Effects 0.000 claims description 33
- 125000004432 carbon atom Chemical group C* 0.000 claims description 32
- 125000000623 heterocyclic group Chemical group 0.000 claims description 25
- 108010035722 Chloride peroxidase Proteins 0.000 claims description 23
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 23
- 108010059896 Manganese peroxidase Proteins 0.000 claims description 23
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims description 23
- 229920002873 Polyethylenimine Polymers 0.000 claims description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 21
- 235000010469 Glycine max Nutrition 0.000 claims description 21
- 244000068988 Glycine max Species 0.000 claims description 21
- 125000000217 alkyl group Chemical group 0.000 claims description 21
- 125000000304 alkynyl group Chemical group 0.000 claims description 21
- 125000003342 alkenyl group Chemical group 0.000 claims description 20
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 claims description 19
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- LEAHFJQFYSDGGP-UHFFFAOYSA-K trisodium;dihydrogen phosphate;hydrogen phosphate Chemical compound [Na+].[Na+].[Na+].OP(O)([O-])=O.OP([O-])([O-])=O LEAHFJQFYSDGGP-UHFFFAOYSA-K 0.000 claims description 17
- 108010015428 Bilirubin oxidase Proteins 0.000 claims description 16
- 108010031396 Catechol oxidase Proteins 0.000 claims description 16
- 102000030523 Catechol oxidase Human genes 0.000 claims description 16
- 239000008055 phosphate buffer solution Substances 0.000 claims description 16
- 229910052736 halogen Inorganic materials 0.000 claims description 15
- 150000002367 halogens Chemical class 0.000 claims description 15
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 13
- 108010054320 Lignin peroxidase Proteins 0.000 claims description 13
- 125000002947 alkylene group Chemical group 0.000 claims description 13
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 claims description 13
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 claims description 12
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 239000004475 Arginine Substances 0.000 claims description 11
- 102000004316 Oxidoreductases Human genes 0.000 claims description 11
- 108090000854 Oxidoreductases Proteins 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 11
- 229960004198 guanidine Drugs 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N syringic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 claims description 10
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 claims description 9
- AUZQQIPZESHNMG-UHFFFAOYSA-N 3-methoxysalicylic acid Chemical compound COC1=CC=CC(C(O)=O)=C1O AUZQQIPZESHNMG-UHFFFAOYSA-N 0.000 claims description 9
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 9
- CBMPTFJVXNIWHP-UHFFFAOYSA-L disodium;hydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].OP([O-])([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O CBMPTFJVXNIWHP-UHFFFAOYSA-L 0.000 claims description 9
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 9
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 229960000318 kanamycin Drugs 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 9
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims description 8
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims description 8
- 239000004472 Lysine Substances 0.000 claims description 8
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 8
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 claims description 8
- 150000002500 ions Chemical class 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 229940063675 spermine Drugs 0.000 claims description 8
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 8
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims description 7
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 7
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 claims description 7
- 241000196324 Embryophyta Species 0.000 claims description 7
- 229940114124 ferulic acid Drugs 0.000 claims description 7
- 235000001785 ferulic acid Nutrition 0.000 claims description 7
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 7
- 229910021645 metal ion Inorganic materials 0.000 claims description 7
- 230000000379 polymerizing effect Effects 0.000 claims description 7
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 7
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 6
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 6
- GZLGNNHEHXBCBI-UHFFFAOYSA-L [Na+].[Na+].OC(=O)C(O)C(O)C(O)=O.[O-]C(=O)C(O)C(O)C([O-])=O Chemical compound [Na+].[Na+].OC(=O)C(O)C(O)C(O)=O.[O-]C(=O)C(O)C(O)C([O-])=O GZLGNNHEHXBCBI-UHFFFAOYSA-L 0.000 claims description 6
- YUTJCNNFTOIOGT-UHFFFAOYSA-N anthracene-1,8,9-triol Chemical compound C1=CC(O)=C2C(O)=C3C(O)=CC=CC3=CC2=C1 YUTJCNNFTOIOGT-UHFFFAOYSA-N 0.000 claims description 6
- 125000005605 benzo group Chemical group 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- 239000004202 carbamide Substances 0.000 claims description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 6
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 6
- 239000003623 enhancer Substances 0.000 claims description 6
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 5
- RMTXUPIIESNLPW-UHFFFAOYSA-N 1,2-dihydroxy-3-(pentadeca-8,11-dienyl)benzene Natural products CCCC=CCC=CCCCCCCCC1=CC=CC(O)=C1O RMTXUPIIESNLPW-UHFFFAOYSA-N 0.000 claims description 5
- DHZVWQPHNWDCFS-UHFFFAOYSA-N 2-hydroxy-3,5-diiodobenzoic acid Chemical compound OC(=O)C1=CC(I)=CC(I)=C1O DHZVWQPHNWDCFS-UHFFFAOYSA-N 0.000 claims description 5
- ZTMADXFOCUXMJE-UHFFFAOYSA-N 2-methylbenzene-1,3-diol Chemical compound CC1=C(O)C=CC=C1O ZTMADXFOCUXMJE-UHFFFAOYSA-N 0.000 claims description 5
- QARRXYBJLBIVAK-UEMSJJPVSA-N 3-[(8e,11e)-pentadeca-8,11-dienyl]benzene-1,2-diol;3-[(8e,11e)-pentadeca-8,11,14-trienyl]benzene-1,2-diol;3-[(8e,11e,13e)-pentadeca-8,11,13-trienyl]benzene-1,2-diol;3-[(e)-pentadec-8-enyl]benzene-1,2-diol;3-pentadecylbenzene-1,2-diol Chemical compound CCCCCCCCCCCCCCCC1=CC=CC(O)=C1O.CCCCCC\C=C\CCCCCCCC1=CC=CC(O)=C1O.CCC\C=C\C\C=C\CCCCCCCC1=CC=CC(O)=C1O.C\C=C\C=C\C\C=C\CCCCCCCC1=CC=CC(O)=C1O.OC1=CC=CC(CCCCCCC\C=C\C\C=C\CC=C)=C1O QARRXYBJLBIVAK-UEMSJJPVSA-N 0.000 claims description 5
- IYROWZYPEIMDDN-UHFFFAOYSA-N 3-n-pentadec-8,11,13-trienyl catechol Natural products CC=CC=CCC=CCCCCCCCC1=CC=CC(O)=C1O IYROWZYPEIMDDN-UHFFFAOYSA-N 0.000 claims description 5
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 claims description 5
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 claims description 5
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 5
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 5
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 5
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 5
- 229960004909 aminosalicylic acid Drugs 0.000 claims description 5
- 235000010208 anthocyanin Nutrition 0.000 claims description 5
- 239000004410 anthocyanin Substances 0.000 claims description 5
- 229930002877 anthocyanin Natural products 0.000 claims description 5
- 150000004636 anthocyanins Chemical class 0.000 claims description 5
- 229940074360 caffeic acid Drugs 0.000 claims description 5
- 235000004883 caffeic acid Nutrition 0.000 claims description 5
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 5
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 5
- SSJXIUAHEKJCMH-UHFFFAOYSA-N cyclohexane-1,2-diamine Chemical compound NC1CCCCC1N SSJXIUAHEKJCMH-UHFFFAOYSA-N 0.000 claims description 5
- SILCDLWESNHZKB-UHFFFAOYSA-L disodium 4-hydroxy-4-oxobutanoate Chemical compound [Na+].[Na+].OC(=O)CCC([O-])=O.OC(=O)CCC([O-])=O SILCDLWESNHZKB-UHFFFAOYSA-L 0.000 claims description 5
- 230000002538 fungal effect Effects 0.000 claims description 5
- XOOMNEFVDUTJPP-UHFFFAOYSA-N naphthalene-1,3-diol Chemical compound C1=CC=CC2=CC(O)=CC(O)=C21 XOOMNEFVDUTJPP-UHFFFAOYSA-N 0.000 claims description 5
- FZZQNEVOYIYFPF-UHFFFAOYSA-N naphthalene-1,6-diol Chemical compound OC1=CC=CC2=CC(O)=CC=C21 FZZQNEVOYIYFPF-UHFFFAOYSA-N 0.000 claims description 5
- WHSXTWFYRGOBGO-UHFFFAOYSA-N o-cresotic acid Natural products CC1=CC=CC(C(O)=O)=C1O WHSXTWFYRGOBGO-UHFFFAOYSA-N 0.000 claims description 5
- QTYWBJZOZDYCGB-UHFFFAOYSA-L potassium;sodium;2-carboxybenzoate;hydroxide Chemical compound [OH-].[Na+].[K+].OC(=O)C1=CC=CC=C1C([O-])=O QTYWBJZOZDYCGB-UHFFFAOYSA-L 0.000 claims description 5
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 claims description 5
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 claims description 5
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 claims description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 5
- DQTMTQZSOJMZSF-UHFFFAOYSA-N urushiol Natural products CCCCCCCCCCCCCCCC1=CC=CC(O)=C1O DQTMTQZSOJMZSF-UHFFFAOYSA-N 0.000 claims description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 4
- UYDGECQHZQNTQS-UHFFFAOYSA-N 2-amino-4,6-dimethylpyridine-3-carboxamide Chemical compound CC1=CC(C)=C(C(N)=O)C(N)=N1 UYDGECQHZQNTQS-UHFFFAOYSA-N 0.000 claims description 4
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 4
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims description 4
- 229920002079 Ellagic acid Polymers 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 4
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
- 229940074393 chlorogenic acid Drugs 0.000 claims description 4
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 4
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 4
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 4
- IEHIPPDDMCEYPI-UHFFFAOYSA-L disodium propanedioate propanedioic acid Chemical compound [Na+].[Na+].OC(=O)CC(O)=O.[O-]C(=O)CC([O-])=O IEHIPPDDMCEYPI-UHFFFAOYSA-L 0.000 claims description 4
- 229960002852 ellagic acid Drugs 0.000 claims description 4
- 235000004132 ellagic acid Nutrition 0.000 claims description 4
- 229940074391 gallic acid Drugs 0.000 claims description 4
- 235000004515 gallic acid Nutrition 0.000 claims description 4
- 229960005219 gentisic acid Drugs 0.000 claims description 4
- 229960001867 guaiacol Drugs 0.000 claims description 4
- 229940095066 hydroxytyrosol Drugs 0.000 claims description 4
- 235000003248 hydroxytyrosol Nutrition 0.000 claims description 4
- 229930027917 kanamycin Natural products 0.000 claims description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 4
- 229930182823 kanamycin A Natural products 0.000 claims description 4
- 229910001338 liquidmetal Inorganic materials 0.000 claims description 4
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 claims description 4
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims description 4
- BUCIWTBCUUHRHZ-UHFFFAOYSA-K potassium;disodium;dihydrogen phosphate;hydrogen phosphate Chemical compound [Na+].[Na+].[K+].OP(O)([O-])=O.OP([O-])([O-])=O BUCIWTBCUUHRHZ-UHFFFAOYSA-K 0.000 claims description 4
- 235000021283 resveratrol Nutrition 0.000 claims description 4
- 229940016667 resveratrol Drugs 0.000 claims description 4
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 claims description 4
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 3
- 235000010523 Cicer arietinum Nutrition 0.000 claims description 3
- 244000045195 Cicer arietinum Species 0.000 claims description 3
- 229920000742 Cotton Polymers 0.000 claims description 3
- 239000001263 FEMA 3042 Substances 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 claims description 3
- 229910021538 borax Inorganic materials 0.000 claims description 3
- VCMFGDACKBCWDX-UHFFFAOYSA-K dipotassium sodium hydrogen phosphate hydroxide Chemical compound [OH-].[Na+].P(=O)(O)([O-])[O-].[K+].[K+] VCMFGDACKBCWDX-UHFFFAOYSA-K 0.000 claims description 3
- LRWJZGCOPMDWFZ-UHFFFAOYSA-N phthalic acid;hydrochloride Chemical compound Cl.OC(=O)C1=CC=CC=C1C(O)=O LRWJZGCOPMDWFZ-UHFFFAOYSA-N 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 239000004328 sodium tetraborate Substances 0.000 claims description 3
- 235000015523 tannic acid Nutrition 0.000 claims description 3
- 229920002258 tannic acid Polymers 0.000 claims description 3
- 229940033123 tannic acid Drugs 0.000 claims description 3
- 239000004250 tert-Butylhydroquinone Substances 0.000 claims description 3
- 235000019281 tert-butylhydroquinone Nutrition 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 claims description 2
- DLYLVPHSKJVGLG-UHFFFAOYSA-N 4-(cyclohexylmethyl)cyclohexane-1,1-diamine Chemical compound C1CC(N)(N)CCC1CC1CCCCC1 DLYLVPHSKJVGLG-UHFFFAOYSA-N 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 2
- 244000020518 Carthamus tinctorius Species 0.000 claims description 2
- 244000303965 Cyamopsis psoralioides Species 0.000 claims description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 2
- 241000222640 Polyporus Species 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 230000007246 mechanism Effects 0.000 claims description 2
- 230000003278 mimic effect Effects 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 125000006717 (C3-C10) cycloalkenyl group Chemical group 0.000 claims 6
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 6
- 238000010189 synthetic method Methods 0.000 claims 5
- 125000006714 (C3-C10) heterocyclyl group Chemical group 0.000 claims 4
- 125000006708 (C5-C14) heteroaryl group Chemical group 0.000 claims 4
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 claims 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 claims 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 claims 1
- 229940093496 esculin Drugs 0.000 claims 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 claims 1
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 42
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 3
- 229940057995 liquid paraffin Drugs 0.000 description 67
- 229940088598 enzyme Drugs 0.000 description 47
- 239000000203 mixture Substances 0.000 description 37
- 239000003921 oil Substances 0.000 description 27
- 235000013824 polyphenols Nutrition 0.000 description 27
- 229910052760 oxygen Inorganic materials 0.000 description 24
- 150000003839 salts Chemical class 0.000 description 24
- 244000251953 Agaricus brunnescens Species 0.000 description 23
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 23
- 235000019198 oils Nutrition 0.000 description 22
- 125000001072 heteroaryl group Chemical group 0.000 description 20
- 238000006555 catalytic reaction Methods 0.000 description 19
- 239000012046 mixed solvent Substances 0.000 description 19
- 238000007667 floating Methods 0.000 description 16
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 15
- 239000000463 material Substances 0.000 description 15
- 239000002253 acid Substances 0.000 description 14
- 239000012188 paraffin wax Substances 0.000 description 14
- 229910052717 sulfur Inorganic materials 0.000 description 14
- 239000010410 layer Substances 0.000 description 12
- 229910052751 metal Inorganic materials 0.000 description 12
- 239000002184 metal Substances 0.000 description 12
- 239000010902 straw Substances 0.000 description 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 10
- 125000000753 cycloalkyl group Chemical group 0.000 description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 9
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 9
- 125000002619 bicyclic group Chemical group 0.000 description 9
- 238000006872 enzymatic polymerization reaction Methods 0.000 description 9
- 239000001301 oxygen Substances 0.000 description 9
- 239000003760 tallow Substances 0.000 description 9
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 8
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 8
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 8
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 8
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 8
- 229910052733 gallium Inorganic materials 0.000 description 8
- 150000002430 hydrocarbons Chemical group 0.000 description 8
- 229920005610 lignin Polymers 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 150000002978 peroxides Chemical class 0.000 description 8
- 238000006116 polymerization reaction Methods 0.000 description 8
- 229920002414 procyanidin Polymers 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- BTQAJGSMXCDDAJ-UHFFFAOYSA-N 2,4,6-trihydroxybenzaldehyde Chemical compound OC1=CC(O)=C(C=O)C(O)=C1 BTQAJGSMXCDDAJ-UHFFFAOYSA-N 0.000 description 7
- GYLUFQJZYAJQDI-UHFFFAOYSA-N 4',6,7-trihydroxyisoflavone Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=C(O)C=C2C1=O GYLUFQJZYAJQDI-UHFFFAOYSA-N 0.000 description 7
- 229930185605 Bisphenol Natural products 0.000 description 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 7
- XFZJEEAOWLFHDH-NFJBMHMQSA-N Epicatechin-(4beta->8)-catechin Natural products C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=CC(O)=C3C[C@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-NFJBMHMQSA-N 0.000 description 7
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 7
- HFVAFDPGUJEFBQ-UHFFFAOYSA-M alizarin red S Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=C(S([O-])(=O)=O)C(O)=C2O HFVAFDPGUJEFBQ-UHFFFAOYSA-M 0.000 description 7
- 125000004429 atom Chemical group 0.000 description 7
- 125000000392 cycloalkenyl group Chemical group 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 7
- 125000002950 monocyclic group Chemical group 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 7
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 7
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 7
- 229920001864 tannin Polymers 0.000 description 7
- 239000001648 tannin Substances 0.000 description 7
- 235000018553 tannin Nutrition 0.000 description 7
- OBBCRPUNCUPUOS-UHFFFAOYSA-N tectorigenin Chemical compound O=C1C2=C(O)C(OC)=C(O)C=C2OC=C1C1=CC=C(O)C=C1 OBBCRPUNCUPUOS-UHFFFAOYSA-N 0.000 description 7
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 6
- SULYEHHGGXARJS-UHFFFAOYSA-N 2',4'-dihydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1O SULYEHHGGXARJS-UHFFFAOYSA-N 0.000 description 6
- HEMGYNNCNNODNX-UHFFFAOYSA-N 3,4-diaminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1N HEMGYNNCNNODNX-UHFFFAOYSA-N 0.000 description 6
- IOCXBXZBNOYTLQ-UHFFFAOYSA-N 3-nitrobenzene-1,2-diamine Chemical compound NC1=CC=CC([N+]([O-])=O)=C1N IOCXBXZBNOYTLQ-UHFFFAOYSA-N 0.000 description 6
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-Glutamic acid Natural products OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 229910052804 chromium Inorganic materials 0.000 description 6
- 239000011651 chromium Substances 0.000 description 6
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 229960005542 ethidium bromide Drugs 0.000 description 6
- 229930182478 glucoside Natural products 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- IJFXRHURBJZNAO-UHFFFAOYSA-N meta--hydroxybenzoic acid Natural products OC(=O)C1=CC=CC(O)=C1 IJFXRHURBJZNAO-UHFFFAOYSA-N 0.000 description 6
- XTBLDMQMUSHDEN-UHFFFAOYSA-N naphthalene-2,3-diamine Chemical compound C1=CC=C2C=C(N)C(N)=CC2=C1 XTBLDMQMUSHDEN-UHFFFAOYSA-N 0.000 description 6
- 150000002894 organic compounds Chemical class 0.000 description 6
- 125000004043 oxo group Chemical group O=* 0.000 description 6
- 229920006254 polymer film Polymers 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- 239000000600 sorbitol Substances 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- KJXSIXMJHKAJOD-LSDHHAIUSA-N (+)-dihydromyricetin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC(O)=C(O)C(O)=C1 KJXSIXMJHKAJOD-LSDHHAIUSA-N 0.000 description 5
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 5
- LBKFGYZQBSGRHY-UHFFFAOYSA-N 3-hydroxy-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1O LBKFGYZQBSGRHY-UHFFFAOYSA-N 0.000 description 5
- 239000004215 Carbon black (E152) Substances 0.000 description 5
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 5
- 239000007810 chemical reaction solvent Substances 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 239000006059 cover glass Substances 0.000 description 5
- 150000001924 cycloalkanes Chemical class 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 230000001747 exhibiting effect Effects 0.000 description 5
- 229930195733 hydrocarbon Natural products 0.000 description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 description 5
- 230000001590 oxidative effect Effects 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 5
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 5
- ZENOXNGFMSCLLL-UHFFFAOYSA-N vanillyl alcohol Chemical compound COC1=CC(CO)=CC=C1O ZENOXNGFMSCLLL-UHFFFAOYSA-N 0.000 description 5
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- KUQNCHZOCSYKOR-UHFFFAOYSA-N 1,1-dioxospiro[2,1$l^{6}-benzoxathiole-3,9'-xanthene]-3',4',5',6'-tetrol Chemical compound O1S(=O)(=O)C2=CC=CC=C2C21C1=CC=C(O)C(O)=C1OC1=C(O)C(O)=CC=C21 KUQNCHZOCSYKOR-UHFFFAOYSA-N 0.000 description 4
- IBHWREHFNDMRPR-UHFFFAOYSA-N 2,4,6-Trihydroxybenzoic acid Chemical compound OC(=O)C1=C(O)C=C(O)C=C1O IBHWREHFNDMRPR-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 4
- JQVAPEJNIZULEK-UHFFFAOYSA-N 4-chlorobenzene-1,3-diol Chemical compound OC1=CC=C(Cl)C(O)=C1 JQVAPEJNIZULEK-UHFFFAOYSA-N 0.000 description 4
- BGQNOPFTJROKJE-UHFFFAOYSA-N 5,6-diamino-1,3-dimethylpyrimidine-2,4-dione Chemical compound CN1C(N)=C(N)C(=O)N(C)C1=O BGQNOPFTJROKJE-UHFFFAOYSA-N 0.000 description 4
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methyloxysalicylic acid Natural products COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- NEZONWMXZKDMKF-SNVBAGLBSA-N Shikonin Chemical compound C1=CC(O)=C2C(=O)C([C@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-SNVBAGLBSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 239000000956 alloy Substances 0.000 description 4
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- VCCBEIPGXKNHFW-UHFFFAOYSA-N biphenyl-4,4'-diol Chemical compound C1=CC(O)=CC=C1C1=CC=C(O)C=C1 VCCBEIPGXKNHFW-UHFFFAOYSA-N 0.000 description 4
- GLYJVQDYLFAUFC-UHFFFAOYSA-N butyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCC GLYJVQDYLFAUFC-UHFFFAOYSA-N 0.000 description 4
- 229950005499 carbon tetrachloride Drugs 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 4
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 229960002989 glutamic acid Drugs 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 4
- VVOAZFWZEDHOOU-UHFFFAOYSA-N honokiol Natural products OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 4
- 229940018564 m-phenylenediamine Drugs 0.000 description 4
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 4
- 239000002105 nanoparticle Substances 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 239000013618 particulate matter Substances 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- XFZJEEAOWLFHDH-UKWJTHFESA-N procyanidin B1 Chemical compound C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=CC(O)=C3C[C@@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UKWJTHFESA-N 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000002356 single layer Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 4
- 235000012141 vanillin Nutrition 0.000 description 4
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 4
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 3
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 description 3
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 3
- FQWLMRXWKZGLFI-YVYUXZJTSA-N (-)-trans-epsilon-viniferin Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC2=C1[C@@H](C=1C=C(O)C=C(O)C=1)[C@H](C=1C=CC(O)=CC=1)O2 FQWLMRXWKZGLFI-YVYUXZJTSA-N 0.000 description 3
- NKNCGBHPGCHYCQ-UHFFFAOYSA-N (2,5-diaminophenyl)methanol Chemical compound NC1=CC=C(N)C(CO)=C1 NKNCGBHPGCHYCQ-UHFFFAOYSA-N 0.000 description 3
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 3
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 3
- FBMQNRKSAWNXBT-UHFFFAOYSA-N 1,4-diaminoanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(N)=CC=C2N FBMQNRKSAWNXBT-UHFFFAOYSA-N 0.000 description 3
- YPTJKHVBDCRKNF-UHFFFAOYSA-N 2',6'-Dihydroxyacetophenone Chemical compound CC(=O)C1=C(O)C=CC=C1O YPTJKHVBDCRKNF-UHFFFAOYSA-N 0.000 description 3
- ABQQPHFTJYCSIA-UHFFFAOYSA-N 2,3-diethylbenzene-1,4-diamine Chemical compound CCC1=C(N)C=CC(N)=C1CC ABQQPHFTJYCSIA-UHFFFAOYSA-N 0.000 description 3
- QSZCGGBDNYTQHH-UHFFFAOYSA-N 2,3-dimethoxyphenol Chemical compound COC1=CC=CC(O)=C1OC QSZCGGBDNYTQHH-UHFFFAOYSA-N 0.000 description 3
- GZVVXXLYQIFVCA-UHFFFAOYSA-N 2,3-dimethylbenzene-1,4-diamine Chemical compound CC1=C(C)C(N)=CC=C1N GZVVXXLYQIFVCA-UHFFFAOYSA-N 0.000 description 3
- BAHPQISAXRFLCL-UHFFFAOYSA-N 2,4-Diaminoanisole Chemical compound COC1=CC=C(N)C=C1N BAHPQISAXRFLCL-UHFFFAOYSA-N 0.000 description 3
- SYEYEGBZVSWYPK-UHFFFAOYSA-N 2,5,6-triamino-4-hydroxypyrimidine Chemical compound NC1=NC(N)=C(N)C(O)=N1 SYEYEGBZVSWYPK-UHFFFAOYSA-N 0.000 description 3
- GMKMEZVLHJARHF-UHFFFAOYSA-N 2,6-diaminopimelic acid Chemical compound OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 3
- AKEUNCKRJATALU-UHFFFAOYSA-N 2,6-dihydroxybenzoic acid Chemical compound OC(=O)C1=C(O)C=CC=C1O AKEUNCKRJATALU-UHFFFAOYSA-N 0.000 description 3
- ZXZZHWVJHLHSNF-UHFFFAOYSA-N 2-(4-aminoanilino)oxyethanol Chemical compound NC1=CC=C(NOCCO)C=C1 ZXZZHWVJHLHSNF-UHFFFAOYSA-N 0.000 description 3
- FXFTWEVIIHVHDS-UHFFFAOYSA-N 2-fluorobenzene-1,4-diamine Chemical compound NC1=CC=C(N)C(F)=C1 FXFTWEVIIHVHDS-UHFFFAOYSA-N 0.000 description 3
- AAUQLHHARJUJEH-UHFFFAOYSA-N 2-hydroxy-5-methoxybenzoic acid Natural products COC1=CC=CC(O)=C1C(O)=O AAUQLHHARJUJEH-UHFFFAOYSA-N 0.000 description 3
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 3
- WEPBGSIAWZTEJR-UHFFFAOYSA-N 3',4',5,7-tetrahydroxy-3-methoxyflavone Chemical compound O1C2=CC(O)=CC(O)=C2C(=O)C(OC)=C1C1=CC=C(O)C(O)=C1 WEPBGSIAWZTEJR-UHFFFAOYSA-N 0.000 description 3
- VTCDZPUMZAZMSB-UHFFFAOYSA-N 3,4,5-trimethoxyphenol Chemical compound COC1=CC(O)=CC(OC)=C1OC VTCDZPUMZAZMSB-UHFFFAOYSA-N 0.000 description 3
- FBTSUTGMWBDAAC-UHFFFAOYSA-N 3,4-Dihydroxystyrene Chemical compound OC1=CC=C(C=C)C=C1O FBTSUTGMWBDAAC-UHFFFAOYSA-N 0.000 description 3
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 3
- UYEMGAFJOZZIFP-UHFFFAOYSA-N 3,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC(O)=C1 UYEMGAFJOZZIFP-UHFFFAOYSA-N 0.000 description 3
- WJXSWCUQABXPFS-UHFFFAOYSA-N 3-hydroxyanthranilic acid Chemical compound NC1=C(O)C=CC=C1C(O)=O WJXSWCUQABXPFS-UHFFFAOYSA-N 0.000 description 3
- LPYUENQFPVNPHY-UHFFFAOYSA-N 3-methoxycatechol Chemical compound COC1=CC=CC(O)=C1O LPYUENQFPVNPHY-UHFFFAOYSA-N 0.000 description 3
- PGSWEKYNAOWQDF-UHFFFAOYSA-N 3-methylcatechol Chemical compound CC1=CC=CC(O)=C1O PGSWEKYNAOWQDF-UHFFFAOYSA-N 0.000 description 3
- HFLGBNBLMBSXEM-UHFFFAOYSA-N 4-Ethyl-1,2-benzenediol Chemical compound CCC1=CC=C(O)C(O)=C1 HFLGBNBLMBSXEM-UHFFFAOYSA-N 0.000 description 3
- DZIHTWJGPDVSGE-UHFFFAOYSA-N 4-[(4-aminocyclohexyl)methyl]cyclohexan-1-amine Chemical compound C1CC(N)CCC1CC1CCC(N)CC1 DZIHTWJGPDVSGE-UHFFFAOYSA-N 0.000 description 3
- UHNUHZHQLCGZDA-UHFFFAOYSA-N 4-[2-(4-aminophenyl)ethyl]aniline Chemical compound C1=CC(N)=CC=C1CCC1=CC=C(N)C=C1 UHNUHZHQLCGZDA-UHFFFAOYSA-N 0.000 description 3
- HXDOZKJGKXYMEW-UHFFFAOYSA-N 4-ethylphenol Chemical compound CCC1=CC=C(O)C=C1 HXDOZKJGKXYMEW-UHFFFAOYSA-N 0.000 description 3
- MRIXVKKOHPQOFK-UHFFFAOYSA-N 4-methoxysalicylic acid Chemical compound COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 description 3
- DGRGLKZMKWPMOH-UHFFFAOYSA-N 4-methylbenzene-1,2-diamine Chemical compound CC1=CC=C(N)C(N)=C1 DGRGLKZMKWPMOH-UHFFFAOYSA-N 0.000 description 3
- ZBCATMYQYDCTIZ-UHFFFAOYSA-N 4-methylcatechol Chemical compound CC1=CC=C(O)C(O)=C1 ZBCATMYQYDCTIZ-UHFFFAOYSA-N 0.000 description 3
- RAUWPNXIALNKQM-UHFFFAOYSA-N 4-nitro-1,2-phenylenediamine Chemical compound NC1=CC=C([N+]([O-])=O)C=C1N RAUWPNXIALNKQM-UHFFFAOYSA-N 0.000 description 3
- GSAOUZGPXSGVRS-UHFFFAOYSA-N 6,7-dihydroxy-2-phenylchromen-4-one Chemical compound C=1C(=O)C=2C=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 GSAOUZGPXSGVRS-UHFFFAOYSA-N 0.000 description 3
- COCYGNDCWFKTMF-UHFFFAOYSA-N 7,8-dihydroxyflavone Chemical compound OC=1C(O)=CC=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 COCYGNDCWFKTMF-UHFFFAOYSA-N 0.000 description 3
- SNCJAJRILVFXAE-UHFFFAOYSA-N 9h-fluorene-2,7-diamine Chemical compound NC1=CC=C2C3=CC=C(N)C=C3CC2=C1 SNCJAJRILVFXAE-UHFFFAOYSA-N 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 3
- JQQBXPCJFAKSPG-SVYIMCMUSA-N Geraniin Chemical compound OC1=C(O)C(O)=CC(C(=O)O[C@H]2[C@@H]3OC(=O)C=4C=C(O)C(O)=C5O[C@@]6(O)C(=O)C=C([C@@H](C5=4)C6(O)O)C(=O)O[C@H]4[C@@H]3OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC[C@H]4O2)=C1 JQQBXPCJFAKSPG-SVYIMCMUSA-N 0.000 description 3
- 229920000061 Geraniin Polymers 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- SVSWTEAHRCVGAR-XJAAUWFPSA-N Gnetin A Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(=O)[C@H]2C(=O)[C@@H]1[C@H](C=1C=C(O)C=C(O)C=1)[C@H]2C1=CC=C(O)C=C1 SVSWTEAHRCVGAR-XJAAUWFPSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 241000991765 Hymenochaete Species 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- 241001071917 Lithospermum Species 0.000 description 3
- 229920000877 Melamine resin Polymers 0.000 description 3
- 241000222350 Pleurotus Species 0.000 description 3
- 229920000385 Procyanidin B1 Polymers 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- 239000002262 Schiff base Substances 0.000 description 3
- 150000004753 Schiff bases Chemical class 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZCDDBUOENGJMLV-QRPNPIFTSA-N Valacyclovir hydrochloride Chemical compound Cl.N1C(N)=NC(=O)C2=C1N(COCCOC(=O)[C@@H](N)C(C)C)C=N2 ZCDDBUOENGJMLV-QRPNPIFTSA-N 0.000 description 3
- KLQXMRBGMLHBBQ-DQTDZZOCSA-N [(2r,3r,4r,5r,6r)-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-4-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2-[[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-3-yl] (e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate Chemical compound C1=C(O)C(OC)=CC=C1CCO[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@H](OC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@@H](O)CO2)O)O1 KLQXMRBGMLHBBQ-DQTDZZOCSA-N 0.000 description 3
- NJYZCEFQAIUHSD-UHFFFAOYSA-N acetoguanamine Chemical compound CC1=NC(N)=NC(N)=N1 NJYZCEFQAIUHSD-UHFFFAOYSA-N 0.000 description 3
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- JPICKYUTICNNNJ-UHFFFAOYSA-N anthrarufin Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1C=CC=C2O JPICKYUTICNNNJ-UHFFFAOYSA-N 0.000 description 3
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- WUADCCWRTIWANL-UHFFFAOYSA-N biochanin A Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O WUADCCWRTIWANL-UHFFFAOYSA-N 0.000 description 3
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- QBPFLULOKWLNNW-UHFFFAOYSA-N chrysazin Chemical compound O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O QBPFLULOKWLNNW-UHFFFAOYSA-N 0.000 description 3
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 3
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 3
- 235000017803 cinnamon Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000019868 cocoa butter Nutrition 0.000 description 3
- 229940110456 cocoa butter Drugs 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 3
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 3
- 235000012734 epicatechin Nutrition 0.000 description 3
- UBOJATHNUASNAV-UHFFFAOYSA-N ethyl 2,4,6-trihydroxybenzoate Chemical compound CCOC(=O)C1=C(O)C=C(O)C=C1O UBOJATHNUASNAV-UHFFFAOYSA-N 0.000 description 3
- KBPUBCVJHFXPOC-UHFFFAOYSA-N ethyl 3,4-dihydroxybenzoate Chemical compound CCOC(=O)C1=CC=C(O)C(O)=C1 KBPUBCVJHFXPOC-UHFFFAOYSA-N 0.000 description 3
- 239000003337 fertilizer Substances 0.000 description 3
- 229920001002 functional polymer Polymers 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 3
- GJMUCSXZXBCQRZ-UHFFFAOYSA-N geraniin Natural products Oc1cc(cc(O)c1O)C(=O)OC2OC3COC(=O)c4cc(O)c(O)c(O)c4c5cc(C(=O)C67OC3C(O6)C2OC(=O)c8cc(O)c(O)c9OC%10(O)C(C(=CC(=O)C%10(O)O)C7=O)c89)c(O)c(O)c5O GJMUCSXZXBCQRZ-UHFFFAOYSA-N 0.000 description 3
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 3
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 description 3
- 235000010209 hesperetin Nutrition 0.000 description 3
- 229960001587 hesperetin Drugs 0.000 description 3
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 3
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 description 3
- BRWIZMBXBAOCCF-UHFFFAOYSA-N hydrazinecarbothioamide Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- JVTZFYYHCGSXJV-UHFFFAOYSA-N isovanillin Chemical compound COC1=CC=C(C=O)C=C1O JVTZFYYHCGSXJV-UHFFFAOYSA-N 0.000 description 3
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 3
- 235000009498 luteolin Nutrition 0.000 description 3
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- KQSABULTKYLFEV-UHFFFAOYSA-N naphthalene-1,5-diamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1N KQSABULTKYLFEV-UHFFFAOYSA-N 0.000 description 3
- DFQICHCWIIJABH-UHFFFAOYSA-N naphthalene-2,7-diol Chemical compound C1=CC(O)=CC2=CC(O)=CC=C21 DFQICHCWIIJABH-UHFFFAOYSA-N 0.000 description 3
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 3
- 239000007764 o/w emulsion Substances 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- 229960005489 paracetamol Drugs 0.000 description 3
- 230000005501 phase interface Effects 0.000 description 3
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 3
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 description 3
- 125000004193 piperazinyl group Chemical group 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- GMISZFQPFDAPGI-UHFFFAOYSA-N proanthocyanidin B5 Natural products OC=1C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 GMISZFQPFDAPGI-UHFFFAOYSA-N 0.000 description 3
- XFZJEEAOWLFHDH-AVFWISQGSA-N procyanidin B3 Chemical compound C1([C@@H]2[C@@H](O)[C@@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=CC(O)=C3C[C@@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-AVFWISQGSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- KQMVAGISDHMXJJ-UHFFFAOYSA-N prunetin Chemical compound C=1C(OC)=CC(O)=C(C2=O)C=1OC=C2C1=CC=C(O)C=C1 KQMVAGISDHMXJJ-UHFFFAOYSA-N 0.000 description 3
- UYLQOGTYNFVQQX-UHFFFAOYSA-N psi-tectorigenin Natural products COC1=C(O)C=C(O)C(C2=O)=C1OC=C2C1=CC=C(O)C=C1 UYLQOGTYNFVQQX-UHFFFAOYSA-N 0.000 description 3
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 3
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- 125000006413 ring segment Chemical group 0.000 description 3
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 3
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 description 3
- 238000010517 secondary reaction Methods 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- UODZHRGDSPLRMD-UHFFFAOYSA-N sym-homospermidine Chemical compound NCCCCNCCCCN UODZHRGDSPLRMD-UHFFFAOYSA-N 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- OYUJPVCKGSEYDD-UHFFFAOYSA-N tectorigenin Natural products COc1c(O)cc2OCC(C(=O)c2c1O)c1ccc(O)cc1 OYUJPVCKGSEYDD-UHFFFAOYSA-N 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 3
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 3
- KUTVNHOAKHJJFL-ZSIJVUTGSA-N (+)-alpha-viniferin Chemical compound C1=CC(O)=CC=C1[C@@H](O1)[C@H]2C(C=C(O)C=C3O[C@H]4C=5C=CC(O)=CC=5)=C3[C@H]4C(C=C(O)C=C3O[C@H]4C=5C=CC(O)=CC=5)=C3[C@H]4C3=C2C1=CC(O)=C3 KUTVNHOAKHJJFL-ZSIJVUTGSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- LSHVYAFMTMFKBA-CTNGQTDRSA-N (-)-catechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-CTNGQTDRSA-N 0.000 description 2
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 2
- LLWFHCJFZGXUAT-UMXPSMRGSA-N (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-19-[[(2R)-2-amino-4-methylpentanoyl]amino]-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid hydrochloride Chemical compound Cl.CC(C)C[C@@H](N)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@H](NC5=O)C(O)=O)c3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1)c(Cl)c2 LLWFHCJFZGXUAT-UMXPSMRGSA-N 0.000 description 2
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 description 2
- FXWDXPVECLXGRZ-XIGYXKQDSA-N (2S,3R,4S,5S)-2-[5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromenylium-3-yl]oxyoxane-3,4,5-triol chloride Chemical compound [Cl-].COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O[C@H]2[C@@H]([C@@H](O)[C@@H](O)CO2)O)=C1 FXWDXPVECLXGRZ-XIGYXKQDSA-N 0.000 description 2
- RXCOGDYOZQGGMK-UHFFFAOYSA-N (3,4-diaminophenyl)-phenylmethanone Chemical compound C1=C(N)C(N)=CC=C1C(=O)C1=CC=CC=C1 RXCOGDYOZQGGMK-UHFFFAOYSA-N 0.000 description 2
- MCTQNEBFZMBRSQ-UHFFFAOYSA-N (3-amino-4-phenyldiazenylphenyl)azanium;chloride Chemical compound Cl.NC1=CC(N)=CC=C1N=NC1=CC=CC=C1 MCTQNEBFZMBRSQ-UHFFFAOYSA-N 0.000 description 2
- BWHAMWGGORIDBK-UHFFFAOYSA-N (4-hydrazinylphthalazin-1-yl)hydrazine;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C(NN)=NN=C(NN)C2=C1 BWHAMWGGORIDBK-UHFFFAOYSA-N 0.000 description 2
- LRMDXTVKVHKWEK-UHFFFAOYSA-N 1,2-diaminoanthracene-9,10-dione Chemical compound C1=CC=C2C(=O)C3=C(N)C(N)=CC=C3C(=O)C2=C1 LRMDXTVKVHKWEK-UHFFFAOYSA-N 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- VWBVCOPVKXNMMZ-UHFFFAOYSA-N 1,5-diaminoanthracene-9,10-dione Chemical compound O=C1C2=C(N)C=CC=C2C(=O)C2=C1C=CC=C2N VWBVCOPVKXNMMZ-UHFFFAOYSA-N 0.000 description 2
- BOKGTLAJQHTOKE-UHFFFAOYSA-N 1,5-dihydroxynaphthalene Chemical compound C1=CC=C2C(O)=CC=CC2=C1O BOKGTLAJQHTOKE-UHFFFAOYSA-N 0.000 description 2
- YFOOEYJGMMJJLS-UHFFFAOYSA-N 1,8-diaminonaphthalene Chemical compound C1=CC(N)=C2C(N)=CC=CC2=C1 YFOOEYJGMMJJLS-UHFFFAOYSA-N 0.000 description 2
- PWGJDPKCLMLPJW-UHFFFAOYSA-N 1,8-diaminooctane Chemical compound NCCCCCCCCN PWGJDPKCLMLPJW-UHFFFAOYSA-N 0.000 description 2
- AVWOEAVWVDLXMA-UHFFFAOYSA-N 1-(diaminomethylidene)guanidine;nitric acid Chemical compound O[N+]([O-])=O.NC(N)=NC(N)=N AVWOEAVWVDLXMA-UHFFFAOYSA-N 0.000 description 2
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 2
- ZDZHCHYQNPQSGG-UHFFFAOYSA-N 1-naphthalen-1-ylnaphthalene Chemical group C1=CC=C2C(C=3C4=CC=CC=C4C=CC=3)=CC=CC2=C1 ZDZHCHYQNPQSGG-UHFFFAOYSA-N 0.000 description 2
- XIROXSOOOAZHLL-UHFFFAOYSA-N 2',3',4'-Trihydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C(O)=C1O XIROXSOOOAZHLL-UHFFFAOYSA-N 0.000 description 2
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 2
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 2
- CRPNQSVBEWWHIJ-UHFFFAOYSA-N 2,3,4-trihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C(O)=C1O CRPNQSVBEWWHIJ-UHFFFAOYSA-N 0.000 description 2
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 2
- JVMSQRAXNZPDHF-UHFFFAOYSA-N 2,4-diaminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C(N)=C1 JVMSQRAXNZPDHF-UHFFFAOYSA-N 0.000 description 2
- IUNJCFABHJZSKB-UHFFFAOYSA-N 2,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C(O)=C1 IUNJCFABHJZSKB-UHFFFAOYSA-N 0.000 description 2
- KZTWOUOZKZQDMN-UHFFFAOYSA-N 2,5-diaminotoluene sulfate Chemical compound OS(O)(=O)=O.CC1=CC(N)=CC=C1N KZTWOUOZKZQDMN-UHFFFAOYSA-N 0.000 description 2
- BWAPJIHJXDYDPW-UHFFFAOYSA-N 2,5-dimethyl-p-phenylenediamine Chemical compound CC1=CC(N)=C(C)C=C1N BWAPJIHJXDYDPW-UHFFFAOYSA-N 0.000 description 2
- NXXYKOUNUYWIHA-UHFFFAOYSA-N 2,6-Dimethylphenol Chemical compound CC1=CC=CC(C)=C1O NXXYKOUNUYWIHA-UHFFFAOYSA-N 0.000 description 2
- RLYCRLGLCUXUPO-UHFFFAOYSA-N 2,6-diaminotoluene Chemical compound CC1=C(N)C=CC=C1N RLYCRLGLCUXUPO-UHFFFAOYSA-N 0.000 description 2
- RHTZDFORBKRGQU-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-3,7,8-trihydroxychromen-4-one Chemical compound C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC=C(O)C(O)=C2O1 RHTZDFORBKRGQU-UHFFFAOYSA-N 0.000 description 2
- UBDZFAGVPPMTIT-UHFFFAOYSA-N 2-aminoguanidine;hydron;chloride Chemical compound [Cl-].NC(N)=N[NH3+] UBDZFAGVPPMTIT-UHFFFAOYSA-N 0.000 description 2
- LIDYFNYBHXPTJG-UHFFFAOYSA-N 2-azaniumyl-2-(2-hydroxyphenyl)acetate Chemical compound OC(=O)C(N)C1=CC=CC=C1O LIDYFNYBHXPTJG-UHFFFAOYSA-N 0.000 description 2
- DLGBEGBHXSAQOC-UHFFFAOYSA-N 2-hydroxy-5-methylbenzoic acid Chemical compound CC1=CC=C(O)C(C(O)=O)=C1 DLGBEGBHXSAQOC-UHFFFAOYSA-N 0.000 description 2
- OBCSAIDCZQSFQH-UHFFFAOYSA-N 2-methyl-1,4-phenylenediamine Chemical compound CC1=CC(N)=CC=C1N OBCSAIDCZQSFQH-UHFFFAOYSA-N 0.000 description 2
- UCQUAMAQHHEXGD-UHFFFAOYSA-N 3',4'-dihydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C(O)=C1 UCQUAMAQHHEXGD-UHFFFAOYSA-N 0.000 description 2
- ZAXCZCOUDLENMH-UHFFFAOYSA-N 3,3,3-tetramine Chemical compound NCCCNCCCNCCCN ZAXCZCOUDLENMH-UHFFFAOYSA-N 0.000 description 2
- YELLAPKUWRTITI-UHFFFAOYSA-N 3,5-dihydroxynaphthalene-2-carboxylic acid Chemical compound C1=CC(O)=C2C=C(O)C(C(=O)O)=CC2=C1 YELLAPKUWRTITI-UHFFFAOYSA-N 0.000 description 2
- PJZLSMMERMMQBJ-UHFFFAOYSA-N 3,5-ditert-butylbenzene-1,2-diol Chemical compound CC(C)(C)C1=CC(O)=C(O)C(C(C)(C)C)=C1 PJZLSMMERMMQBJ-UHFFFAOYSA-N 0.000 description 2
- PECYZEOJVXMISF-UHFFFAOYSA-N 3-aminoalanine Chemical compound [NH3+]CC(N)C([O-])=O PECYZEOJVXMISF-UHFFFAOYSA-N 0.000 description 2
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 2
- VNTAONUWHQBAMC-UHFFFAOYSA-N 3-phenothiazin-10-ylpropanoic acid Chemical compound C1=CC=C2N(CCC(=O)O)C3=CC=CC=C3SC2=C1 VNTAONUWHQBAMC-UHFFFAOYSA-N 0.000 description 2
- IBOFVQJTBBUKMU-UHFFFAOYSA-N 4,4'-methylene-bis-(2-chloroaniline) Chemical compound C1=C(Cl)C(N)=CC=C1CC1=CC=C(N)C(Cl)=C1 IBOFVQJTBBUKMU-UHFFFAOYSA-N 0.000 description 2
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 2
- ZWUBBMDHSZDNTA-UHFFFAOYSA-N 4-Chloro-meta-phenylenediamine Chemical compound NC1=CC=C(Cl)C(N)=C1 ZWUBBMDHSZDNTA-UHFFFAOYSA-N 0.000 description 2
- BXIXXXYDDJVHDL-UHFFFAOYSA-N 4-Chloro-ortho-phenylenediamine Chemical compound NC1=CC=C(Cl)C=C1N BXIXXXYDDJVHDL-UHFFFAOYSA-N 0.000 description 2
- KYXFGKLZVUDIIX-YVYUXZJTSA-N 4-[(2R,3R)-3-(3,5-dihydroxyphenyl)-6-hydroxy-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,3-diol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC2=C1[C@@H](C=1C=C(O)C=C(O)C=1)[C@H](C=1C(=CC(O)=CC=1)O)O2 KYXFGKLZVUDIIX-YVYUXZJTSA-N 0.000 description 2
- MZZSUXPEXUEIAK-JTKBGCJKSA-N 4-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[(2r,3r)-4-hydroxy-2-(4-hydroxyphenyl)-6-[(e)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-3-yl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,2-diol Chemical compound C1=CC(O)=CC=C1\C=C\C(C=C1O)=CC2=C1[C@@H](C=1C=C(O)C=3[C@@H]([C@H](OC=3C=1)C=1C=C(O)C(O)=CC=1)C=1C=C(O)C=C(O)C=1)[C@H](C=1C=CC(O)=CC=1)O2 MZZSUXPEXUEIAK-JTKBGCJKSA-N 0.000 description 2
- RRRCKIRSVQAAAS-UHFFFAOYSA-N 4-[3-(3,4-dihydroxyphenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]benzene-1,2-diol Chemical compound C1=C(O)C(O)=CC=C1C1(C=2C=C(O)C(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 RRRCKIRSVQAAAS-UHFFFAOYSA-N 0.000 description 2
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 2
- GWYPJBKNXSRAPX-UHFFFAOYSA-N 4-hydroxy-2-methoxybenzoic acid Chemical compound COC1=CC(O)=CC=C1C(O)=O GWYPJBKNXSRAPX-UHFFFAOYSA-N 0.000 description 2
- YHXHKYRQLYQUIH-UHFFFAOYSA-N 4-hydroxymandelic acid Chemical compound OC(=O)C(O)C1=CC=C(O)C=C1 YHXHKYRQLYQUIH-UHFFFAOYSA-N 0.000 description 2
- XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1 XQXPVVBIMDBYFF-UHFFFAOYSA-N 0.000 description 2
- XJNPNXSISMKQEX-UHFFFAOYSA-N 4-nitrocatechol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1O XJNPNXSISMKQEX-UHFFFAOYSA-N 0.000 description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 2
- XESZUVZBAMCAEJ-UHFFFAOYSA-N 4-tert-butylcatechol Chemical compound CC(C)(C)C1=CC=C(O)C(O)=C1 XESZUVZBAMCAEJ-UHFFFAOYSA-N 0.000 description 2
- QYSWOQHLIDKEOL-UHFFFAOYSA-N 5,6-diamino-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound NC=1NC(=S)NC(=O)C=1N QYSWOQHLIDKEOL-UHFFFAOYSA-N 0.000 description 2
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 description 2
- MLACDGUOKDOLGC-UHFFFAOYSA-N 5-(2-aminoethyl)benzene-1,2,4-triol;hydron;bromide Chemical compound Br.NCCC1=CC(O)=C(O)C=C1O MLACDGUOKDOLGC-UHFFFAOYSA-N 0.000 description 2
- QLMRJHFAGVFUAC-UHFFFAOYSA-N 5-(2-aminoethyl)benzene-1,2,4-triol;hydron;chloride Chemical compound Cl.NCCC1=CC(O)=C(O)C=C1O QLMRJHFAGVFUAC-UHFFFAOYSA-N 0.000 description 2
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 2
- LLXQONIKJLTKCF-UHFFFAOYSA-N 7,3',4'-trihydroxy-3,8-dimethoxyflavone Chemical compound COC1=C(O)C=CC(C(C=2OC)=O)=C1OC=2C1=CC=C(O)C(O)=C1 LLXQONIKJLTKCF-UHFFFAOYSA-N 0.000 description 2
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 2
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 2
- 101710134784 Agnoprotein Proteins 0.000 description 2
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 2
- 108010025188 Alcohol oxidase Proteins 0.000 description 2
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 2
- 241000208223 Anacardiaceae Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LZJRNLRASBVRRX-ZDUSSCGKSA-N Boldine Chemical compound CN1CCC2=CC(O)=C(OC)C3=C2[C@@H]1CC1=C3C=C(OC)C(O)=C1 LZJRNLRASBVRRX-ZDUSSCGKSA-N 0.000 description 2
- 241000123650 Botrytis cinerea Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- MOJZMWJRUKIQGL-WNCKYJNFSA-N Catechin-(4alpha->8)-gallocatechin-(4alpha->8)-catechin Chemical compound C1([C@@H]2[C@@H](O)[C@@H](C3=C(O)C=C(O)C=C3O2)C2=C3O[C@@H]([C@@H](O)[C@@H](C3=C(O)C=C2O)C=2C(O)=CC(O)=C3C[C@@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)C=2C=C(O)C(O)=CC=2)=CC=C(O)C(O)=C1 MOJZMWJRUKIQGL-WNCKYJNFSA-N 0.000 description 2
- UXAFRQPVHYZDED-ZZEDUEFDSA-N Colchicoside Chemical compound C1([C@@H](NC(C)=O)CCC2=C3)=CC(=O)C(OC)=CC=C1C2=C(OC)C(OC)=C3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UXAFRQPVHYZDED-ZZEDUEFDSA-N 0.000 description 2
- UXAFRQPVHYZDED-UHFFFAOYSA-N Colchicoside Natural products C1=C2CCC(NC(C)=O)C3=CC(=O)C(OC)=CC=C3C2=C(OC)C(OC)=C1OC1OC(CO)C(O)C(O)C1O UXAFRQPVHYZDED-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 2
- SYGUVOLSUJYPPS-UHFFFAOYSA-N Demethoxysudachitin Chemical compound C=1C(=O)C2=C(O)C(OC)=C(O)C(OC)=C2OC=1C1=CC=C(O)C=C1 SYGUVOLSUJYPPS-UHFFFAOYSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- VKOUCJUTMGHNOR-UHFFFAOYSA-N Diphenolic acid Chemical compound C=1C=C(O)C=CC=1C(CCC(O)=O)(C)C1=CC=C(O)C=C1 VKOUCJUTMGHNOR-UHFFFAOYSA-N 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- FCYKAQOGGFGCMD-UHFFFAOYSA-N Fulvic acid Natural products O1C2=CC(O)=C(O)C(C(O)=O)=C2C(=O)C2=C1CC(C)(O)OC2 FCYKAQOGGFGCMD-UHFFFAOYSA-N 0.000 description 2
- 108010015133 Galactose oxidase Proteins 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- PNMUAGGSDZXTHX-BYPYZUCNSA-N Gly-Gln Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(N)=O PNMUAGGSDZXTHX-BYPYZUCNSA-N 0.000 description 2
- PZHNKNRPGLTZPO-VZRGJMDUSA-N Grifolin Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC1=C(O)C=C(C)C=C1O PZHNKNRPGLTZPO-VZRGJMDUSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- SNKFFCBZYFGCQN-VWUOOIFGSA-N Lithospermic acid B Natural products C([C@H](C(=O)O)OC(=O)\C=C\C=1C=2[C@H](C(=O)O[C@H](CC=3C=C(O)C(O)=CC=3)C(O)=O)[C@H](OC=2C(O)=CC=1)C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 SNKFFCBZYFGCQN-VWUOOIFGSA-N 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 description 2
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 108700020962 Peroxidase Proteins 0.000 description 2
- 244000025272 Persea americana Species 0.000 description 2
- 235000008673 Persea americana Nutrition 0.000 description 2
- FFFPYJTVNSSLBQ-UHFFFAOYSA-N Phenolphthalin Chemical compound OC(=O)C1=CC=CC=C1C(C=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 FFFPYJTVNSSLBQ-UHFFFAOYSA-N 0.000 description 2
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000995749 Polyporus brumalis Species 0.000 description 2
- NSEWTSAADLNHNH-TXZJYACMSA-N Proanthocyanidin A1 Chemical compound C1([C@H]2OC3=C4[C@H]5C6=C(O)C=C(O)C=C6O[C@]([C@@H]5O)(OC4=CC(O)=C3C[C@@H]2O)C=2C=C(O)C(O)=CC=2)=CC=C(O)C(O)=C1 NSEWTSAADLNHNH-TXZJYACMSA-N 0.000 description 2
- 229920002350 Procyanidin B2 Polymers 0.000 description 2
- XFZJEEAOWLFHDH-HNTGQZGLSA-N Procyanidin B3 Natural products C1([C@@H]2[C@@H](O)[C@@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=CC(O)=C3C[C@@H]([C@@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-HNTGQZGLSA-N 0.000 description 2
- 229920000236 Procyanidin B3 Polymers 0.000 description 2
- XFZJEEAOWLFHDH-RBYKNZBFSA-N Procyanidin B4 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@@H]1c1c(O)cc(O)c3c1O[C@H]([C@@H](O)C3)c1cc(O)c(O)cc1)c(O)cc(O)c2 XFZJEEAOWLFHDH-RBYKNZBFSA-N 0.000 description 2
- 229920001505 Procyanidin B4 Polymers 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- QJTYCCFDQWFJHU-UHFFFAOYSA-N Quercetin-5-O-beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC2=C1C(=O)C(O)=C(C=1C=C(O)C(O)=CC=1)O2 QJTYCCFDQWFJHU-UHFFFAOYSA-N 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 229920001800 Shellac Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 description 2
- 241000222355 Trametes versicolor Species 0.000 description 2
- FNYLWPVRPXGIIP-UHFFFAOYSA-N Triamterene Chemical compound NC1=NC2=NC(N)=NC(N)=C2N=C1C1=CC=CC=C1 FNYLWPVRPXGIIP-UHFFFAOYSA-N 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 description 2
- 241000863486 Vinca minor Species 0.000 description 2
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- GNRIZKKCNOBBMO-UHFFFAOYSA-N alpha-mangostin Chemical compound OC1=C(CC=C(C)C)C(O)=C2C(=O)C3=C(CC=C(C)C)C(OC)=C(O)C=C3OC2=C1 GNRIZKKCNOBBMO-UHFFFAOYSA-N 0.000 description 2
- YUSWMAULDXZHPY-UHFFFAOYSA-N amentoflavone Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 YUSWMAULDXZHPY-UHFFFAOYSA-N 0.000 description 2
- ACHKKGDWZVCSNH-UHFFFAOYSA-N amiloride hydrochloride Chemical compound Cl.NC(N)=NC(=O)C1=NC(Cl)=C(N)N=C1N ACHKKGDWZVCSNH-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- QZBYOYPROVGOGE-UHFFFAOYSA-N aminopropylcadaverine Chemical compound NCCCCCNCCCN QZBYOYPROVGOGE-UHFFFAOYSA-N 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000010775 animal oil Substances 0.000 description 2
- AHKDJQYHVWSRLT-UHFFFAOYSA-N anthragallol Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=C(O)C(O)=C2O AHKDJQYHVWSRLT-UHFFFAOYSA-N 0.000 description 2
- NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- ZROGCCBNZBKLEL-MPRHSVQHSA-N astilbin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1C(=O)C2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1 ZROGCCBNZBKLEL-MPRHSVQHSA-N 0.000 description 2
- 238000010560 atom transfer radical polymerization reaction Methods 0.000 description 2
- OHDRQQURAXLVGJ-AXMZSLBLSA-N azane;(2z)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-AXMZSLBLSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 229940092738 beeswax Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- YXVFYQXJAXKLAK-UHFFFAOYSA-N biphenyl-4-ol Chemical compound C1=CC(O)=CC=C1C1=CC=CC=C1 YXVFYQXJAXKLAK-UHFFFAOYSA-N 0.000 description 2
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 2
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- QGNBTYAQAPLTMX-UHFFFAOYSA-L calcium dobesilate Chemical compound [Ca+2].OC1=CC=C(O)C(S([O-])(=O)=O)=C1.OC1=CC=C(O)C(S([O-])(=O)=O)=C1 QGNBTYAQAPLTMX-UHFFFAOYSA-L 0.000 description 2
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 description 2
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 description 2
- KVVSCMOUFCNCGX-UHFFFAOYSA-N cardol Chemical compound CCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 KVVSCMOUFCNCGX-UHFFFAOYSA-N 0.000 description 2
- NPLTVGMLNDMOQE-UHFFFAOYSA-N carthamidin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=C(O)C(O)=C2C(=O)C1 NPLTVGMLNDMOQE-UHFFFAOYSA-N 0.000 description 2
- SHNIKUXMZFPPCS-UHFFFAOYSA-N chembl1433124 Chemical compound OC1=CC(O)=CC=C1N=NC1=NC=CS1 SHNIKUXMZFPPCS-UHFFFAOYSA-N 0.000 description 2
- BPHHNXJPFPEJOF-UHFFFAOYSA-J chembl296966 Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]S(=O)(=O)C1=CC(S([O-])(=O)=O)=C(N)C2=C(O)C(N=NC3=CC=C(C=C3OC)C=3C=C(C(=CC=3)N=NC=3C(=C4C(N)=C(C=C(C4=CC=3)S([O-])(=O)=O)S([O-])(=O)=O)O)OC)=CC=C21 BPHHNXJPFPEJOF-UHFFFAOYSA-J 0.000 description 2
- IHJCXVZDYSXXFT-UHFFFAOYSA-N chloraminophenamide Chemical compound NC1=CC(Cl)=C(S(N)(=O)=O)C=C1S(N)(=O)=O IHJCXVZDYSXXFT-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- KMOUJOKENFFTPU-UHFFFAOYSA-N cosmosiin Chemical compound OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=CC(O)=CC=3)OC2=C1 KMOUJOKENFFTPU-UHFFFAOYSA-N 0.000 description 2
- 235000007240 daidzein Nutrition 0.000 description 2
- YQLZOAVZWJBZSY-UHFFFAOYSA-N decane-1,10-diamine Chemical compound NCCCCCCCCCCN YQLZOAVZWJBZSY-UHFFFAOYSA-N 0.000 description 2
- 239000000385 dialysis solution Substances 0.000 description 2
- 229960000452 diethylstilbestrol Drugs 0.000 description 2
- HUPFGZXOMWLGNK-UHFFFAOYSA-N diflunisal Chemical compound C1=C(O)C(C(=O)O)=CC(C=2C(=CC(F)=CC=2)F)=C1 HUPFGZXOMWLGNK-UHFFFAOYSA-N 0.000 description 2
- KQILIWXGGKGKNX-UHFFFAOYSA-N dihydromyricetin Natural products OC1C(=C(Oc2cc(O)cc(O)c12)c3cc(O)c(O)c(O)c3)O KQILIWXGGKGKNX-UHFFFAOYSA-N 0.000 description 2
- XCGZWJIXHMSSQC-UHFFFAOYSA-N dihydroquercetin Natural products OC1=CC2OC(=C(O)C(=O)C2C(O)=C1)c1ccc(O)c(O)c1 XCGZWJIXHMSSQC-UHFFFAOYSA-N 0.000 description 2
- 229960004352 diosmin Drugs 0.000 description 2
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- VTEBSADXXKSKOE-UHFFFAOYSA-L disodium;4-[[2,4-diamino-5-[[3-[[2,4-diamino-5-[(4-sulfonatophenyl)diazenyl]phenyl]diazenyl]phenyl]diazenyl]phenyl]diazenyl]benzenesulfonate Chemical compound [Na+].[Na+].NC1=CC(N)=C(N=NC=2C=C(C=CC=2)N=NC=2C(=CC(N)=C(N=NC=3C=CC(=CC=3)S([O-])(=O)=O)C=2)N)C=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 VTEBSADXXKSKOE-UHFFFAOYSA-L 0.000 description 2
- 229960002311 dithranol Drugs 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 2
- ADFCQWZHKCXPAJ-GFCCVEGCSA-N equol Chemical compound C1=CC(O)=CC=C1[C@@H]1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-GFCCVEGCSA-N 0.000 description 2
- SBHXYTNGIZCORC-ZDUSSCGKSA-N eriodictyol Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-ZDUSSCGKSA-N 0.000 description 2
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 2
- 229940011399 escin Drugs 0.000 description 2
- 229930186222 escin Natural products 0.000 description 2
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 2
- NHWGPUVJQFTOQX-UHFFFAOYSA-N ethyl-[2-[2-[ethyl(dimethyl)azaniumyl]ethyl-methylamino]ethyl]-dimethylazanium Chemical compound CC[N+](C)(C)CCN(C)CC[N+](C)(C)CC NHWGPUVJQFTOQX-UHFFFAOYSA-N 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 2
- 229960001596 famotidine Drugs 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- PHLYOKFVXIVOJC-UHFFFAOYSA-N gallein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C(O)=C1OC1=C(O)C(O)=CC=C21 PHLYOKFVXIVOJC-UHFFFAOYSA-N 0.000 description 2
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 2
- 229940045109 genistein Drugs 0.000 description 2
- 235000006539 genistein Nutrition 0.000 description 2
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 2
- JPMYFOBNRRGFNO-UHFFFAOYSA-N genkwanin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 JPMYFOBNRRGFNO-UHFFFAOYSA-N 0.000 description 2
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 description 2
- LBQIJVLKGVZRIW-ZDUSSCGKSA-N glabridin Chemical compound C1([C@H]2CC3=CC=C4OC(C=CC4=C3OC2)(C)C)=CC=C(O)C=C1O LBQIJVLKGVZRIW-ZDUSSCGKSA-N 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 125000003147 glycosyl group Chemical group 0.000 description 2
- PKWIYNIDEDLDCJ-UHFFFAOYSA-N guanazole Chemical compound NC1=NNC(N)=N1 PKWIYNIDEDLDCJ-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- PWSKHLMYTZNYKO-UHFFFAOYSA-N heptane-1,7-diamine Chemical compound NCCCCCCCN PWSKHLMYTZNYKO-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 2
- QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 2
- FVYXIJYOAGAUQK-UHFFFAOYSA-N honokiol Chemical compound C1=C(CC=C)C(O)=CC=C1C1=CC(CC=C)=CC=C1O FVYXIJYOAGAUQK-UHFFFAOYSA-N 0.000 description 2
- 239000004021 humic acid Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 2
- HUOOMAOYXQFIDQ-UHFFFAOYSA-N isoginkgetin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)OC)=C2O1 HUOOMAOYXQFIDQ-UHFFFAOYSA-N 0.000 description 2
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- UHNXUSWGOJMEFO-QNDFHXLGSA-N luteolin-4'-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)C=C1O UHNXUSWGOJMEFO-QNDFHXLGSA-N 0.000 description 2
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 description 2
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 2
- 239000008204 material by function Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 238000001465 metallisation Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000002052 molecular layer Substances 0.000 description 2
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 2
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 2
- LSHROXHEILXKHM-UHFFFAOYSA-N n'-[2-[2-[2-(2-aminoethylamino)ethylamino]ethylamino]ethyl]ethane-1,2-diamine Chemical compound NCCNCCNCCNCCNCCN LSHROXHEILXKHM-UHFFFAOYSA-N 0.000 description 2
- 239000002120 nanofilm Substances 0.000 description 2
- NXPPAOGUKPJVDI-UHFFFAOYSA-N naphthalene-1,2-diol Chemical compound C1=CC=CC2=C(O)C(O)=CC=C21 NXPPAOGUKPJVDI-UHFFFAOYSA-N 0.000 description 2
- PCILLCXFKWDRMK-UHFFFAOYSA-N naphthalene-1,4-diol Chemical compound C1=CC=C2C(O)=CC=C(O)C2=C1 PCILLCXFKWDRMK-UHFFFAOYSA-N 0.000 description 2
- ZUVBIBLYOCVYJU-UHFFFAOYSA-N naphthalene-1,7-diol Chemical compound C1=CC=C(O)C2=CC(O)=CC=C21 ZUVBIBLYOCVYJU-UHFFFAOYSA-N 0.000 description 2
- JRNGUTKWMSBIBF-UHFFFAOYSA-N naphthalene-2,3-diol Chemical compound C1=CC=C2C=C(O)C(O)=CC2=C1 JRNGUTKWMSBIBF-UHFFFAOYSA-N 0.000 description 2
- HQHBAGKIEAOSNM-UHFFFAOYSA-N naphtholphthalein Chemical compound C1=CC=C2C(C3(C4=CC=CC=C4C(=O)O3)C3=CC=C(C4=CC=CC=C43)O)=CC=C(O)C2=C1 HQHBAGKIEAOSNM-UHFFFAOYSA-N 0.000 description 2
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 2
- 235000007625 naringenin Nutrition 0.000 description 2
- 229940117954 naringenin Drugs 0.000 description 2
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 2
- 229930019673 naringin Natural products 0.000 description 2
- 229940052490 naringin Drugs 0.000 description 2
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- OIXVKQDWLFHVGR-WQDIDPJDSA-N neomycin B sulfate Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO OIXVKQDWLFHVGR-WQDIDPJDSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- KRFBMPVGAYGGJE-UHFFFAOYSA-N nevadensin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C(OC)=C(O)C(OC)=C2O1 KRFBMPVGAYGGJE-UHFFFAOYSA-N 0.000 description 2
- VKCYHJWLYTUGCC-UHFFFAOYSA-N nonan-2-one Chemical compound CCCCCCCC(C)=O VKCYHJWLYTUGCC-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229920000620 organic polymer Polymers 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- YNVJOQCPHWKWSO-ZBVBGGFBSA-N pallidol Chemical compound C1=CC(O)=CC=C1[C@@H]1C2=C(O)C=C(O)C=C2[C@@H]2[C@H]1C(C=C(O)C=C1O)=C1[C@H]2C1=CC=C(O)C=C1 YNVJOQCPHWKWSO-ZBVBGGFBSA-N 0.000 description 2
- JHXPPGKKFCNRED-UHFFFAOYSA-N pallidol Natural products Oc1ccc(cc1)C1C2C(C(c3c2cc(O)cc3O)c2ccc(O)cc2)c2c1cc(O)cc2O JHXPPGKKFCNRED-UHFFFAOYSA-N 0.000 description 2
- WOTPFVNWMLFMFW-ISLYRVAYSA-N para red Chemical compound OC1=CC=C2C=CC=CC2=C1\N=N\C1=CC=C(N(=O)=O)C=C1 WOTPFVNWMLFMFW-ISLYRVAYSA-N 0.000 description 2
- 229940056211 paraffin Drugs 0.000 description 2
- NSEWTSAADLNHNH-UHFFFAOYSA-N pavetannin A-2 Natural products OC1CC2=C(O)C=C3OC(C4O)(C=5C=C(O)C(O)=CC=5)OC5=CC(O)=CC(O)=C5C4C3=C2OC1C1=CC=C(O)C(O)=C1 NSEWTSAADLNHNH-UHFFFAOYSA-N 0.000 description 2
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 2
- YCOZIPAWZNQLMR-UHFFFAOYSA-N pentadecane Chemical compound CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 2
- IOUVKUPGCMBWBT-QNDFHXLGSA-N phlorizin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-QNDFHXLGSA-N 0.000 description 2
- CDRPUGZCRXZLFL-OWOJBTEDSA-N piceatannol Chemical compound OC1=CC(O)=CC(\C=C\C=2C=C(O)C(O)=CC=2)=C1 CDRPUGZCRXZLFL-OWOJBTEDSA-N 0.000 description 2
- 125000005936 piperidyl group Chemical group 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- NSEWTSAADLNHNH-LSBOWGMISA-N proanthocyanidin A2 Chemical compound C1([C@H]2OC3=C4[C@H]5C6=C(O)C=C(O)C=C6O[C@]([C@@H]5O)(OC4=CC(O)=C3C[C@H]2O)C=2C=C(O)C(O)=CC=2)=CC=C(O)C(O)=C1 NSEWTSAADLNHNH-LSBOWGMISA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- XFZJEEAOWLFHDH-VUGKQVTMSA-N procyanidin B4 Chemical compound C1([C@@H]2[C@@H](O)[C@@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=CC(O)=C3C[C@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-VUGKQVTMSA-N 0.000 description 2
- GMISZFQPFDAPGI-CVJZBMGUSA-N procyanidin B5 Chemical compound C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=C3C[C@H]([C@H](OC3=CC=2O)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 GMISZFQPFDAPGI-CVJZBMGUSA-N 0.000 description 2
- GMISZFQPFDAPGI-ZBRHZRBFSA-N procyanidin B6 Chemical compound C1([C@@H]2[C@@H](O)[C@@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=C3C[C@@H]([C@H](OC3=CC=2O)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 GMISZFQPFDAPGI-ZBRHZRBFSA-N 0.000 description 2
- GMISZFQPFDAPGI-JJYFIROESA-N procyanidin B8 Chemical compound C1([C@@H]2[C@@H](O)[C@@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=C3C[C@H]([C@H](OC3=CC=2O)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 GMISZFQPFDAPGI-JJYFIROESA-N 0.000 description 2
- MOJZMWJRUKIQGL-XILRTYJMSA-N procyanidin C1 Chemical compound C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C2=C3O[C@@H]([C@H](O)[C@H](C3=C(O)C=C2O)C=2C(O)=CC(O)=C3C[C@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)C=2C=C(O)C(O)=CC=2)=CC=C(O)C(O)=C1 MOJZMWJRUKIQGL-XILRTYJMSA-N 0.000 description 2
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- ZZYXNRREDYWPLN-UHFFFAOYSA-N pyridine-2,3-diamine Chemical compound NC1=CC=CN=C1N ZZYXNRREDYWPLN-UHFFFAOYSA-N 0.000 description 2
- WKSAUQYGYAYLPV-UHFFFAOYSA-N pyrimethamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1 WKSAUQYGYAYLPV-UHFFFAOYSA-N 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 2
- GUEIZVNYDFNHJU-UHFFFAOYSA-N quinizarin Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(O)=CC=C2O GUEIZVNYDFNHJU-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 238000012712 reversible addition−fragmentation chain-transfer polymerization Methods 0.000 description 2
- WDZCUPBHRAEYDL-GZAUEHORSA-N rifapentine Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N(CC1)CCN1C1CCCC1 WDZCUPBHRAEYDL-GZAUEHORSA-N 0.000 description 2
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 description 2
- SOEDEYVDCDYMMH-UHFFFAOYSA-N robinetin Chemical compound C=1C(O)=CC=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 SOEDEYVDCDYMMH-UHFFFAOYSA-N 0.000 description 2
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 238000005185 salting out Methods 0.000 description 2
- 229930190376 scutellarin Natural products 0.000 description 2
- 239000013545 self-assembled monolayer Substances 0.000 description 2
- 239000004208 shellac Substances 0.000 description 2
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 2
- 235000013874 shellac Nutrition 0.000 description 2
- 229940113147 shellac Drugs 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 2
- HIWPGCMGAMJNRG-RTPHMHGBSA-N sophorose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-RTPHMHGBSA-N 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000012177 spermaceti Substances 0.000 description 2
- 229940084106 spermaceti Drugs 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- RSKNEEODWFLVFF-UHFFFAOYSA-N sulfuric acid;2,5,6-triamino-1h-pyrimidin-4-one Chemical compound OS(O)(=O)=O.NC1=NC(=O)C(N)=C(N)N1 RSKNEEODWFLVFF-UHFFFAOYSA-N 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- KCDXJAYRVLXPFO-UHFFFAOYSA-N syringaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1O KCDXJAYRVLXPFO-UHFFFAOYSA-N 0.000 description 2
- COBXDAOIDYGHGK-UHFFFAOYSA-N syringaldehyde Natural products COC1=CC=C(C=O)C(OC)=C1O COBXDAOIDYGHGK-UHFFFAOYSA-N 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical compound NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 2
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- PRZSXZWFJHEZBJ-UHFFFAOYSA-N thymol blue Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=CC(O)=C(C(C)C)C=2)C)=C1C PRZSXZWFJHEZBJ-UHFFFAOYSA-N 0.000 description 2
- PSWFFKRAVBDQEG-YGQNSOCVSA-N thymopentin Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PSWFFKRAVBDQEG-YGQNSOCVSA-N 0.000 description 2
- YCVPRTHEGLPYPB-VOTSOKGWSA-N trans-pinosylvin Chemical compound OC1=CC(O)=CC(\C=C\C=2C=CC=CC=2)=C1 YCVPRTHEGLPYPB-VOTSOKGWSA-N 0.000 description 2
- IIYFAKIEWZDVMP-UHFFFAOYSA-N tridecane Chemical compound CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 2
- 229960001082 trimethoprim Drugs 0.000 description 2
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 2
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000007762 w/o emulsion Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- ORXQGKIUCDPEAJ-YRNVUSSQSA-N xanthohumol Chemical compound COC1=CC(O)=C(CC=C(C)C)C(O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 ORXQGKIUCDPEAJ-YRNVUSSQSA-N 0.000 description 2
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 1
- 229930013915 (+)-catechin Natural products 0.000 description 1
- 235000007219 (+)-catechin Nutrition 0.000 description 1
- WMBWREPUVVBILR-GHTZIAJQSA-N (+)-gallocatechin gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-GHTZIAJQSA-N 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- ITYNGVSTWVVPIC-DHGKCCLASA-N (-)-allo-Aromadendrene Chemical compound C([C@@H]1[C@H]2C1(C)C)CC(=C)[C@@H]1[C@H]2[C@H](C)CC1 ITYNGVSTWVVPIC-DHGKCCLASA-N 0.000 description 1
- 229930014124 (-)-epigallocatechin gallate Natural products 0.000 description 1
- 235000004911 (-)-epigallocatechin gallate Nutrition 0.000 description 1
- BWRBVBFLFQKBPT-UHFFFAOYSA-N (2-nitrophenyl)methanol Chemical compound OCC1=CC=CC=C1[N+]([O-])=O BWRBVBFLFQKBPT-UHFFFAOYSA-N 0.000 description 1
- LILPTCHQLRKZNG-CKKRXTSSSA-N (2R,3R)-trans-delta-viniferin Chemical compound C1=CC(O)=CC=C1[C@H]1[C@H](C=2C=C(O)C=C(O)C=2)C2=CC(\C=C\C=3C=C(O)C=C(O)C=3)=CC=C2O1 LILPTCHQLRKZNG-CKKRXTSSSA-N 0.000 description 1
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 1
- UEFYRKLFGLQPGD-OOJXKGFFSA-N (2r,3s,4r,5r)-2-acetyl-2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(=O)[C@](O)(C=O)[C@@H](O)[C@H](O)[C@H](O)CO UEFYRKLFGLQPGD-OOJXKGFFSA-N 0.000 description 1
- YKFCISHFRZHKHY-NGQGLHOPSA-N (2s)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid;trihydrate Chemical compound O.O.O.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 YKFCISHFRZHKHY-NGQGLHOPSA-N 0.000 description 1
- VIYKYVYAKVNDPS-HKGPVOKGSA-N (2s)-2-azanyl-3-[3,4-bis(oxidanyl)phenyl]propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 VIYKYVYAKVNDPS-HKGPVOKGSA-N 0.000 description 1
- DDXRHRXGIWOVDQ-MGAUJLSLSA-L (2s)-3-amino-n-[(1r,2s,3s,4r,5s)-5-amino-4-[(2r,3r,4s,5s,6r)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-2-[(2r,3r,4r,5r)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxypropanamide;sulfate Chemical compound [O-]S([O-])(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@H]1[C@H](NC(=O)[C@@H](O)CN)C[C@H](N)[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)O)[C@@H]1O DDXRHRXGIWOVDQ-MGAUJLSLSA-L 0.000 description 1
- OEGPRYNGFWGMMV-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methanol Chemical compound COC1=CC=C(CO)C=C1OC OEGPRYNGFWGMMV-UHFFFAOYSA-N 0.000 description 1
- LQQIVYSCPWCSSD-QHCPKHFHSA-N (3r)-3-(1-benzylpiperidin-4-yl)-3-phenylpiperidine-2,6-dione Chemical compound O=C1NC(=O)CC[C@]1(C=1C=CC=CC=1)C1CCN(CC=2C=CC=CC=2)CC1 LQQIVYSCPWCSSD-QHCPKHFHSA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 1
- SKYZYDSNJIOXRL-BTQNPOSSSA-N (6ar)-6-methyl-5,6,6a,7-tetrahydro-4h-dibenzo[de,g]quinoline-10,11-diol;hydrochloride Chemical compound Cl.C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 SKYZYDSNJIOXRL-BTQNPOSSSA-N 0.000 description 1
- MWWSFMDVAYGXBV-FGBSZODSSA-N (7s,9s)-7-[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydron;chloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-FGBSZODSSA-N 0.000 description 1
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 description 1
- HUXWBFFRUHXOBU-CPRQJHDUSA-N (E,5R,6S,7R,8R)-1-(3,4-dihydroxyphenyl)-5,6,7,8,9-pentahydroxynon-1-ene-3,4-dione Chemical compound C(\C=C\C1=CC(O)=C(O)C=C1)(=O)C(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO HUXWBFFRUHXOBU-CPRQJHDUSA-N 0.000 description 1
- ULPMRIXXHGUZFA-UHFFFAOYSA-N (R)-4-Methyl-3-hexanone Natural products CCC(C)C(=O)CC ULPMRIXXHGUZFA-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- YXHVCZZLWZYHSA-UHFFFAOYSA-N (Z)-6-[8-pentadecenyl]salicylic acid Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-UHFFFAOYSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- UBYFOQCYKRXTMK-UHFFFAOYSA-N 1,1-diphenylethane-1,2-diol Chemical compound C=1C=CC=CC=1C(O)(CO)C1=CC=CC=C1 UBYFOQCYKRXTMK-UHFFFAOYSA-N 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 1
- FRASJONUBLZVQX-UHFFFAOYSA-N 1,4-dioxonaphthalene Natural products C1=CC=C2C(=O)C=CC(=O)C2=C1 FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 description 1
- DGQXIDAJSBKRMJ-UHFFFAOYSA-N 1-(10-methyl-2-phenothiazinyl)ethanone Chemical compound C1=C(C(C)=O)C=C2N(C)C3=CC=CC=C3SC2=C1 DGQXIDAJSBKRMJ-UHFFFAOYSA-N 0.000 description 1
- TZDMVWHGWNZKCQ-UHFFFAOYSA-N 1-(2,8-dihydroxy-10H-phenazin-5-yl)ethanone Chemical compound CC(=O)N1C2=CC=C(O)C=C2NC2=CC(O)=CC=C12 TZDMVWHGWNZKCQ-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- TYLXQNXNZJNXSM-UHFFFAOYSA-N 1-[3-(4-methylpiperazin-1-yl)propyl]-10h-phenothiazine Chemical compound C1CN(C)CCN1CCCC1=CC=CC2=C1NC1=CC=CC=C1S2 TYLXQNXNZJNXSM-UHFFFAOYSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- OGSOWLVSXPXECI-UHFFFAOYSA-N 1-hydroxypyrrolidine-2,5-dione;3-phenothiazin-10-ylpropanoic acid Chemical compound ON1C(=O)CCC1=O.C1=CC=C2N(CCC(=O)O)C3=CC=CC=C3SC2=C1 OGSOWLVSXPXECI-UHFFFAOYSA-N 0.000 description 1
- IQZBMUCMEBSKSS-UHFFFAOYSA-N 10-ethylphenothiazine Chemical compound C1=CC=C2N(CC)C3=CC=CC=C3SC2=C1 IQZBMUCMEBSKSS-UHFFFAOYSA-N 0.000 description 1
- BETLSGXAHKBRAR-UHFFFAOYSA-N 10-ethylphenothiazine-4-carboxylic acid Chemical compound C1=CC=C(C(O)=O)C2=C1N(CC)C1=CC=CC=C1S2 BETLSGXAHKBRAR-UHFFFAOYSA-N 0.000 description 1
- QXBUYALKJGBACG-UHFFFAOYSA-N 10-methylphenothiazine Chemical compound C1=CC=C2N(C)C3=CC=CC=C3SC2=C1 QXBUYALKJGBACG-UHFFFAOYSA-N 0.000 description 1
- ICFDTWPLDBJRBV-UHFFFAOYSA-N 10-methylphenoxazine Chemical compound C1=CC=C2N(C)C3=CC=CC=C3OC2=C1 ICFDTWPLDBJRBV-UHFFFAOYSA-N 0.000 description 1
- GFVSLJXVNAYUJE-UHFFFAOYSA-N 10-prop-2-enylphenothiazine Chemical compound C1=CC=C2N(CC=C)C3=CC=CC=C3SC2=C1 GFVSLJXVNAYUJE-UHFFFAOYSA-N 0.000 description 1
- OWAUKFUWHPAXQH-UHFFFAOYSA-N 10-propan-2-ylphenothiazine Chemical compound C1=CC=C2N(C(C)C)C3=CC=CC=C3SC2=C1 OWAUKFUWHPAXQH-UHFFFAOYSA-N 0.000 description 1
- LNXZDZDPYBPHAM-UHFFFAOYSA-N 10-propylphenothiazine Chemical compound C1=CC=C2N(CCC)C3=CC=CC=C3SC2=C1 LNXZDZDPYBPHAM-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- OFAPSLLQSSHRSQ-UHFFFAOYSA-N 1H-triazine-2,4-diamine Chemical compound NN1NC=CC(N)=N1 OFAPSLLQSSHRSQ-UHFFFAOYSA-N 0.000 description 1
- HHYBCLNAPQRAAN-UHFFFAOYSA-N 2,2-dichloro-5,5-dimethylcyclohexane-1,3-dione Chemical compound CC1(C)CC(=O)C(Cl)(Cl)C(=O)C1 HHYBCLNAPQRAAN-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- FODBVCSYJKNBLO-UHFFFAOYSA-N 2,3-dimethoxybenzoic acid Chemical compound COC1=CC=CC(C(O)=O)=C1OC FODBVCSYJKNBLO-UHFFFAOYSA-N 0.000 description 1
- JTTIOYHBNXDJOD-UHFFFAOYSA-N 2,4,6-triaminopyrimidine Chemical compound NC1=CC(N)=NC(N)=N1 JTTIOYHBNXDJOD-UHFFFAOYSA-N 0.000 description 1
- BPRYUXCVCCNUFE-UHFFFAOYSA-N 2,4,6-trimethylphenol Chemical compound CC1=CC(C)=C(O)C(C)=C1 BPRYUXCVCCNUFE-UHFFFAOYSA-N 0.000 description 1
- SWELIMKTDYHAOY-UHFFFAOYSA-N 2,4-diamino-6-hydroxypyrimidine Chemical compound NC1=CC(=O)N=C(N)N1 SWELIMKTDYHAOY-UHFFFAOYSA-N 0.000 description 1
- CKAAWCHIBBNLOJ-UHFFFAOYSA-N 2,4-diaminobutanoic acid;hydron;dichloride Chemical compound Cl.Cl.NCCC(N)C(O)=O CKAAWCHIBBNLOJ-UHFFFAOYSA-N 0.000 description 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- MJAVQHPPPBDYAN-UHFFFAOYSA-N 2,6-dimethylbenzene-1,4-diamine Chemical compound CC1=CC(N)=CC(C)=C1N MJAVQHPPPBDYAN-UHFFFAOYSA-N 0.000 description 1
- VNXWANZMRATDQM-UHFFFAOYSA-N 2-(2-phenylethyl)benzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1CCC1=CC=CC=C1 VNXWANZMRATDQM-UHFFFAOYSA-N 0.000 description 1
- GHUPMTRNFXDXOB-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-8-methoxychromen-4-one Chemical compound COC1=C(O)C=CC(C(C=2O)=O)=C1OC=2C1=CC=C(O)C(O)=C1 GHUPMTRNFXDXOB-UHFFFAOYSA-N 0.000 description 1
- YWNSGSNRKLNTHJ-UHFFFAOYSA-N 2-(4-aminoanilino)ethanol;sulfuric acid Chemical compound OS(O)(=O)=O.NC1=CC=C(NCCO)C=C1 YWNSGSNRKLNTHJ-UHFFFAOYSA-N 0.000 description 1
- KGZUHYIHYBDNLC-UHFFFAOYSA-N 2-(4-aminophenyl)-6-methyl-1,3-benzothiazole-7-sulfonic acid Chemical compound S1C2=C(S(O)(=O)=O)C(C)=CC=C2N=C1C1=CC=C(N)C=C1 KGZUHYIHYBDNLC-UHFFFAOYSA-N 0.000 description 1
- LKOZCPLGVMQJCW-UHFFFAOYSA-N 2-[(4-aminophenyl)methyl]-1-(diaminomethylidene)guanidine Chemical compound NC(N)=N\C(N)=N\Cc1ccc(N)cc1 LKOZCPLGVMQJCW-UHFFFAOYSA-N 0.000 description 1
- SNKFFCBZYFGCQN-UHFFFAOYSA-N 2-[3-[3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydro-1-benzofuran-4-yl]prop-2-enoyloxy]-3-(3,4-dihydroxyphenyl)propanoic acid Chemical compound C=1C=C(O)C=2OC(C=3C=C(O)C(O)=CC=3)C(C(=O)OC(CC=3C=C(O)C(O)=CC=3)C(O)=O)C=2C=1C=CC(=O)OC(C(=O)O)CC1=CC=C(O)C(O)=C1 SNKFFCBZYFGCQN-UHFFFAOYSA-N 0.000 description 1
- DNUYOWCKBJFOGS-UHFFFAOYSA-N 2-[[10-(2,2-dicarboxyethyl)anthracen-9-yl]methyl]propanedioic acid Chemical compound C1=CC=C2C(CC(C(=O)O)C(O)=O)=C(C=CC=C3)C3=C(CC(C(O)=O)C(O)=O)C2=C1 DNUYOWCKBJFOGS-UHFFFAOYSA-N 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- VOBIHUAWDXUCPH-UHFFFAOYSA-N 2-chloro-5,5-dimethylcyclohexane-1,3-dione Chemical compound CC1(C)CC(=O)C(Cl)C(=O)C1 VOBIHUAWDXUCPH-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- IYAYIUGCUKYFGY-UHFFFAOYSA-N 2-hydroxy-1-(2-hydroxyphenyl)ethanone Chemical compound OCC(=O)C1=CC=CC=C1O IYAYIUGCUKYFGY-UHFFFAOYSA-N 0.000 description 1
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 1
- UJABSZITRMATFL-UHFFFAOYSA-N 2-methyl-5-phenylfuran-3-carbonyl chloride Chemical compound ClC(=O)C1=C(C)OC(C=2C=CC=CC=2)=C1 UJABSZITRMATFL-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- QGQXAMBOYWULFX-LZWSPWQCSA-N 2-morpholin-4-ylethyl (e)-6-(4,6-dihydroxy-7-methyl-3-oxo-1h-2-benzofuran-5-yl)-4-methylhex-4-enoate Chemical compound OC=1C=2C(=O)OCC=2C(C)=C(O)C=1C\C=C(/C)CCC(=O)OCCN1CCOCC1 QGQXAMBOYWULFX-LZWSPWQCSA-N 0.000 description 1
- HVHNMNGARPCGGD-UHFFFAOYSA-N 2-nitro-p-phenylenediamine Chemical compound NC1=CC=C(N)C([N+]([O-])=O)=C1 HVHNMNGARPCGGD-UHFFFAOYSA-N 0.000 description 1
- YZEUHQHUFTYLPH-UHFFFAOYSA-N 2-nitroimidazole Chemical compound [O-][N+](=O)C1=NC=CN1 YZEUHQHUFTYLPH-UHFFFAOYSA-N 0.000 description 1
- UPNWMTKPFHVTNT-UHFFFAOYSA-N 2-phenoxazin-10-ylethanol Chemical compound C1=CC=C2N(CCO)C3=CC=CC=C3OC2=C1 UPNWMTKPFHVTNT-UHFFFAOYSA-N 0.000 description 1
- WNYJRJRHKRZXEO-UHFFFAOYSA-N 2-propan-2-ylbenzene-1,4-diamine Chemical compound CC(C)C1=CC(N)=CC=C1N WNYJRJRHKRZXEO-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- PUKLDDOGISCFCP-JSQCKWNTSA-N 21-Deoxycortisone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2=O PUKLDDOGISCFCP-JSQCKWNTSA-N 0.000 description 1
- OTJUFGKCGUDJEI-LVXARBLLSA-N 3',4'-dihydroxy malibatol a Chemical compound C1([C@@H]2[C@H](C=3C=C(O)C=C4OC(=C(C=34)C3=C(O)C(O)=CC(O)=C32)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C=C1 OTJUFGKCGUDJEI-LVXARBLLSA-N 0.000 description 1
- PCYGLFXKCBFGPC-UHFFFAOYSA-N 3,4-Dihydroxy hydroxymethyl benzene Natural products OCC1=CC=C(O)C(O)=C1 PCYGLFXKCBFGPC-UHFFFAOYSA-N 0.000 description 1
- UENRXLSRMCSUSN-UHFFFAOYSA-N 3,5-diaminobenzoic acid Chemical compound NC1=CC(N)=CC(C(O)=O)=C1 UENRXLSRMCSUSN-UHFFFAOYSA-N 0.000 description 1
- FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 description 1
- UFJORDZSBNSRQT-UHFFFAOYSA-N 3-(4-oxo-2-phenylchromen-3-yl)-2-phenylchromen-4-one Chemical compound O1C2=CC=CC=C2C(=O)C(C=2C(C3=CC=CC=C3OC=2C=2C=CC=CC=2)=O)=C1C1=CC=CC=C1 UFJORDZSBNSRQT-UHFFFAOYSA-N 0.000 description 1
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 1
- FHXUYFKYRBLZJU-UHFFFAOYSA-N 3-(5-methyl-3-oxo-1h-pyrazol-2-yl)benzenesulfonic acid Chemical compound N1C(C)=CC(=O)N1C1=CC=CC(S(O)(=O)=O)=C1 FHXUYFKYRBLZJU-UHFFFAOYSA-N 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- PFCHFHIRKBAQGU-UHFFFAOYSA-N 3-hexanone Chemical compound CCCC(=O)CC PFCHFHIRKBAQGU-UHFFFAOYSA-N 0.000 description 1
- HJBLUNHMOKFZQX-UHFFFAOYSA-N 3-hydroxy-1,2,3-benzotriazin-4-one Chemical compound C1=CC=C2C(=O)N(O)N=NC2=C1 HJBLUNHMOKFZQX-UHFFFAOYSA-N 0.000 description 1
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- LWGBAJWQEZJNLO-UHFFFAOYSA-N 3-phenothiazin-10-ylpropan-1-ol Chemical compound C1=CC=C2N(CCCO)C3=CC=CC=C3SC2=C1 LWGBAJWQEZJNLO-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- UHNXUSWGOJMEFO-UHFFFAOYSA-N 4'-O-beta-D-Glucopyranoside-3',4',5,7-Tetrahydroxyflavone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)C=C1O UHNXUSWGOJMEFO-UHFFFAOYSA-N 0.000 description 1
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical class C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 description 1
- PPAULTVPKLVLII-UHFFFAOYSA-N 4,5-diaminopyrimidine Chemical compound NC1=CN=CN=C1N PPAULTVPKLVLII-UHFFFAOYSA-N 0.000 description 1
- IWFHBRFJOHTIPU-UHFFFAOYSA-N 4,5-dichlorobenzene-1,2-diamine Chemical compound NC1=CC(Cl)=C(Cl)C=C1N IWFHBRFJOHTIPU-UHFFFAOYSA-N 0.000 description 1
- JTGCXYYDAVPSFD-UHFFFAOYSA-N 4-(4-hydroxyphenyl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=C(O)C=C1 JTGCXYYDAVPSFD-UHFFFAOYSA-N 0.000 description 1
- AQVKHRQMAUJBBP-UHFFFAOYSA-N 4-Bromocatechol Chemical compound OC1=CC=C(Br)C=C1O AQVKHRQMAUJBBP-UHFFFAOYSA-N 0.000 description 1
- 239000004101 4-Hexylresorcinol Substances 0.000 description 1
- FUKHOQPXEPBRFC-NSCUHMNNSA-N 4-[(e)-2-(4-methoxyphenyl)ethenyl]aniline Chemical compound C1=CC(OC)=CC=C1\C=C\C1=CC=C(N)C=C1 FUKHOQPXEPBRFC-NSCUHMNNSA-N 0.000 description 1
- NFPYJDZQOKCYIE-UHFFFAOYSA-N 4-amino-3-hydroxybenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1O NFPYJDZQOKCYIE-UHFFFAOYSA-N 0.000 description 1
- 235000019360 4-hexylresorcinol Nutrition 0.000 description 1
- AGAHETWGCFCMDK-UHFFFAOYSA-N 4-methoxybenzene-1,2-diamine Chemical compound COC1=CC=C(N)C(N)=C1 AGAHETWGCFCMDK-UHFFFAOYSA-N 0.000 description 1
- UHNXUSWGOJMEFO-LELZANKISA-N 5,7,3',4'-Tetrahydroxyflavone 4'-beta-D-glucopyranoside Natural products O[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)C=C1O UHNXUSWGOJMEFO-LELZANKISA-N 0.000 description 1
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 description 1
- VQTZGUYEOZNKQH-UHFFFAOYSA-N 5-[(2,4,6-trioxo-1,3-diazinan-5-yl)imino]-1,3-diazinane-2,4,6-trione Chemical compound O=C1NC(=O)NC(=O)C1N=C1C(=O)NC(=O)NC1=O VQTZGUYEOZNKQH-UHFFFAOYSA-N 0.000 description 1
- UWPJYQYRSWYIGZ-UHFFFAOYSA-N 5-aminonaphthalene-2-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2C(N)=CC=CC2=C1 UWPJYQYRSWYIGZ-UHFFFAOYSA-N 0.000 description 1
- LCGTWRLJTMHIQZ-UHFFFAOYSA-N 5H-dibenzo[b,f]azepine Chemical compound C1=CC2=CC=CC=C2NC2=CC=CC=C21 LCGTWRLJTMHIQZ-UHFFFAOYSA-N 0.000 description 1
- NEEWJIPREFDATB-UHFFFAOYSA-N 6,7-dihydroxynaphthalene-2-carboxylic acid Chemical compound C1=C(O)C(O)=CC2=CC(C(=O)O)=CC=C21 NEEWJIPREFDATB-UHFFFAOYSA-N 0.000 description 1
- KAUQJMHLAFIZDU-UHFFFAOYSA-N 6-Hydroxy-2-naphthoic acid Chemical compound C1=C(O)C=CC2=CC(C(=O)O)=CC=C21 KAUQJMHLAFIZDU-UHFFFAOYSA-N 0.000 description 1
- YLKRUSPZOTYMAT-YFKPBYRVSA-N 6-hydroxy-L-dopa Chemical compound OC(=O)[C@@H](N)CC1=CC(O)=C(O)C=C1O YLKRUSPZOTYMAT-YFKPBYRVSA-N 0.000 description 1
- BUEWYDIBDQYWNO-UHFFFAOYSA-N 7,12-dihydroxynaphtho[2,3-f]quinoline-5,6-dione Chemical compound Oc1c2C(=O)C(=O)c3ncccc3-c2c(O)c2ccccc12 BUEWYDIBDQYWNO-UHFFFAOYSA-N 0.000 description 1
- WWGFXSLWIRYIBP-UHFFFAOYSA-N 7,8-dihydroxy-4H-chromen-4-one Natural products O1C=CC(=O)C=2C1=C(O)C(O)=CC=2 WWGFXSLWIRYIBP-UHFFFAOYSA-N 0.000 description 1
- AQSOTOUQTVJNMY-UHFFFAOYSA-N 7-(dimethylamino)-4-hydroxy-3-oxophenoxazin-10-ium-1-carboxylic acid;chloride Chemical compound [Cl-].OC(=O)C1=CC(=O)C(O)=C2OC3=CC(N(C)C)=CC=C3[NH+]=C21 AQSOTOUQTVJNMY-UHFFFAOYSA-N 0.000 description 1
- OKAUOXITMZTUOJ-UHFFFAOYSA-N 7-aminonaphthalene-2-sulfonic acid Chemical compound C1=CC(S(O)(=O)=O)=CC2=CC(N)=CC=C21 OKAUOXITMZTUOJ-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- UNFNRIIETORURP-UHFFFAOYSA-N 7-methoxynaphthalen-2-ol Chemical compound C1=CC(O)=CC2=CC(OC)=CC=C21 UNFNRIIETORURP-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- 241000931515 Acer palmatum Species 0.000 description 1
- 235000002754 Acer pseudoplatanus Nutrition 0.000 description 1
- 240000004731 Acer pseudoplatanus Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- JBMKAUGHUNFTOL-UHFFFAOYSA-N Aldoclor Chemical class C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NC=NS2(=O)=O JBMKAUGHUNFTOL-UHFFFAOYSA-N 0.000 description 1
- HKIKAXXIWJHWLY-ZIIYPAMZSA-N Aloesin Chemical compound C=12OC(CC(=O)C)=CC(=O)C2=C(C)C=C(O)C=1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HKIKAXXIWJHWLY-ZIIYPAMZSA-N 0.000 description 1
- HKIKAXXIWJHWLY-QEVGBQTESA-N Aloesin Natural products O=C(CC=1Oc2c([C@H]3[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O3)c(O)cc(C)c2C(=O)C=1)C HKIKAXXIWJHWLY-QEVGBQTESA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229930195573 Amycin Natural products 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000011446 Amygdalus persica Nutrition 0.000 description 1
- LYZCFNXBZZIFFR-UHFFFAOYSA-N Angoroside C Natural products COc1ccc(CCOC2OC(CC3OCC(O)C(O)C3O)C(OC(=O)C=Cc4ccc(O)c(OC)c4)C(OC5OC(C)C(O)C(O)C5O)C2O)cc1O LYZCFNXBZZIFFR-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- ZROGCCBNZBKLEL-FHXNIQKESA-N Astilbin Natural products O([C@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 ZROGCCBNZBKLEL-FHXNIQKESA-N 0.000 description 1
- FYEHYMARPSSOBO-UHFFFAOYSA-N Aurin Chemical compound C1=CC(O)=CC=C1C(C=1C=CC(O)=CC=1)=C1C=CC(=O)C=C1 FYEHYMARPSSOBO-UHFFFAOYSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- CAHQGWAXKLQREW-UHFFFAOYSA-N Benzal chloride Chemical compound ClC(Cl)C1=CC=CC=C1 CAHQGWAXKLQREW-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- YWJXCIXBAKGUKZ-HJJNZUOJSA-N Bergenin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@H]2C3=C(O)C(OC)=C(O)C=C3C(=O)O[C@@H]21 YWJXCIXBAKGUKZ-HJJNZUOJSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 1
- JUQPZRLQQYSMEQ-UHFFFAOYSA-N CI Basic red 9 Chemical compound [Cl-].C1=CC(N)=CC=C1C(C=1C=CC(N)=CC=1)=C1C=CC(=[NH2+])C=C1 JUQPZRLQQYSMEQ-UHFFFAOYSA-N 0.000 description 1
- 241001073507 Callicarpa Species 0.000 description 1
- 108700000434 Cannabis sativa edestin Proteins 0.000 description 1
- SWRFKGRMQVLMKA-JIZJWZDPSA-N Casuarictin Chemical compound OC1=C(O)C(O)=CC(C(=O)O[C@H]2[C@@H]3OC(=O)C4=CC(O)=C(O)C(O)=C4C4=C(O)C(O)=C(O)C=C4C(=O)O[C@H]3[C@@H]3OC(=O)C4=CC(O)=C(O)C(O)=C4C4=C(O)C(O)=C(O)C=C4C(=O)OC[C@H]3O2)=C1 SWRFKGRMQVLMKA-JIZJWZDPSA-N 0.000 description 1
- MMQXBTULXAEKQE-VSLJGAQWSA-N Casuarinin Chemical compound O([C@@H]1COC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(O)C=C2C(=O)O[C@H]1[C@@H]1OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(O)C3=C2C(=O)O[C@H]1[C@H]3O)C(=O)C1=CC(O)=C(O)C(O)=C1 MMQXBTULXAEKQE-VSLJGAQWSA-N 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 229920000818 Catalin Polymers 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 240000001829 Catharanthus roseus Species 0.000 description 1
- DSEKYWAQQVUQTP-UHFFFAOYSA-N Cerin Natural products CC12CCC3(C)C4CC(C)(C)CCC4(C)CCC3(C)C2CCC2(C)C1CC(O)C(=O)C2C DSEKYWAQQVUQTP-UHFFFAOYSA-N 0.000 description 1
- 241000293770 Cerrena unicolor Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 1
- 102000007345 Chromogranins Human genes 0.000 description 1
- 108010007718 Chromogranins Proteins 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 108010073254 Colicins Proteins 0.000 description 1
- IQFVPQOLBLOTPF-UHFFFAOYSA-L Congo Red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(N=NC3=CC=C(C=C3)C3=CC=C(C=C3)N=NC3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-UHFFFAOYSA-L 0.000 description 1
- 235000001673 Coprinus macrorhizus Nutrition 0.000 description 1
- 244000251987 Coprinus macrorhizus Species 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- 241000222356 Coriolus Species 0.000 description 1
- ACBOFPQSBWBAQR-UHFFFAOYSA-N Cosmosiin Natural products OCC1OC(Oc2cc(O)c3C(=O)C=C(Oc3c2)c4cccc(O)c4)C(O)C(O)C1O ACBOFPQSBWBAQR-UHFFFAOYSA-N 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 241000732800 Cymbidium Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- PAFLSMZLRSPALU-QMMMGPOBSA-N Danshensu Natural products OC(=O)[C@@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-QMMMGPOBSA-N 0.000 description 1
- 241000208175 Daucus Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- JRWZLRBJNMZMFE-UHFFFAOYSA-N Dobutamine Chemical compound C=1C=C(O)C(O)=CC=1CCNC(C)CCC1=CC=C(O)C=C1 JRWZLRBJNMZMFE-UHFFFAOYSA-N 0.000 description 1
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 244000085625 Equisetum Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 108010057366 Flavodoxin Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- KFFCKOBAHMGTMW-LGQRSHAYSA-N Forsythin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)[C@@H]2CO1 KFFCKOBAHMGTMW-LGQRSHAYSA-N 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- ODXMIHPUPFEYDB-HISCDKSNSA-N Gemin A Chemical compound OC1=C(O)C(O)=CC(C(=O)O[C@@H]2[C@H]([C@@H]3OC(=O)C4=CC(O)=C(O)C(O)=C4C4=C(O)C(O)=C(O)C=C4C(=O)OC[C@H]3O[C@@H]2OC(=O)C=2C=C(OC=3C(=CC(O)=C(O)C=3O)C(=O)O[C@@H]3[C@@H]4OC(=O)C5=CC(O)=C(O)C(O)=C5C5=C(O)C(O)=C(O)C=C5C(=O)O[C@H]4[C@@H]4OC(=O)C5=CC(O)=C(O)C(O)=C5C5=C(O)C(O)=C(O)C=C5C(=O)OC[C@H]4O3)C(O)=C(O)C=2)OC(=O)C=2C=C(O)C(O)=C(O)C=2)=C1 ODXMIHPUPFEYDB-HISCDKSNSA-N 0.000 description 1
- BZIGXGRVQSNLNL-UHFFFAOYSA-N Gemin A Natural products Oc1ccc(C(=O)OC2C(OC(=O)c3cc(O)c(O)c(Oc4c(O)c(O)c(O)cc4C(=O)OC5OC6COC(=O)c7cc(O)c(O)c(O)c7c8c(O)c(O)c(O)cc8C(=O)OC6C9OC(=O)c%10cc(O)c(O)c(O)c%10c%11c(O)c(O)c(O)cc%11C(=O)OC59)c3)OC%12COC(=O)c%13cc(O)c(O)c(O)c%13c%14c(O)c(O)c(O)cc%14C(=O)OC%12C2OC(=O)c%15cc(O)c(O)c(O)c%15)c(O)c1O BZIGXGRVQSNLNL-UHFFFAOYSA-N 0.000 description 1
- SDTOABMYDICPQU-UHFFFAOYSA-N Genkwanin Natural products C=1C(C)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 SDTOABMYDICPQU-UHFFFAOYSA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- YXHVCZZLWZYHSA-FPLPWBNLSA-N Ginkgoic acid Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-FPLPWBNLSA-N 0.000 description 1
- KVGHRSAHESCTFR-PDCCCBJGSA-N Gnetin C Natural products C1=CC(O)=CC=C1\C=C\C(C=C1O)=CC2=C1[C@H](C=1C=C(O)C=C(O)C=1)[C@@H](C=1C=CC(O)=CC=1)O2 KVGHRSAHESCTFR-PDCCCBJGSA-N 0.000 description 1
- PZHNKNRPGLTZPO-UHFFFAOYSA-N Grifolin Natural products CC(C)=CCCC(C)=CCCC(C)=CCC1=C(O)C=C(C)C=C1O PZHNKNRPGLTZPO-UHFFFAOYSA-N 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- BYTORXDZJWWIKR-UHFFFAOYSA-N Hinokiol Natural products CC(C)c1cc2CCC3C(C)(CO)C(O)CCC3(C)c2cc1O BYTORXDZJWWIKR-UHFFFAOYSA-N 0.000 description 1
- 101000971078 Homo sapiens Bcl-2-like protein 11 Proteins 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- DZUKXCCSULKRJA-UHFFFAOYSA-N Isopratol Natural products C=1C(OC)=CC=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 DZUKXCCSULKRJA-UHFFFAOYSA-N 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- FDQAOULAVFHKBX-UHFFFAOYSA-N Isosilybin A Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC(=CC=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-UHFFFAOYSA-N 0.000 description 1
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 1
- YKGCBLWILMDSAV-GOSISDBHSA-N Isoxanthohumol Natural products O(C)c1c2C(=O)C[C@H](c3ccc(O)cc3)Oc2c(C/C=C(\C)/C)c(O)c1 YKGCBLWILMDSAV-GOSISDBHSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- 229920001732 Lignosulfonate Polymers 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- QTDMGAWIBXJNRR-UHFFFAOYSA-N Mangostin Natural products CC(=CCc1c(O)cc2Oc3cc(C)c(O)c(CC=C(C)C)c3C(=O)c2c1O)C QTDMGAWIBXJNRR-UHFFFAOYSA-N 0.000 description 1
- 238000006683 Mannich reaction Methods 0.000 description 1
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 description 1
- MZSGWZGPESCJAN-MOBFUUNNSA-N Melitric acid A Natural products O([C@@H](C(=O)O)Cc1cc(O)c(O)cc1)C(=O)/C=C/c1cc(O)c(O/C(/C(=O)O)=C/c2cc(O)c(O)cc2)cc1 MZSGWZGPESCJAN-MOBFUUNNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- 235000009815 Momordica Nutrition 0.000 description 1
- 241000218984 Momordica Species 0.000 description 1
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 1
- 241000751065 Monotropa hypopitys Species 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 description 1
- VSRVRBXGIRFARR-CIYSLCTESA-N Neohesperidose Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 VSRVRBXGIRFARR-CIYSLCTESA-N 0.000 description 1
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 1
- 108010053775 Nisin Proteins 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 101710195703 Oxygen-dependent coproporphyrinogen-III oxidase Proteins 0.000 description 1
- 101710146072 Oxygen-independent coproporphyrinogen III oxidase Proteins 0.000 description 1
- PDHAOJSHSJQANO-OWOJBTEDSA-N Oxyresveratrol Chemical compound OC1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 PDHAOJSHSJQANO-OWOJBTEDSA-N 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- NJFRRNXUFGQUEK-UHFFFAOYSA-N Parthenocissin A Natural products C1=CC(O)=CC=C1C=C1C(C=C(O)C=C2O)=C2C(C=2C=C(O)C=C(O)C=2)C1C1=CC=C(O)C=C1 NJFRRNXUFGQUEK-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000222393 Phanerochaete chrysosporium Species 0.000 description 1
- 235000010632 Phaseolus coccineus Nutrition 0.000 description 1
- 244000042209 Phaseolus multiflorus Species 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 229940126902 Phlorizin Drugs 0.000 description 1
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 1
- IIXHQGSINFQLRR-UHFFFAOYSA-N Piceatannol Natural products Oc1ccc(C=Cc2c(O)c(O)c3CCCCc3c2O)cc1O IIXHQGSINFQLRR-UHFFFAOYSA-N 0.000 description 1
- 235000011615 Pinus koraiensis Nutrition 0.000 description 1
- 240000007263 Pinus koraiensis Species 0.000 description 1
- OKPNYGAWTYOBFZ-UHFFFAOYSA-N Pirenoxine Chemical compound C12=NC3=CC=CC=C3OC2=CC(=O)C2=C1C(=O)C=C(C(=O)O)N2 OKPNYGAWTYOBFZ-UHFFFAOYSA-N 0.000 description 1
- 101001037768 Plasmodium berghei 58 kDa phosphoprotein Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010093965 Polymyxin B Proteins 0.000 description 1
- BPGGESYJUXPYQA-UHFFFAOYSA-N Procyanidin A1 Natural products COc1ccc(cc1OC)C2Oc3c(CC2OC(=O)C)c(OC)cc4OC5(Oc6cc(OC)c(OC)cc6C(C5OC(=O)C)c34)c7ccc(OC)c(OC)c7 BPGGESYJUXPYQA-UHFFFAOYSA-N 0.000 description 1
- 229920002658 Procyanidin A1 Polymers 0.000 description 1
- 229920002982 Procyanidin A2 Polymers 0.000 description 1
- GMISZFQPFDAPGI-HZZPXJBDSA-N Procyanidin B5 Natural products C1([C@@H]2[C@H](O)[C@@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=C3C[C@H]([C@H](OC3=CC=2O)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 GMISZFQPFDAPGI-HZZPXJBDSA-N 0.000 description 1
- 229920001263 Procyanidin B5 Polymers 0.000 description 1
- GMISZFQPFDAPGI-AQHQUFFSSA-N Procyanidin B6 Natural products C1([C@@H]2[C@@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=C3C[C@@H]([C@H](OC3=CC=2O)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 GMISZFQPFDAPGI-AQHQUFFSSA-N 0.000 description 1
- 229920001952 Procyanidin B6 Polymers 0.000 description 1
- GMISZFQPFDAPGI-OSYQBESMSA-N Procyanidin B8 Natural products C1([C@@H]2[C@@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=C3C[C@H]([C@H](OC3=CC=2O)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 GMISZFQPFDAPGI-OSYQBESMSA-N 0.000 description 1
- 229920002071 Procyanidin B8 Polymers 0.000 description 1
- MOJZMWJRUKIQGL-FQVWZTFVSA-N Procyanidin C1 Natural products O[C@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@@H]3[C@@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@H]1c1c(O)cc(O)c2c1O[C@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FQVWZTFVSA-N 0.000 description 1
- 229920001554 Procyanidin C1 Polymers 0.000 description 1
- 229920002956 Procyanidin C2 Polymers 0.000 description 1
- ZGUGWUXLJSTTMA-UHFFFAOYSA-N Promazinum Chemical compound C1=CC=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZGUGWUXLJSTTMA-UHFFFAOYSA-N 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 239000004216 Rhodoxanthin Substances 0.000 description 1
- VWXMLZQUDPCJPL-ZDHAIZATSA-N Rhodoxanthin Chemical compound CC\1=CC(=O)CC(C)(C)C/1=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C1\C(C)=CC(=O)CC1(C)C VWXMLZQUDPCJPL-ZDHAIZATSA-N 0.000 description 1
- VWXMLZQUDPCJPL-XPZLFLLQSA-N Rhodoxanthin Natural products O=C1C=C(C)/C(=C\C=C(/C=C/C=C(\C=C\C=C\C(=C/C=C/C(=C\C=C\2/C(C)=CC(=O)CC/2(C)C)/C)\C)/C)\C)/C(C)(C)C1 VWXMLZQUDPCJPL-XPZLFLLQSA-N 0.000 description 1
- HJYYPODYNSCCOU-ZDHWWVNNSA-N Rifamycin SV Natural products COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(=O)C)C1C)C)cc(O)c4c3C2=O HJYYPODYNSCCOU-ZDHWWVNNSA-N 0.000 description 1
- OVVGHDNPYGTYIT-VHBGUFLRSA-N Robinobiose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 OVVGHDNPYGTYIT-VHBGUFLRSA-N 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- 235000021501 Rumex crispus Nutrition 0.000 description 1
- 240000004284 Rumex crispus Species 0.000 description 1
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 description 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 1
- 244000173853 Sanguisorba officinalis Species 0.000 description 1
- 241000220156 Saxifraga Species 0.000 description 1
- VLGROHBNWZUINI-UHFFFAOYSA-N Silybin Natural products COc1cc(ccc1O)C2OC3C=C(C=CC3OC2CO)C4Oc5cc(O)cc(O)c5C(=O)C4O VLGROHBNWZUINI-UHFFFAOYSA-N 0.000 description 1
- DMQNLOWHFHPWEA-UHFFFAOYSA-N Sinapic acid ethyl ester Natural products CCOC(=O)C=CC1=CC(OC)=C(O)C(OC)=C1 DMQNLOWHFHPWEA-UHFFFAOYSA-N 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- JXASPPWQHFOWPL-UHFFFAOYSA-N Tamarixin Natural products C1=C(O)C(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 JXASPPWQHFOWPL-UHFFFAOYSA-N 0.000 description 1
- 108010053950 Teicoplanin Proteins 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 1
- 241000223258 Thermomyces lanuginosus Species 0.000 description 1
- 108010046075 Thymosin Proteins 0.000 description 1
- 102000007501 Thymosin Human genes 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 description 1
- 241000001727 Tropicoporus linteus Species 0.000 description 1
- 229930186414 Tubuloside Natural products 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- FVECELJHCSPHKY-WTFKENEKSA-N Veratrine (amorphous) Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)O[C@@H]1[C@]2(O)O[C@@]34C[C@@]5(O)[C@H](CN6[C@@H](CC[C@H](C)C6)[C@@]6(C)O)[C@]6(O)[C@@H](O)C[C@@]5(O)[C@@H]4CC[C@H]2[C@]3(C)CC1 FVECELJHCSPHKY-WTFKENEKSA-N 0.000 description 1
- 241000863480 Vinca Species 0.000 description 1
- FEPAFOYQTIEEIS-IZUGRSKYSA-N [(2r,3r,4r)-3,4,5-trihydroxy-4-[(3,4,5-trihydroxybenzoyl)oxymethyl]oxolan-2-yl]methyl 3,4,5-trihydroxybenzoate Chemical compound C([C@H]1OC([C@@]([C@@H]1O)(O)COC(=O)C=1C=C(O)C(O)=C(O)C=1)O)OC(=O)C1=CC(O)=C(O)C(O)=C1 FEPAFOYQTIEEIS-IZUGRSKYSA-N 0.000 description 1
- IIYNOSFQRKUHOL-FZOOHXBBSA-N [(2r,3s,4r,5r,6s)-6-(2-acetyl-5-methoxyphenoxy)-2-[[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-4,5-dihydroxyoxan-3-yl] 3,4,5-trihydroxybenzoate Chemical compound COC1=CC=C(C(C)=O)C(O[C@H]2[C@@H]([C@@H](O)[C@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)[C@@H](CO[C@H]3[C@@H]([C@@](O)(CO)CO3)O)O2)O)=C1 IIYNOSFQRKUHOL-FZOOHXBBSA-N 0.000 description 1
- QNVPMKAFCVXMFH-NDDHQHNUSA-N [(3s,4r,5r)-5-[[(2r,3s,4s,5r,6s)-6-(2-acetyl-5-methoxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methoxy]-3,4-dihydroxyoxolan-3-yl]methyl 3,4,5-trihydroxybenzoate Chemical compound COC1=CC=C(C(C)=O)C(O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]3[C@@H]([C@@](O)(COC(=O)C=4C=C(O)C(O)=C(O)C=4)CO3)O)O2)O)=C1 QNVPMKAFCVXMFH-NDDHQHNUSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 229960001413 acetanilide Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
- GUAFOGOEJLSQBT-UHFFFAOYSA-N aesculetin dimethyl ether Natural products C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 1
- SOSLMHZOJATCCP-AEIZVZFYSA-N afzelin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O SOSLMHZOJATCCP-AEIZVZFYSA-N 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 229960002648 alanylglutamine Drugs 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- VWXMLZQUDPCJPL-JCFHCUBBSA-N all-trans-Rhodoxanthin Natural products CC(=C/C=C/C(=C/C=C/1C(=CC(=O)CC1(C)C)C)/C)C=CC=CC(=CC=CC(=CC=C2/C(=CC(=O)CC2(C)C)C)C)C VWXMLZQUDPCJPL-JCFHCUBBSA-N 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- VSRVRBXGIRFARR-OUEGHFHCSA-N alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O VSRVRBXGIRFARR-OUEGHFHCSA-N 0.000 description 1
- NESNOMLNDJUFBJ-UHFFFAOYSA-N alpha-Viniferin Natural products Oc1ccc(cc1)C2Oc3cc(O)cc4C5C(Oc6cc(O)cc(C7C(Oc8cc(O)cc(C2c34)c78)c9cccc(O)c9)c56)c%10cccc(O)c%10 NESNOMLNDJUFBJ-UHFFFAOYSA-N 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- ZVFQDLCERPGZMO-UHFFFAOYSA-N alpha-mangostin Natural products OC1=C(CC=C(C)C)C(O)=C2C(=O)C3=C(CC=C(C)C)C(OC)=C(O)C=C3CC2=C1 ZVFQDLCERPGZMO-UHFFFAOYSA-N 0.000 description 1
- CJCSPKMFHVPWAR-JTQLQIEISA-N alpha-methyl-L-dopa Chemical compound OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 CJCSPKMFHVPWAR-JTQLQIEISA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- HITDPRAEYNISJU-UHFFFAOYSA-N amenthoflavone Natural products Oc1ccc(cc1)C2=COc3c(C2=O)c(O)cc(O)c3c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O HITDPRAEYNISJU-UHFFFAOYSA-N 0.000 description 1
- HVSKSWBOHPRSBD-UHFFFAOYSA-N amentoflavone Natural products Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)c(c3O2)c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O HVSKSWBOHPRSBD-UHFFFAOYSA-N 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960004104 amiloride hydrochloride Drugs 0.000 description 1
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 229960000836 amitriptyline Drugs 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- KHFQPAMXJRRXJD-UHFFFAOYSA-N anthragallol Natural products O=C1C2=CC=CC=C2C(=O)C2=C1C=C(OC)C(OC)=C2O KHFQPAMXJRRXJD-UHFFFAOYSA-N 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- SDNYTAYICBFYFH-TUFLPTIASA-N antipain Chemical compound NC(N)=NCCC[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SDNYTAYICBFYFH-TUFLPTIASA-N 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 229960003990 apomorphine hydrochloride Drugs 0.000 description 1
- CXWQXGNFZLHLHQ-DPFCLETOSA-N apomorphine hydrochloride Chemical compound [H+].[H+].O.[Cl-].[Cl-].C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3.C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 CXWQXGNFZLHLHQ-DPFCLETOSA-N 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 238000013473 artificial intelligence Methods 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- BNQDCRGUHNALGH-UHFFFAOYSA-N benserazide Chemical compound OCC(N)C(=O)NNCC1=CC=C(O)C(O)=C1O BNQDCRGUHNALGH-UHFFFAOYSA-N 0.000 description 1
- 229960001335 benserazide hydrochloride Drugs 0.000 description 1
- ULFCBIUXQQYDEI-UHFFFAOYSA-N benserazide hydrochloride Chemical compound Cl.OCC(N)C(=O)NNCC1=CC=C(O)C(O)=C1O ULFCBIUXQQYDEI-UHFFFAOYSA-N 0.000 description 1
- VERMEZLHWFHDLK-UHFFFAOYSA-N benzene-1,2,3,4-tetrol Chemical compound OC1=CC=C(O)C(O)=C1O VERMEZLHWFHDLK-UHFFFAOYSA-N 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 150000004074 biphenyls Chemical class 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- LZJRNLRASBVRRX-UHFFFAOYSA-N boldine trifluoroacetic acid salt Natural products CN1CCC2=CC(O)=C(OC)C3=C2C1CC1=C3C=C(OC)C(O)=C1 LZJRNLRASBVRRX-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- WQSDYZZEIBAPIN-UHFFFAOYSA-N caffeoylglucose Natural products OC1C(O)C(O)C(CO)OC1OC(=O)C=CC1=CC=C(O)C(O)=C1 WQSDYZZEIBAPIN-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960005438 calcium dobesilate Drugs 0.000 description 1
- ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 description 1
- 229950011318 cannabidiol Drugs 0.000 description 1
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 description 1
- QXACEHWTBCFNSA-UHFFFAOYSA-N cannabigerol Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- UFMJCOLGRWKUKO-UHFFFAOYSA-N cardol diene Natural products CCCC=CCC=CCCCCCCCC1=CC(O)=CC(O)=C1 UFMJCOLGRWKUKO-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- MMQXBTULXAEKQE-UHFFFAOYSA-N casuarinin Chemical compound OC1C2OC(=O)C3=C1C(O)=C(O)C(O)=C3C1=C(O)C(O)=C(O)C=C1C(=O)OC2C1OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(O)C=C2C(=O)OCC1OC(=O)C1=CC(O)=C(O)C(O)=C1 MMQXBTULXAEKQE-UHFFFAOYSA-N 0.000 description 1
- XFQYJNINHLZMIU-UHFFFAOYSA-N cataline Natural products CN1CC(O)C2=CC(OC)=C(OC)C3=C2C1CC1=C3C=C(OC)C(OC)=C1 XFQYJNINHLZMIU-UHFFFAOYSA-N 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229940083181 centrally acting adntiadrenergic agent methyldopa Drugs 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- UWGBIKPRXRSRNM-UHFFFAOYSA-N cevadine Natural products CC=C(C)/C(=O)OC1CCC2(C)C3CCC4C5(O)CC(O)C6(O)C(CN7CC(C)CCC7C6(C)O)C5(O)CC24OCC13O UWGBIKPRXRSRNM-UHFFFAOYSA-N 0.000 description 1
- JQXXHWHPUNPDRT-YOPQJBRCSA-N chembl1332716 Chemical compound O([C@](C1=O)(C)O\C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CCN(C)CC1 JQXXHWHPUNPDRT-YOPQJBRCSA-N 0.000 description 1
- NGPGYVQZGRJHFJ-UHFFFAOYSA-N chembl1604790 Chemical compound OC1=CC(O)=CC=C1N=NC1=CC=C([N+]([O-])=O)C=C1 NGPGYVQZGRJHFJ-UHFFFAOYSA-N 0.000 description 1
- DDTDNCYHLGRFBM-YZEKDTGTSA-N chembl2367892 Chemical compound CC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@@H]([C@H]1C(N[C@@H](C2=CC(O)=CC(O[C@@H]3[C@H]([C@H](O)[C@H](O)[C@@H](CO)O3)O)=C2C=2C(O)=CC=C(C=2)[C@@H](NC(=O)[C@@H]2NC(=O)[C@@H]3C=4C=C(O)C=C(C=4)OC=4C(O)=CC=C(C=4)[C@@H](N)C(=O)N[C@H](CC=4C=C(Cl)C(O5)=CC=4)C(=O)N3)C(=O)N1)C(O)=O)=O)C(C=C1Cl)=CC=C1OC1=C(O[C@H]3[C@H]([C@@H](O)[C@H](O)[C@H](CO)O3)NC(C)=O)C5=CC2=C1 DDTDNCYHLGRFBM-YZEKDTGTSA-N 0.000 description 1
- MVQBFZXBLLMXGS-UHFFFAOYSA-N chembl331220 Chemical compound C1=CC=C2C(N=NC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C=C(S(O)(=O)=O)C2=C1 MVQBFZXBLLMXGS-UHFFFAOYSA-N 0.000 description 1
- GCOPXRXOORFRHV-HOFKKMOUSA-N chembl476084 Chemical compound C1([C@@H]2[C@H](C=3C=C(O)C=C4OC(=C(C=34)C3=CC(O)=CC(O)=C32)C=2C=CC(O)=CC=2)O)=CC=C(O)C=C1 GCOPXRXOORFRHV-HOFKKMOUSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229960001701 chloroform Drugs 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 235000015838 chrysin Nutrition 0.000 description 1
- 229940043370 chrysin Drugs 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- FQWLMRXWKZGLFI-UHFFFAOYSA-N cis epsilon-viniferine Natural products C1=CC(O)=CC=C1C=CC1=CC(O)=CC2=C1C(C=1C=C(O)C=C(O)C=1)C(C=1C=CC(O)=CC=1)O2 FQWLMRXWKZGLFI-UHFFFAOYSA-N 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 229960001577 dantron Drugs 0.000 description 1
- 125000004855 decalinyl group Chemical group C1(CCCC2CCCCC12)* 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- FUSADYLVRMROPL-UHFFFAOYSA-N demethylxanthohumol Natural products CC(C)=CCC1=C(O)C=C(O)C(C(=O)C=CC=2C=CC(O)=CC=2)=C1O FUSADYLVRMROPL-UHFFFAOYSA-N 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- NMGYKLMMQCTUGI-UHFFFAOYSA-J diazanium;titanium(4+);hexafluoride Chemical compound [NH4+].[NH4+].[F-].[F-].[F-].[F-].[F-].[F-].[Ti+4] NMGYKLMMQCTUGI-UHFFFAOYSA-J 0.000 description 1
- 125000005959 diazepanyl group Chemical group 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 239000002283 diesel fuel Substances 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 229960000616 diflunisal Drugs 0.000 description 1
- 229960004865 dihydralazine sulfate Drugs 0.000 description 1
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 description 1
- 125000005045 dihydroisoquinolinyl group Chemical group C1(NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000005046 dihydronaphthyl group Chemical group 0.000 description 1
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- HKIKRHWMSGKSAN-UHFFFAOYSA-J disodium 5,6-dihydroxy-3,4-dihydronaphtho[2,3-f]isoquinoline-7,12-dione disulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O.[O-]S([O-])=O.Oc1c(O)c2C(=O)c3ccccc3C(=O)c2c2C=CNCc12 HKIKRHWMSGKSAN-UHFFFAOYSA-J 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000012769 display material Substances 0.000 description 1
- 125000005883 dithianyl group Chemical group 0.000 description 1
- 229960001654 dobutamine hydrochloride Drugs 0.000 description 1
- BQKADKWNRWCIJL-UHFFFAOYSA-N dobutamine hydrochloride Chemical compound [Cl-].C=1C=C(O)C(O)=CC=1CC[NH2+]C(C)CCC1=CC=C(O)C=C1 BQKADKWNRWCIJL-UHFFFAOYSA-N 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 229960002918 doxorubicin hydrochloride Drugs 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 238000007772 electroless plating Methods 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- VFSWRBJYBQXUTE-UHFFFAOYSA-N epi-Gallocatechin 3-O-gallate Natural products Oc1ccc2C(=O)C(OC(=O)c3cc(O)c(O)c(O)c3)C(Oc2c1)c4cc(O)c(O)c(O)c4 VFSWRBJYBQXUTE-UHFFFAOYSA-N 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229960003265 epirubicin hydrochloride Drugs 0.000 description 1
- SXRAUGAFMDOHKN-UHFFFAOYSA-N epsilon-viniferin Natural products CC1(Oc2cc(O)cc(C=Cc3ccc(O)cc3)c2C1(C)c4cc(O)cc(O)c4)c5ccc(O)cc5 SXRAUGAFMDOHKN-UHFFFAOYSA-N 0.000 description 1
- TUJPOVKMHCLXEL-UHFFFAOYSA-N eriodictyol Natural products C1C(=O)C2=CC(O)=CC(O)=C2OC1C1=CC=C(O)C(O)=C1 TUJPOVKMHCLXEL-UHFFFAOYSA-N 0.000 description 1
- 235000011797 eriodictyol Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- SBHXYTNGIZCORC-UHFFFAOYSA-N eriodyctiol Natural products O1C2=CC(O)=CC(O)=C2C(=O)CC1C1=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-UHFFFAOYSA-N 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- VNUQOJUAIRBYQO-PPAUOFQQSA-N esculentin Chemical compound O([C@H]1[C@@H](OC)C[C@@H](O[C@@H]1C)O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2CC3=CC[C@@]4(O)[C@@]5(O)CC[C@](O)([C@@]5(C)[C@H](O)[C@@H](O)C4[C@@]3(C)CC2)C(C)=O)C[C@H]1OC)[C@@H]1O[C@H](C)[C@@H](O)[C@H](OC)[C@H]1O VNUQOJUAIRBYQO-PPAUOFQQSA-N 0.000 description 1
- VNUQOJUAIRBYQO-UHFFFAOYSA-N esculentin Natural products COC1CC(OC2CCC3(C)C4C(O)C(O)C5(C)C(O)(CCC5(O)C4(O)CC=C3C2)C(=O)C)OC(C)C1OC6CC(OC)C(OC7OC(C)C(O)C(OC)C7O)C(C)O6 VNUQOJUAIRBYQO-UHFFFAOYSA-N 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- DMQNLOWHFHPWEA-AATRIKPKSA-N ethyl (e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC(OC)=C(O)C(OC)=C1 DMQNLOWHFHPWEA-AATRIKPKSA-N 0.000 description 1
- VLQVUMOCVOTYDO-UHFFFAOYSA-N ethyl 2,3,4-trihydroxybenzoate Chemical compound CCOC(=O)C1=CC=C(O)C(O)=C1O VLQVUMOCVOTYDO-UHFFFAOYSA-N 0.000 description 1
- RHMQSXRCGOZYND-UHFFFAOYSA-N ethyl 2,3-dihydroxybenzoate Chemical compound CCOC(=O)C1=CC=CC(O)=C1O RHMQSXRCGOZYND-UHFFFAOYSA-N 0.000 description 1
- WKUVKFZZCHINKG-UHFFFAOYSA-N ethyl 4-hydroxy-3,5-dimethoxybenzoate Chemical compound CCOC(=O)C1=CC(OC)=C(O)C(OC)=C1 WKUVKFZZCHINKG-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Natural products CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- VHAOPSKMVGIXMU-UHFFFAOYSA-N faberidine Natural products COc1cc2CCN(C)C(Cc3ccc(OC)c(OC)c3Oc4cc5CC6N(C)CCc7cc(OC)c(OC)c(c5cc4OC)c67)c2cc1O VHAOPSKMVGIXMU-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229940043075 fluocinolone Drugs 0.000 description 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- OXHVQSRYUNGYOK-UHFFFAOYSA-N forsythoside E Natural products COc1ccc(CCOC2OC(COC3OC(C)C(O)C(O)C3O)C(O)C(O)C2O)cc1O OXHVQSRYUNGYOK-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 229940095100 fulvic acid Drugs 0.000 description 1
- 239000002509 fulvic acid Substances 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- FNUPUYFWZXZMIE-HUUCEWRRSA-N fustin Chemical compound C1([C@@H]2[C@@H](C(C3=CC=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 FNUPUYFWZXZMIE-HUUCEWRRSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003502 gasoline Substances 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 229940093767 glabridin Drugs 0.000 description 1
- PMPYOYXFIHXBJI-ZDUSSCGKSA-N glabridin Natural products C1([C@H]2CC=3C=CC4=C(C=3OC2)CCC(O4)(C)C)=CC=C(O)C=C1O PMPYOYXFIHXBJI-ZDUSSCGKSA-N 0.000 description 1
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000005858 glycosidation reaction Methods 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- SEFNUEXMMDHMHO-UHFFFAOYSA-N gnetin D Natural products C1=CC(O)=CC=C1C=CC(C=C1O)=CC2=C1C(C=1C=C(O)C=C(O)C=1)C(C=1C(=CC(O)=CC=1)O)O2 SEFNUEXMMDHMHO-UHFFFAOYSA-N 0.000 description 1
- MZZSUXPEXUEIAK-UHFFFAOYSA-N gnetin J Natural products C1=CC(O)=CC=C1C=CC(C=C1O)=CC2=C1C(C=1C=C(O)C=3C(C(OC=3C=1)C=1C=C(O)C(O)=CC=1)C=1C=C(O)C=C(O)C=1)C(C=1C=CC(O)=CC=1)O2 MZZSUXPEXUEIAK-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229930187533 granatin Natural products 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000011121 hardwood Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- 125000005549 heteroarylene group Chemical group 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- AXEYWFGSQDLHDX-UHFFFAOYSA-N hexane-1,3,6-triamine Chemical compound NCCCC(N)CCN AXEYWFGSQDLHDX-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- ZLUGESOGDIWBKF-UHFFFAOYSA-N hexyl 4-hydroxy-3,5-dimethoxybenzoate Chemical compound CCCCCCOC(=O)C1=CC(OC)=C(O)C(OC)=C1 ZLUGESOGDIWBKF-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960003258 hexylresorcinol Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000000687 hydroquinonyl group Chemical group C1(O)=C(C=C(O)C=C1)* 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- ADFCQWZHKCXPAJ-UHFFFAOYSA-N indofine Natural products C1=CC(O)=CC=C1C1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-UHFFFAOYSA-N 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 1
- CGPVRBMMGYBFAC-UHFFFAOYSA-N isoginkgetin Natural products COc1ccc(cc1)C2=COc3c(C2=O)c(O)cc(O)c3c4cc(ccc4OC)C5=CC(=O)c6c(O)cc(O)cc6O5 CGPVRBMMGYBFAC-UHFFFAOYSA-N 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940102253 isopropanolamine Drugs 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- GCOPXRXOORFRHV-UHFFFAOYSA-N malibatol A Natural products C12=C(O)C=C(O)C=C2C(C=23)=C(C=4C=CC(O)=CC=4)OC3=CC(O)=CC=2C(O)C1C1=CC=C(O)C=C1 GCOPXRXOORFRHV-UHFFFAOYSA-N 0.000 description 1
- OTJUFGKCGUDJEI-UHFFFAOYSA-N malibatol B Natural products C12=C(O)C=C(O)C(O)=C2C(C=23)=C(C=4C=C(O)C(O)=CC=4)OC3=CC(O)=CC=2C(O)C1C1=CC=C(O)C=C1 OTJUFGKCGUDJEI-UHFFFAOYSA-N 0.000 description 1
- 235000009584 malvidin Nutrition 0.000 description 1
- 229960003951 masoprocol Drugs 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229960005321 mecobalamin Drugs 0.000 description 1
- 229960004963 mesalazine Drugs 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 150000004972 metal peroxides Chemical class 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- VCRSYEXMIHNELG-UHFFFAOYSA-N methyl 3-phenothiazin-10-ylpropanoate Chemical compound C1=CC=C2N(CCC(=O)OC)C3=CC=CC=C3SC2=C1 VCRSYEXMIHNELG-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- ZMXJAEGJWHJMGX-UHFFFAOYSA-N methyl syringate Chemical compound COC(=O)C1=CC(OC)=C(O)C(OC)=C1 ZMXJAEGJWHJMGX-UHFFFAOYSA-N 0.000 description 1
- YFBSBLHMAWUCJB-UHFFFAOYSA-N methyl syringate Natural products COc1cc(cc(OC)c1O)C(=O)OO YFBSBLHMAWUCJB-UHFFFAOYSA-N 0.000 description 1
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 description 1
- 235000007672 methylcobalamin Nutrition 0.000 description 1
- 239000011585 methylcobalamin Substances 0.000 description 1
- JSUCYWKTQFNHPZ-UHFFFAOYSA-N methylideneurea;prop-2-enamide Chemical compound NC(=O)C=C.NC(=O)N=C JSUCYWKTQFNHPZ-UHFFFAOYSA-N 0.000 description 1
- HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 235000007708 morin Nutrition 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 239000010705 motor oil Substances 0.000 description 1
- 229960000951 mycophenolic acid Drugs 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- LYIHWEQBSAINHO-UHFFFAOYSA-N n,n-diethyl-2-(2-methoxy-6-prop-2-enylphenoxy)ethanamine;hydrochloride Chemical compound Cl.CCN(CC)CCOC1=C(CC=C)C=CC=C1OC LYIHWEQBSAINHO-UHFFFAOYSA-N 0.000 description 1
- HEPIDYSGDJMWNR-UHFFFAOYSA-N n,n-dimethyl-4-[[(3-methyl-1,3-benzothiazol-2-ylidene)hydrazinylidene]methyl]aniline Chemical compound C1=CC(N(C)C)=CC=C1C=NN=C1N(C)C2=CC=CC=C2S1 HEPIDYSGDJMWNR-UHFFFAOYSA-N 0.000 description 1
- WUMMWZQSOKKQLO-UHFFFAOYSA-N n-(4-cyanophenyl)-n-hydroxyacetamide Chemical compound CC(=O)N(O)C1=CC=C(C#N)C=C1 WUMMWZQSOKKQLO-UHFFFAOYSA-N 0.000 description 1
- NQIMONOHVBBZKE-UHFFFAOYSA-N n-[2-(3,4-dihydroxyphenyl)ethyl]-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NCCC1=CC=C(O)C(O)=C1 NQIMONOHVBBZKE-UHFFFAOYSA-N 0.000 description 1
- MIYKHJXFICMPOJ-UHFFFAOYSA-N n-benzyl-1-phenylmethanimine Chemical compound C=1C=CC=CC=1CN=CC1=CC=CC=C1 MIYKHJXFICMPOJ-UHFFFAOYSA-N 0.000 description 1
- WIBFFTLQMKKBLZ-SEYXRHQNSA-N n-butyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCC WIBFFTLQMKKBLZ-SEYXRHQNSA-N 0.000 description 1
- GMJUGPZVHVVVCG-UHFFFAOYSA-N n-hydroxy-n-phenylacetamide Chemical compound CC(=O)N(O)C1=CC=CC=C1 GMJUGPZVHVVVCG-UHFFFAOYSA-N 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- FTVWIRXFELQLPI-UHFFFAOYSA-N naringenin Chemical compound C1=CC(O)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-UHFFFAOYSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 229940053050 neomycin sulfate Drugs 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- FRZBKSSGEGEIAN-UHFFFAOYSA-N nevadensin Natural products COc1cccc(c1)-c1cc(=O)c2c(O)c(OC)c(O)c(OC)c2o1 FRZBKSSGEGEIAN-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000004309 nisin Substances 0.000 description 1
- 235000010297 nisin Nutrition 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- ZCYXXKJEDCHMGH-UHFFFAOYSA-N nonane Chemical compound CCCC[CH]CCCC ZCYXXKJEDCHMGH-UHFFFAOYSA-N 0.000 description 1
- BKIMMITUMNQMOS-UHFFFAOYSA-N normal nonane Natural products CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- YAGMLECKUBJRNO-UHFFFAOYSA-N octyl 4-(dimethylamino)benzoate Chemical compound CCCCCCCCOC(=O)C1=CC=C(N(C)C)C=C1 YAGMLECKUBJRNO-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000003566 oxetanyl group Chemical group 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- GPNDARIEYHPYAY-UHFFFAOYSA-N palladium(ii) nitrate Chemical compound [Pd+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O GPNDARIEYHPYAY-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- KJKJUXGEMYCCJN-UHFFFAOYSA-N parathiazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1CCN1CCCC1 KJKJUXGEMYCCJN-UHFFFAOYSA-N 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 125000005342 perphosphate group Chemical group 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L persulfate group Chemical group S(=O)(=O)([O-])OOS(=O)(=O)[O-] JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- ZQHYKVKNPWDQSL-KNXBSLHKSA-N phenazocine Chemical compound C([C@@]1(C)C2=CC(O)=CC=C2C[C@@H]2[C@@H]1C)CN2CCC1=CC=CC=C1 ZQHYKVKNPWDQSL-KNXBSLHKSA-N 0.000 description 1
- 229960000897 phenazocine Drugs 0.000 description 1
- 229960003799 phenazopyridine hydrochloride Drugs 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 description 1
- 235000019139 phlorizin Nutrition 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 229960001553 phloroglucinol Drugs 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- YCVPRTHEGLPYPB-UHFFFAOYSA-N pinosylvine Natural products OC1=CC(O)=CC(C=CC=2C=CC=CC=2)=C1 YCVPRTHEGLPYPB-UHFFFAOYSA-N 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- NQJGJBLOXXIGHL-UHFFFAOYSA-N podocarpusflavone A Natural products COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)c(c3O2)c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O NQJGJBLOXXIGHL-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000024 polymyxin B Polymers 0.000 description 1
- 229960005266 polymyxin b Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- VLFKNLZNDSEVBZ-UHFFFAOYSA-N procyanidin B-2 monogallate Natural products OC1C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1C(C=1OC2C=3C=C(O)C(O)=CC=3)=C(O)C=C(O)C=1CC2OC(=O)C1=CC(O)=C(O)C(O)=C1 VLFKNLZNDSEVBZ-UHFFFAOYSA-N 0.000 description 1
- VLFKNLZNDSEVBZ-BTWXELLASA-N procyanidin B2 3'-O-gallate Chemical compound O([C@@H]1CC=2C(O)=CC(O)=C(C=2O[C@@H]1C=1C=C(O)C(O)=CC=1)[C@H]1C2=C(O)C=C(O)C=C2O[C@@H]([C@@H]1O)C=1C=C(O)C(O)=CC=1)C(=O)C1=CC(O)=C(O)C(O)=C1 VLFKNLZNDSEVBZ-BTWXELLASA-N 0.000 description 1
- 229960003598 promazine Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- IQHIEHIKNWLKFB-ITTSEVFZSA-N pumcalin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1OC(=O)C1=CC(O)=C(O)C(O)=C11)O)O)OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(OC3=O)C4=C2C(=O)OC2=C4C3=C1C(O)=C2O IQHIEHIKNWLKFB-ITTSEVFZSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000004353 pyrazol-1-yl group Chemical group [H]C1=NN(*)C([H])=C1[H] 0.000 description 1
- 125000004289 pyrazol-3-yl group Chemical group [H]N1N=C(*)C([H])=C1[H] 0.000 description 1
- 125000004497 pyrazol-5-yl group Chemical group N1N=CC=C1* 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 229960000611 pyrimethamine Drugs 0.000 description 1
- HBCQSNAFLVXVAY-UHFFFAOYSA-N pyrimidine-2-thiol Chemical compound SC1=NC=CC=N1 HBCQSNAFLVXVAY-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- SZDMSNWMQAMVTJ-UHFFFAOYSA-N quercetin-3-O-glucoside Natural products OC1OC(COC2=C(C(=O)c3cc(O)cc(O)c3O2)c4ccc(O)c(O)c4)C(O)C(O)C1O SZDMSNWMQAMVTJ-UHFFFAOYSA-N 0.000 description 1
- FZKBNCDAGYDHTP-UHFFFAOYSA-N quercetin-3-O-glycoside Natural products OC1C(O)C(O)C(O)OC1COC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O FZKBNCDAGYDHTP-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
- 229920013730 reactive polymer Polymers 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- LILPTCHQLRKZNG-UHFFFAOYSA-N resveratrol trans-dehydrodimer Natural products C1=CC(O)=CC=C1C1C(C=2C=C(O)C=C(O)C=2)C2=CC(C=CC=3C=C(O)C=C(O)C=3)=CC=C2O1 LILPTCHQLRKZNG-UHFFFAOYSA-N 0.000 description 1
- 150000008265 rhamnosides Chemical class 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 235000019246 rhodoxanthin Nutrition 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical compound OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 description 1
- VFYNXKZVOUXHDX-VDPUEHCXSA-N rifamycin b diethylamide Chemical compound CC1=C(O)C(C=2O)=C3C(OCC(=O)N(CC)CC)=CC=2NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]2(C)OC1=C3C2=O VFYNXKZVOUXHDX-VDPUEHCXSA-N 0.000 description 1
- 229940109171 rifamycin sv Drugs 0.000 description 1
- 229960002599 rifapentine Drugs 0.000 description 1
- 229960003040 rifaximin Drugs 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 235000015639 rosmarinus officinalis Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- OVVGHDNPYGTYIT-BNXXONSGSA-N rutinose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 OVVGHDNPYGTYIT-BNXXONSGSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- WVYADZUPLLSGPU-UHFFFAOYSA-N salsalate Chemical compound OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O WVYADZUPLLSGPU-UHFFFAOYSA-N 0.000 description 1
- STCJJTBMWHMRCD-UHFFFAOYSA-N salvianolic acid B Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=O)C=Cc2cc(O)c(O)c3OC(C(C(=O)OC(Cc4ccc(O)c(O)c4)C(=O)O)c23)c5ccc(O)c(O)c5 STCJJTBMWHMRCD-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 229940055619 selenocysteine Drugs 0.000 description 1
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
- 235000016491 selenocysteine Nutrition 0.000 description 1
- 239000002094 self assembled monolayer Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000011540 sensing material Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 235000014899 silybin Nutrition 0.000 description 1
- 229940043175 silybin Drugs 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- 229960001435 sisomicin sulfate Drugs 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000009450 smart packaging Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011122 softwood Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- QNVPMKAFCVXMFH-UHFFFAOYSA-N suffruticoside A Natural products COC1=CC=C(C(C)=O)C(OC2C(C(O)C(O)C(COC3C(C(O)(COC(=O)C=4C=C(O)C(O)=C(O)C=4)CO3)O)O2)O)=C1 QNVPMKAFCVXMFH-UHFFFAOYSA-N 0.000 description 1
- IIYNOSFQRKUHOL-UHFFFAOYSA-N suffruticoside B Natural products COC1=CC=C(C(C)=O)C(OC2C(C(O)C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(COC3C(C(O)(CO)CO3)O)O2)O)=C1 IIYNOSFQRKUHOL-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- BJNLLBUOHPVGFT-QRZIFLFXSA-N teichomycin Chemical compound CCCCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)OC=2C(=CC(=CC=2)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@H]2C(N[C@H](C3=CC(O)=CC(O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C3C=3C(O)=CC=C(C=3)[C@@H](NC3=O)C(=O)N2)C(O)=O)=O)Cl)=C(OC=2C(=CC(C[C@H](C(N4)=O)NC(=O)[C@H](N)C=5C=C(O6)C(O)=CC=5)=CC=2)Cl)C=C1[C@H]3NC(=O)[C@@H]4C1=CC6=CC(O)=C1 BJNLLBUOHPVGFT-QRZIFLFXSA-N 0.000 description 1
- 229960001608 teicoplanin Drugs 0.000 description 1
- 229960005105 terbutaline sulfate Drugs 0.000 description 1
- KFVSLSTULZVNPG-UHFFFAOYSA-N terbutaline sulfate Chemical compound [O-]S([O-])(=O)=O.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1 KFVSLSTULZVNPG-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 235000014620 theaflavin Nutrition 0.000 description 1
- 229940026509 theaflavin Drugs 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 239000003451 thiazide diuretic agent Substances 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000005556 thienylene group Chemical group 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 1
- LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-N trans-4-coumaric acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960001288 triamterene Drugs 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- ODHXBMXNKOYIBV-UHFFFAOYSA-N triphenylamine Chemical compound C1=CC=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 ODHXBMXNKOYIBV-UHFFFAOYSA-N 0.000 description 1
- 125000005455 trithianyl group Chemical group 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- 229940064636 valacyclovir hydrochloride Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- SVSWTEAHRCVGAR-UHFFFAOYSA-N vitisinol D Natural products C1=CC(O)=CC=C1C=CC1=CC(=O)C2C(=O)C1C(C=1C=C(O)C=C(O)C=1)C2C1=CC=C(O)C=C1 SVSWTEAHRCVGAR-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 235000008209 xanthohumol Nutrition 0.000 description 1
- UVBDKJHYMQEAQV-UHFFFAOYSA-N xanthohumol Natural products OC1=C(CC=C(C)C)C(OC)=CC(OC)=C1C(=O)C=CC1=CC=C(O)C=C1 UVBDKJHYMQEAQV-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
- C08G83/008—Supramolecular polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Manufacturing & Machinery (AREA)
- Materials Engineering (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The copolymer film and the method for synthesizing the copolymer film by the enzymatic self-assembly are prepared at the interface of two liquid phases by the enzymatic reaction of a film-forming monomer containing phenolic hydroxyl, a film-forming monomer containing at least two amino groups and a catalyst. The preparation method has the advantages of simple operation steps, mild reaction conditions and wide selection range of the film forming monomers, and can select the film forming monomers according to application requirements to prepare the copolymer film with corresponding functions. The preparation method of the invention is easy to upgrade from laboratory to industrialized mass production, and has better application prospect.
Description
Technical Field
The invention belongs to a novel polymer material, belongs to the fields of modern chemistry, biology, material science and application science and engineering thereof, and particularly relates to a copolymer membrane and a method and application thereof for enzymatic self-assembly synthesis at a liquid-liquid interface.
Background
Millions of organic matters are found, but the types of monomers which can be truly used as synthetic polymer raw materials are quite limited, and at most hundreds of organic matters are available, so that two or more monomers are utilized to carry out collocation copolymerization in different modes and different proportions to obtain various copolymers with different properties so as to meet different use requirements [ Wang Huai three, kou Xiaokang ]. The polymer chemistry teaching [ M ]. Beijing: scientific press, 2007:213] is still an important development direction. The design and enzymatic synthesis of novel functional polymer materials, the synthesis and application of the nano polymer are all the leading edges of polymer research and development.
The two-dimensional material and the quasi-two-dimensional material have wide application prospects in the front fields of quantum information, artificial intelligence, integrated circuits, life health, brain science, aerospace science and technology and the like, as well as the fields of sensors, logic switches, pharmaceutical preparations, medical diagnosis, electronic information, flexible wearing equipment, intelligent clothing, food safety detection, environmental protection and intelligent packaging. Films with thicknesses on the order of nanometers (1-100 nm), which may be referred to as "nanofilms", may exhibit nanomaterial properties.
The large-scale synthesis of high-quality films with wide adjustability will promote the development of artificial solids with design functions. However, many "bottom-up" polymer film fabrication techniques have significant drawbacks in terms of controllability and the like. The control of the thickness of many layers, particularly the thickness of nanofilms and their uniformity, remains a difficulty in process implementation. Uncontrollable reactions are difficult to realize in large scale commercial production and fewer processes are available to make ultra-thin multilayer films of organic polymer composites.
The stability of the film is very important for the application of the film. LB film (film of monolayer or multi-molecular layer with orderly arranged molecules prepared by Langmuir-Blodgett film forming technology) is evenly and completely regularly arranged on the molecular level. However, the mechanical strength of the LB film deposited with small molecules is not high (the LB film deposited on the substrate is scratched with a force of only several newtons), and the heat resistance, the solvent resistance and the environmental resistance are poor, and practical application is limited. In order to overcome these disadvantages, it is effective to introduce a group capable of further polymerization reaction into a film-forming small organic molecule compound to make it high-molecular [ He Pingsheng: polymerization of monolayer and Langmuir-Blodgett film [ M ]. Co-fertilizer: chinese university of science and technology Press, 2008:58.]. However, since the LB film requires amphipathic property of the film-forming organic compound monomer molecules, and the molecular chain length is limited by suitable conditions, the selection range of LB film-forming monomers is greatly limited, and difficulty is brought to the design of LB film-forming materials. Moreover, since the polymerization of monomers into polymers is a transition from van der Waals interaction distance to chemical bond distance, the shortening of the distance between molecules leads to shrinkage of the formed monolayer polymer or polymerized LB film, and the overall order of the film is not ensured [ He Pingsheng: polymerization of monolayer and Langmuir-Blodgett film [ M ]. Co-fertilizer: chinese university of science and technology Press, 2008:61.].
The supermolecular material is a modern novel material in development stage, and is based on supermolecular chemistry, and is prepared by utilizing intermolecular non-covalent bond linkage (such as hydrogen bond interaction, electron donor-acceptor interaction, ion interaction and the like) [ Zhang Zhijie ], material physical chemistry [ M ]. Beijing: chemical industry press 2020:53.]. The self-assembled membrane is an ordered supermolecule system formed by spontaneous adsorption of active molecules on heterogeneous interfaces through chemical bonds.
The development of more kinds of copolymer films and simple preparation methods thereof meets specific application requirements and becomes the direction of researchers.
Disclosure of Invention
The invention provides a method for synthesizing a copolymer film, the copolymer film prepared by the method and application thereof.
The invention relates to a method for preparing an organic copolymer film by polymerizing and self-assembling two kinds of film-forming monomers under the catalysis of a catalyst at two mutually-insoluble liquid phase interfaces (liquid-liquid interfaces), wherein one kind of film-forming monomers is an organic compound containing phenolic hydroxyl groups, and the other kind of film-forming monomers is an organic compound containing at least two amino groups. The organic copolymer film can introduce other molecules and/or atoms into the surface of the film through secondary and/or repeated chemical and/or enzymatic reactions to obtain the expected chemical composition, molecular structure, physical property and chemical property, realize the performance of the film and meet the application requirements.
In order to improve the technical problems, the invention provides a method for synthesizing a copolymer film, which comprises the following steps:
and (2) dissolving a film-forming monomer containing phenolic hydroxyl groups, a film-forming monomer containing at least two amino groups and a catalyst in an aqueous phase and/or a liquid phase which is mutually insoluble in water, and polymerizing at the interface of the two phases to form the copolymer film.
Preferably, the copolymer film is obtained by dissolving a film-forming monomer containing a phenolic hydroxyl group and a film-forming monomer containing at least two amino groups in a solvent, adding a catalyst, mixing to obtain a water phase, contacting the water phase with a liquid phase which is mutually insoluble with water, and polymerizing at the interface of the two phases to form a film.
Preferably, the film-forming monomer containing phenolic hydroxyl groups is dissolved in a solvent, a catalyst is added and mixed to obtain an aqueous phase, the film-forming monomer containing at least two amino groups is dissolved in a liquid phase which is mutually insoluble with water, the aqueous phase is contacted with the liquid phase which is mutually insoluble with water to generate enzymatic reaction, and the copolymer film is polymerized at the interface of the two phases to form the film.
Preferably, the film-forming monomer containing at least two amino groups is dissolved in a solvent, a catalyst is added and mixed to obtain an aqueous phase, the film-forming monomer containing phenolic hydroxyl groups is dissolved in a liquid phase which is mutually insoluble with water, the aqueous phase is contacted with the liquid phase which is mutually insoluble with water, and the copolymer film is polymerized at the interface of the two phases to obtain the copolymer film.
Preferably, the catalyst is dissolved in an aqueous phase, a film-forming monomer containing phenolic hydroxyl groups and a film-forming monomer containing at least two amino groups are dissolved in a liquid phase which is mutually insoluble with water, the aqueous phase is contacted with the liquid phase which is mutually insoluble with water to generate enzymatic reaction, and the copolymer film is polymerized at the interface of the two phases to form the film.
According to an embodiment of the present invention, the aqueous phase is an aqueous solution having a water content of not less than 50% by total mass; the film forming monomer can be dissolved and can contain a certain amount of organic solvent which is dissolved in water, wherein the organic solvent can be at least one of methanol, ethanol, isopropanol, acetone, methyl formate, ethyl acetate, acetonitrile, tetrahydrofuran, N-dimethylformamide, 1, 4-dioxane, dimethyl sulfoxide, diethylene glycol butyl ether and diethylene glycol;
according to an embodiment of the present invention, the solvent is selected from water or a buffer solution, and a buffer solution and buffer pair of the buffer solution are pH buffers suitable for supporting the polymerization reaction, not limited to any specific pH buffer. The buffer solution is preferably a sodium acetate-acetic acid buffer solution, disodium hydrogen phosphate-citric acid buffer solution, potassium hydrogen phthalate-sodium hydroxide buffer solution, tartaric acid-sodium tartrate buffer solution, sodium citrate-citric acid buffer solution, trisodium phosphate-phosphoric acid buffer solution, sodium malonate-malonic acid buffer solution, sodium succinate-succinic acid buffer solution, phthalic acid-hydrochloric acid buffer solution, disodium hydrogen phosphate-sodium dihydrogen phosphate buffer solution, disodium hydrogen phosphate-potassium dihydrogen phosphate buffer solution, dipotassium hydrogen phosphate-sodium hydroxide buffer solution, tris-hydrochloric acid buffer solution, boric acid-borax buffer solution, glycine-sodium hydroxide buffer solution.
According to an embodiment of the present invention, the liquid phase that is not water-miscible may be an oil that is liquid at ordinary temperature, an oil that is solid at a set temperature, or a liquid metal. The normal temperature liquid oil may be at least one of vegetable oil, mineral oil and synthetic water insoluble liquid. The vegetable oil can be peanut oil, soybean oil, linseed oil, castor oil, rapeseed oil, corn oil, olive oil, sesame oil, cinnamon oil, essential oil, etc. The mineral oil can be petroleum (crude oil), condensate oil, gasoline, kerosene, diesel oil, lubricating oil, transformer oil, engine oil, liquid paraffin, paraffin and coal tar. The synthetic water insoluble liquid includes at least one of various silicone oils, aromatic hydrocarbons (such as benzene, toluene, xylene, dichlorotoluene, bromobenzene, etc.), alkanes (such as pentadecane, tetradecane, tridecane, dodecane, undecane, nonane, isooctane, hexane, trichloromethane, tetrachloromethane, carbon tetrachloride, carbon disulfide, etc.), cycloalkanes (such as cyclohexane, cyclopentane, cycloheptane, etc.), ethers (such as petroleum ether, butyl ether, etc.), esters (such as butyl oleate, butyl acetate, butyl palmitate, etc.), ketones (such as 2-nonanone, methyl isobutyl ketone, 3-hexanone, etc.), organic acids (such as octanoic acid, etc.). The oil is solid at a set temperature, such as at least one of paraffin, cocoa butter, coconut oil, palm oil, and animal oil. The animal oil can be derived from pig, cattle, sheep, horse, chicken, whale, insect (such as Cera flava, insect wax, etc.), etc. Such as gallium, mercury, low melting point alloys.
According to an embodiment of the invention, the catalyst may be at least one of a peroxidase and/or an oxidoreductase having laccase activity and/or an artificial enzyme having the aforementioned catalytic activity;
according to an embodiment of the present invention, the peroxidase may be selected from at least one of manganese peroxidase (Manganese peroxidase, mnP, EC 1.11.1.13), lignin peroxidase (lin peroxidase, liP, EC 1.11.1.14) and Chloroperoxidase (Chloroperoxidase, CPO, EC 1.11.1.10), plant peroxidase (Plant peroxidase); the plant peroxidase may be horseradish peroxidase (Horseradish peroxidase, HRP, EC 1.11.1.7), soybean peroxidase (Soybean peroxidase, SBP, EC 1.11.1.7), rice peroxidase (Rice peroxidase), cotton peroxidase (Cotton peroxidase), safflower bean peroxidase (Runner beans peroxidase), chickpea peroxidase (Garbanzo beans peroxidase), guar peroxidase (Guar beans peroxidase), pea peroxidase (Pea peroxidase), and the like.
According to an embodiment of the invention, the oxidoreductase having Laccase activity is at least one of a enzyme classification EC 1.10.3.2 specified by the nomenclature committee of the international union of biochemistry and molecular biology (Nomenclature Committee of the International Union of Biochemistry and molecular Biology, IUBMB) comprising any Laccase (lacccase) from plants, animals, fungi, bacteria, yeasts or obtained by biotechnology, and/or any fragment exhibiting Laccase activity from its source, and/or an enzyme exhibiting similar activity, such as Catechol oxidase (Catechol oxidase, CO, EC 1.10.3.1) or any fragment exhibiting Catechol oxidase activity from its source, monophenol monooxidase (Monophenol monooxygenase, EC 1.14.18.1) or any fragment exhibiting monophenol monooxidase activity from its source, bilirubin oxidase (Bilirubin oxidase, BOD, EC 1.3.3.5) or any fragment exhibiting bilirubin oxidase activity from its source.
According to an embodiment of the invention, the laccase of plant origin is selected from laccase in the group consisting of Anacardiaceae (Anacardiaceae), momordica (podocarpae), aesculus (aeacculus sp.), acer palmatum (Acer pseudoplatanus), vinca (Catharanthus roseus), carrot (Daucus carrata), dichomitius squalens), ginkgo (ginko biloba), apple (Malus pumila), cymbidium (Monotropa hypopithys), avocado (Persea americana), peach (Prunus persica), potato (Solanum tuberosum), rosemary (Rosmarinus officinalis), vinca minor (Vinca minor) extracts.
According to an embodiment of the invention, the laccase is preferably a fungal laccase. The fungal laccase is selected from the group consisting of agaricus bisporus (Agaricus bisporus), aspergillus nidulans (Agaricus bisporus), botrytis cinerea (Botrytis cinerea), ceralopecuroides (Agaricus bisporus), acremonium monocolor (Cerrena unicolor), coriolus thermophilus (Agaricus bisporus), acremonium bud (Agaricus bisporus), coprinus cinereus (Agaricus bisporus), coriolus versicolor (Agaricus bisporus), phellinus linteus (Agaricus bisporus), ganoderma lucidum (Agaricus bisporus), callicarpa sativa (Agaricus bisporus), monascus pinnatifida (Agaricus bisporus), rumex crispus (Agaricus bisporus), pleurotus saxifraga (Agaricus bisporus), thermomyces lanuginosus (Agaricus bisporus), myces lanuginosus (Agaricus bisporus), phanerochaete chrysosporium (Agaricus bisporus), pleurotus roseus, pachytridactylotheca (Agaricus bisporus), pleurotus grifolius (Agaricus bisporus), hymenochaete pensis (Agaricus bisporus), hymenochaetes rupulus (Agaricus bisporus), hymenochaete, russella (Agaricus bisporus) and (Agaricus bisporus), trametes versicolor (Tramates versicolor) and laccase variants thereof.
Preferably, the fungus laccase is Polyporus winter (Polyporus brumalis) (the preservation number of the strain is CCTCC NO: M2020809) laccase.
Laccase may also be an enzyme produced by a method comprising the steps of: culturing a host cell transformed with a recombinant DNA vector carrying a DNA sequence encoding the function of the laccase in a culture medium under conditions such that the laccase is expressed, and recovering the laccase from the culture.
Fungal laccase has the following advantages over other enzymes: (1) The catalytic substrate is wide, and the enhancer added with the enzyme can catalyze more substrates; (2) a high redox potential compared to bacterial laccase; (3) the industrialized preparation is easier to realize; (4) lower cost; (5) no coenzyme is required; (6) The oxidant uses molecular oxygen, so that hydrogen peroxide is not required to be added in the reaction; (7) Water is the only byproduct and does not form an enzyme-substrate complex that is useless; (8) glycosylation modification is carried out, so that the stability of the enzyme is good; (9) low sensitivity to metal ions in the medium; (10) resistance to a number of organic solvents.
According to an embodiment of the present invention, the phenolic hydroxyl group-containing compound has a structure as shown in formula I:
wherein each R 1 The same or different are independently selected from H, halogen, CN, NO 2 OH, SH, COOH, unsubstituted or substituted by one, two or more R a1 Substituted with the following groups: c (C) 1-40 Alkyl, C 2-40 Alkenyl, C 2-40 Alkynyl, C 3-40 Cycloalkyl, C 3-40 Cycloalkenyl, C 3-40 Cycloalkynyl radicals, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclyl, -OR 1-2 、-SR 1-3 、-NR 1-4 R 1-5 、-C(O)R 1-6 、-OC(O)R 1-7 、-S(O) 2 R 1-8 、-OS(O) 2 R 1-9 、-P(O)R 1-10 R 1-11 、-N=NR 1-12 ;
A 1 Presence or absence; when A is 1 When present, is selected from unsubstituted or substituted by one, two or more R b1 Substituted C linked to the benzoring 6-20 Aryl, 5-20 membered heteroaryl, 5-20 membered heterocyclyl; or A 1 Selected from chemical bonds, unsubstituted or optionally substituted by one, two or more R c1 Substituted O, C (O), C (O) O, S, S (O) 2 、N、C 1-6 Alkylene, ch= N, N = N, CH =n-n=ch, ch=ch-CO-CH 2 -CO-CH=CH;
m is an integer of 0 to 5.
Each R a1 、R b1 、R c1 Identical or different, independently of one another, from the group consisting of H, halogen, CN, OH, SH, oxo (= O), NO 2 、COOH、-OR 1-2 、-SR 1-3 、-NR 1-4 R 1-5 、-C(O)R 1-6 、-OC(O)R 1-7 、-S(O) 2 R 1-8 、-OS(O) 2 R 1-9 、P(O)R 1- 10 R 1-11 Unsubstituted or optionally substituted by one, two or more R 1-12 Substituted C 1-40 Alkyl, C 2-40 Alkenyl, C 2-40 Alkynyl, C 3-40 Cycloalkyl, C 3-40 Cycloalkenyl, C 3-40 Cycloalkynyl radicals, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclyl;
each R is 1-2 、R 1-3 、R 1-4 、R 1-5 、R 1-6 、R 1-7 、R 1-8 、R 1-9 、R 1-10 、R 1-11 、R 1-12 Identical or different, independently of one another, from the group consisting of H, halogen, CN, OH, SH, oxo (= O), NO 2 、COOH、C 1-40 Alkyl, C 2-40 Alkenyl, C 2-40 Alkynyl, C 3-40 Cycloalkyl, C 3-40 Cycloalkenyl, C 3-40 Cycloalkynyl radicals, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclyl.
According to an embodiment of the present invention, formula I has the structure shown in formulas I-1 to I-13:
wherein R is 1 M and R c1 Having the definition set forth above; b is selected from O or R 1 Substituted N; D. d (D) 1 、D 2 And D 3 Identical or different, independently of one another, from chemical bonds, unsubstituted or optionally substituted by one, two or more R c1 Substituted O, CH 2 C (O) or N-CO-CH 3 The method comprises the steps of carrying out a first treatment on the surface of the E and E 1 Identical or different, independently of one anotherSelected from chemical bonds, unsubstituted or optionally substituted by one, two or more R c1 Substituted O, C (O), C (O) O, S, S (O) 2 、N、Se、P、C 1-6 Alkylene, ch=ch, ch= N, N = N, CH =n-n=ch, ch=ch-CO-CH 2 -CO-ch=ch; n is an integer of 0 to 5; f (F) 1 And F 2 The same or different, independently of one another, are selected from N, CH or O + ;R 1 ’、R 1 "and R 1 Is the same as defined in the following.
Preferably, the compound of formula I-1 is selected from catechol (CAS: 120-80-9), 3-methylcatechol (CAS: 488-17-5), 3, 4-dihydroxytoluene (CAS: 452-86-8), 4-ethylcatechol (CAS: 1124-39-6), 4-tert-butyl-1, 2-benzenediol (CAS: 98-29-3), 3, 5-di-tert-butyl-1, 2-benzenediol (CAS: 1020-31-1), 3-methoxycatechol (CAS: 934-00-9), 3, 4-dihydroxybenzaldehyde (CAS: 139-85-5), 3, 4-dihydroxystyrene (CAS: 6053-02-7), 2',4' -dihydroxyacetophenone (CAS: 89-84-9), hydroxytyrosol (CAS: 10597-60-1), dopamine (CAS: 51-61-6) and salts thereof, 3-methacryl dopamine (CAS: 471915-89-6), epinephrine (CAS: 51-43), isopropanolamine (CAS: 139-5), 3, 4-dihydroxyacetophenone (CAS: 35-9), 5-bromocatechol (CAS: 35-35), and salts thereof, and the like, and the reagent (3, 4-dihydroxycatechol, 3-dihydroxybenzaldehyde (CAS: 39-5) may be selected from the group consisting of catechol, 3-dihydroxyacetophenone (CAS: 39-9) Esters such as ethyl 3, 4-dihydroxybenzoate (CAS: 3943-89-3), esters such as ethyl 2, 3-dihydroxybenzoate, 4-nitrocatechol (CAS: 3316-09-4), urushiol, suilin (CAS: 103538-03-0), grifolin (CAS: 6903-07-7), ilicifolin B (CAS: 22581-07-3), resorcinol (CAS: 108-46-3), 4-chlororesorcinol (CAS: 95-88-5), 2, 6-dihydroxytoluene (CAS: 608-25-3), 2, 4-dihydroxybenzaldehyde (CAS: 1995-1-2), 2',4' -dihydroxyacetophenone (CAS: 89-84-9), 2',6' -dihydroxyacetophenone (CAS: 699-83-2), 4-hexylresorcinol (CAS: 136-77-6), cardiotonic phenol (Cardol), terbutaline sulfate (CAS: 31-32-5), hydroquinone (CAS: 123-9), hydroquinone (CAS: 108-46-3), 4-chlororesorcinol (CAS: 95-88-5), 2,6 '-dihydroxyacetophenone (CAS: 35-35), 2', 35-dihydroxyacetophenone (CAS: 35-35), and 15235-6-5) Calcium dobesilate (CAS: 20123-80-2), cannabigerol (CAS: 25654-31-3), oxacinne sulfate (CAS: 5874-97-5), cannabidiol (CAS: 13956-29-1), phloroglucinol (CAS: 6099-90-7), 2,4, 6-trihydroxybenzaldehyde (CAS: 487-70-7), ethyl 2,4, 6-trihydroxybenzoate (CAS: 90536-74-6) and the like, hydrochloric acid-6-hydroxydopamine (CAS: 28094-15-7), hydrobromic acid 6-hydroxydopamine (CAS: 636-00-0), 2,4, 5-trihydroxybenzylalanine (CAS: 23358-64-7), pyrogallol (CAS: 87-66-1), 2',3',4' -trihydroxy acetophenone (CAS: 528-21-2), 2,3, 4-trihydroxybenzaldehyde (CAS: 2144-08-3), methyl 2,4, 6-trihydroxybenzoate (CAS: 99-24-1), bromoethyl bromide (CAS: 90536-74-6), and the like), methyl phenol (CAS: 106-6-5-hydroxydopamine (CAS: 35-6-hydroxy-6), methyl phenol (CAS: 106-6-5), methyl phenol (CAS: 106-6-5-hydroxy phenol) and the like, 6-hydroxy phenol (CAS: 106-6-5-methyl phenol) and the like, 2, 3-dimethoxyphenol (CAS: 5150-42-5), 4-ethylphenol (CAS: 123-07-9), vanillin (CAS: 121-33-5), isovanillin (CAS: 621-59-0), vanillyl alcohol (CAS: 498-00-0), guaiacol (CAS: 90-05-1), o-acetaminophen (CAS: 614-80-2), acetaminophen (CAS: 103-90-2), 3,4, 5-trimethoxyphenol (CAS: 642-71-7), 4- (2' -thiazolylazo) resorcinol (CAS: 2246-46-0), esters such as ethyl 2,3, 4-trihydroxybenzoate, benserazide hydrochloride (CAS: 14919-77-8), and the like.
Preferably, the compound of I-2 is selected from the group consisting of 3', 4-dihydroxyflavone (CAS: 4143-64-0), 6, 7-dihydroxyflavone (CAS: 38183-04-9), 7, 8-dihydroxyflavone (CAS: 38183-03-8), farnesin (CAS: 480-44-4), coryza (CAS: 480-40-0), kaempferin (CAS: 491-54-3), lycopene (CAS: 520-12-7), isorhamnetin (CAS: 480-19-3), geransin (CAS: 520-34-3), coumartin (CAS: 4423-37-4), daidzein (CAS: 491-71-4), valin (CAS: 480-15-9), azascine (CAS: 529-51-1), tamaxanthin (CAS: 603-61-2), 5, 7-dihydroxy-2- (4-hydroxyphenyl) -6, 8-dimethoxy-4H-1-benzopyran-4-one (CAS: 520-35-80), coumarone (CAS: 4323-37-4), azascine (CAS: 491-48), azascine (CAS: 548-35-48), homogin (CAS: 52-35-8), homogin (CAS: 52-35-8) Dihydroquercetin (CAS: 6151-25-3), 6-methoxygambogin (CAS: 520-11-6), 3-O-methyl quercetin (CAS: 1486-70-0), morin (CAS: 480-16-0), luteolin (CAS: 491-70-3), quercetin (CAS: 117-39-5), myricetin (CAS: 529-44-2), genkwanin (CAS: 437-64-9), 5, 7-dihydroxy-6,8,4 ' -trimethoxyflavone (CAS: 10176-66-6), pimannoxin (CAS: 56003-01-1), kaempferol (CAS: 520-18-3), scutellarin (CAS: 529-53-3), 7,3',4' -trihydroxy-3, 8-dimethoxyflavone, 3,7,3',4' -tetrahydroxy-8-methoxyflavone, 3,7,8,3',4' -pentahydroxyflavone, and the like.
Preferably, the compound of I-3 is selected from Dekkoxaden (CAS: 897-46-1), daidzein (CAS: 486-66-8), biochanin A (CAS: 491-80-5), 4',6, 7-trihydroxyisoflavone (CAS: 17817-31-1), genistein (CAS: 446-72-0), olol (CAS: 480-23-9), karaine (CAS: 20575-57-9), prunetin (CAS: 552-59-0), and the like.
Preferably, the compound of I-4 is selected from escin (CAS: 305-01-1), 4-methyl escin (CAS: 529-84-0), and the like.
Preferably, the compound of I-5 is selected from the group consisting of hesperetin (CAS: 520-33-2), naringenin (CAS: 67604-48-2), flavodoxin (CAS: 20725-03-5), naringenin (CAS: 480-41-1), epicatechin (CAS: 24808-04-6), robinetin (CAS: 4382-33-6), dihydroquercetin (CAS: 480-18-2), dihydromyricetin (CAS: 27200-12-0), eriodictyol (CAS: 552-58-9), non-sirolimus (CAS: 490-49-3), (+) -Rhobatanol (CAS: 17445-90-8), gallocatechin (CAS: 3371-27-5), 4', 7-dihydroxyisoflavan (CAS: 531-95-3), avermectin (CAS: 2545-00-8), (+) -catechin (CAS: 154-23-4), epigallocatechin (CAS: 970-74-1), epicatechin, broussonetianol, phenazocine, monomeric procyanidins, monomeric faberidine, monomeric procyanidins, dihydromyricetin, 3' -hydroxy-35-84, etc.
Preferably, the compound of I-6 is selected from the group consisting of anthocyanin (CAS: 528-58-5), delphinidin chloride (CAS: 528-53-0), pelargonidin (CAS: 134-04-3), cassidine chloride (CAS: 23130-31-6), petuniin (CAS: 1429-30-7), malvidin (CAS: 643-84-5), and the like.
Preferably, the compound of I-7 is selected from the group consisting of p-phenylphenol (CAS: 92-69-3), azo violet (CAS: 74-39-5), 2, 4-dihydroxybenzophenone (CAS: 131-56-6), phenethylresorcinol (CAS: 85-27-8), xanthohumol (CAS: 6754-58-1), resveratrol (CAS: 501-36-0), rosmarinic acid (CAS: 20283-92-5), phloretin (CAS: 60-82-2), nordihydroguaiaretic acid (CAS: 500-38-9), tetrahydroxy stilbene, piceatannol (CAS: 10083-24-6), curcumin (CAS: 458-37-7), bisphenol A (CAS: 80-05-7), 2 '-dihydroxybiphenyl (CAS: 1806-29-7), 4' -dihydroxybiphenyl (CAS: 92-88-6), phenolphthaline (CAS: 81-90-3), thiobischlorophenol (CAS: 97-18-7), bischlorophenol (CAS: 97-23-4), 2 '-dihydroxybenzophenone (CAS: 835-11-0), 4' -dihydroxybenzophenone (CAS: 80-35-607) and 4-99-96-5 2,2' -dihydroxy-4-methoxybenzophenone (CAS: 131-53-3), honokiol (CAS: 35354-74-6), magnolol (CAS: 528-43-8), diethylstilbestrol (CAS: 5635-50-7), diethylstilbestrol (CAS: 6898-97-1), 3', 5' - (tetraisopropyl) biphenyl 4,4' -diol (CAS: 2416-95-7), 2' -dihydroxydiphenyl ether (CAS: 15764-52-0), dobutamine hydrochloride (CAS: 49745-95-1), witch hazel tannin (CAS: 469-32-9), 2, 3', 4', 5-hexahydroxydiphenylsulfone, 3', 4', 5' -hexahydroxydiphenylsulfone, 2', 3', 4' -hexahydroxydiphenylsulfone, hexahydroxydiphenylacid, and the like.
Preferably, the compound of I-8 is selected from 2, 3-dihydroxynaphthalene (CAS: 92-44-4), 1, 2-dihydroxynaphthalene (CAS: 574-00-5), 1, 3-dihydroxynaphthalene (CAS: 132-86-5), 1, 5-dihydroxynaphthalene (CAS: 83-56-7), 1, 6-dihydroxynaphthalene (CAS: 575-44-0), 1, 7-dihydroxynaphthalene (CAS: 575-38-2), 1, 4-dihydroxynaphthalene (CAS: 571-60-8), 2, 7-dihydroxynaphthalene (CAS: 582-17-2), 6, 7-dihydroxy-2-sodium naphthalene sulfonate (CAS: 135-53-5), 3, 5-dihydroxy-2-naphthoic acid (CAS: 89-35-0), calcium carboxylic acid (CAS: 3737-95-9), calcium magnesium reagent (CAS: 3147-14-6), edestin blue R (CAS: 2538-85-4), chromium-2R (CAS: 4197-07-3), dicarboxyphenyl acid (CAS: 130-85-8), beryllium II (51550-25-5), chromic acid (CAS: 582-17-2), 6, 7-dihydroxy-2-naphthoic acid (CAS: 89-35-25), chromium (3838-35-6), chromium (3848), chromium (387-35-9), and chromium (387-35-6), chromium (387-35-9), and chromium (387-35-9) And Everest blue SE (CAS: 1058-92-0), etc.
Preferably, the compound of I-9 is selected from shikonin (CAS: 517-89-5) and the like.
Preferably, the compound of I-10 is selected from the group consisting of aloesin (CAS: 481-72-1), dithranol (CAS: 1143-38-0), 1, 5-dihydroxyanthraquinone (CAS: 117-12-4), 1, 4-dihydroxyanthraquinone (CAS: 81-64-1), 1, 8-dihydroxyanthraquinone (CAS: 117-10-2), 10-acetyl-3, 7-dihydroxyphenazine (CAS: 119171-73-2), anthralin (CAS: 117-12-4), chrysophanol (CAS: 481-74-3), rhein (CAS: 478-43-3), 1,2, 3-trihydroxyanthraquinone (CAS: 602-64-2), rhodoxanthin (CAS: 81-54-9), alizarin red (CAS: 130-22-3), alizarin complexing indicator (CAS: 3952-78-1), alizarin (CAS: 72-48-0), alizarin red S (CAS: 130-22-3), tolanthraquinone hydrochloride (70476-82-3), fluocinolone (CAS: 518-5), emodin (CAS: 518-82), and alizarin (CAS: 35-82), and alizarin (35-8-35-81-82) Alpha-mangostin (CAS: 6147-11-1), and the like.
Preferably, the compound of I-11 is selected from the group consisting of galloblue (CAS: 1562-85-2), azulene (CAS: 1562-90-9), and the like.
Preferably, the compound of I-12 is selected from 1,8, 9-trihydroxyanthracene (CAS: 480-22-8), and the like.
Preferably, the compound of I-13 is selected from the group consisting of parahydroxybenzoic acid (CAS: 99-96-7), m-hydroxybenzoic acid (CAS 99-06-9), vanillic acid (CAS 121-34-6), isovanillic acid (CAS 645-08-9), 4-hydroxy-2-methoxybenzoic acid (CAS 90111-34-5), 3-hydroxy-5-methoxybenzoic acid (CAS 19520-75-6), salicylic acid (CAS 69-72-7), p-aminosalicylic acid (CAS 65-49-6), m-aminosalicylic acid (CAS 89-57-6), 3-methylsalicylic acid (CAS 83-40-9), 5-methylsalicylic acid (CAS 89-56-5), 3-methoxysalicylic acid (CAS 877-22-5), 4-methoxysalicylic acid (CAS 2237-36-7), 5-methoxysalicylic acid (CAS 2612-02-4), 6-methoxysalicylic acid (CAS 3147-64-6), 3, 5-diiodosalicylic acid (CAS 133-91-5), syringic acid (CAS 530-57-6), eugenol (CAS 35-37-60), and 35-37-60-45-35-60, such as ginkgolic acid Diflunisal (CAS: 22494-42-4), gentisic acid (CAS: 490-79-9), pyrocatechol (CAS: 303-38-8), resorcinol acid (CAS: 89-86-1), 3, 5-dihydroxybenzoic acid (CAS: 99-10-5), 2, 6-dihydroxybenzoic acid (CAS: 303-07-1), gallic acid (CAS: 149-91-7), ferulic acid (CAS: 1135-24-6), p-coumaric acid (CAS: 501-98-4), tyrosine, sinapic acid (CAS: 530-59-6), 4-hydroxymandelic acid (CAS: 1198-84-1), 2-hydroxyphenylglycine (CAS: 25178-38-5), caffeic acid (CAS: 331-39-5), diphenolic acid (CAS: 126-00-1), protocatechuic acid (CAS: 99-50-3), danshensu (CAS: 76822-21-4), dopa, methyldopa (CAS: 555-30-6), 2,4, 6-trihydroxybenzoic acid (CAS: 5783-30-7), and the like.
According to an embodiment of the present invention, formula I also includes substances in which two or more structural units represented by formulas I-1 to I-13 are present in the structure, such as pinosylvin (CAS: 521-34-6), cinnamon tannins (CAS: 86631-38-1), 2 '-dihydroxy-1, 1' -binaphthyl (CAS: 602-09-5), 6 '-dithiodinaphthol (CAS: 6088-51-3), hyperin (CAS: 548-04-9), thiopyrimidine pamoate (CAS: 22204-24-6), 2, 3-dihydroginkgetin (CAS: 34421-19-7), amentoflavone (CAS: 1617-53-4), isoginkgetin (CAS: 548-19-6), norginkgetin (CAS: 521-32-4), 5' -methoxyginkgetin (CAS: 77053-35-1), ginkgetin (CAS: 481-46-9), procyanidin B1 (CAS: 20315-25-7), procyanidin B2 (CAS: 29106-49-8), procyanidin B3 (CAS: 23567-23-9), procyanidin B4 (CAS: 06-51-2), procyanidin B5 (CAS: 12798-57-1), procyanidin B6 (CAS: 12798-58-2), procyanidin B (CAS: 3878-59), procyanidin B8 (CAS: 12798-60-6), (-) -epigallocatechin gallate (CAS: 989-51-5), epicatechin gallate (CAS: 1257-08-5), catechin gallate (CAS: 130405-40-2), gallocatechin gallate (CAS: 4233-96-9), procyanidin B2-3' -O-gallate, dehydrocatechin B, tetrabrominated tannin, procyanidin B-2,3' -O-gallate, procyanidin B-2,3' -di-O-gallate, procyanidin B1 (CAS: 78362-04-6), procyanidin B2 (CAS: 87392-61-8), procyanidin B3 (CAS: 78362-05-7), procyanidin B4 (CAS: 68964-95-4), and the like.
According to an embodiment of the invention, the compounds of formula I further comprise: saxifragin (CAS: 477-90-7), hanbain (CAS: 632-85-9), tectorigenin (CAS: 548-77-6), licoflavone (CAS: 59870-68-7), ellagic acid (CAS: 476-66-4), catalin (CAS: 82-08-6), yunnan J (CAS: 99217-67-1), hematoxylin oxide (CAS: 475-25-2), rhodol (CAS: 569-77-7), gnetin A (CAS: 82084-87-5), pyrogallol red (CAS: 32638-88-3), hematoxylin (CAS: 517-28-2), catechol violet (CAS: 115-41-3), 1-naphtholphthalein (CAS: 596-01-0), azoarsin I (CAS: 520-10-5), azoarsin III (CAS: 1668-00-4), phenolphthalein (CAS: 77-09-8), phenol red (CAS: 74-8), tetraiodoform (CAS: 569-77-7), ganin A (CAS: 82084-87-5), pyrogallol red (CAS: 32638-88-3), hematoxylin (CAS: 517-5-125-3), hematoxylin (CAS: 596-5), 4-5-40-5), and luciferin (CAS: 596-5) Rosolic acid (CAS: 633-00-1), thymol blue (CAS 76-61-9), alizarin violet (CAS 2103-64-2), glabridin (CAS 60008-03-9), ke Pusu, anthocyanin, cuacodine, heimiolA, balanicarpol α -H, dehydrocatechin A, fulvic acid (CAS 479-66-3) and salts thereof, mycophenolic acid (CAS 24280-93-1), alizarin blue S (CAS 66675-89-6), apomorphine hydrochloride (CAS 41372-20-7), (4E) -6- (4, 6-dihydroxy-7-methyl-3-oxo-1, 3-dihydroisobenzofuran-5-yl) -4-methyl-4-hexenoic acid 2- (morpholin-4-yl) ethyl ester (CAS 1322681-36-6), (+) -boldine (CAS 70-0), pseudoclip 24-6), tubuloside (CAS 57-94-3), silybin (888-7-methyl-3), fuzosin (13292-92-1), fuzosin (13292-92-35-6), and rifampicin (13292-35-80-1) Rifamycin SV, rifaximin (CAS: 80621-81-4), doxorubicin hydrochloride (CAS: 25316-40-9), epirubicin hydrochloride (CAS: 56360-09-1), rifapentine (CAS: 61379-65-5), doxorubicin (CAS: 54193-28-1), li Fumi Tet (CAS: 2750-76-7), vancomycin and salts thereof, norvancomycin hydrochloride (CAS: 213997-73-0), yellow-3-en-3-ol, teicoplanin (CAS: 61036-62-2), malibatol A, malibatol B (CAS: 204644-72-4), suffruticoside A, suffruticoside B, vactanol C, and the like.
According to an embodiment of the invention, the compounds of formula I further comprise: polyphenols.
According to an embodiment of the present invention, the polyphenol comprises: procyanidin (CAS: 4852-22-6), procyanidin A1 (CAS: 103883-03-0), procyanidin A2 (CAS: 41743-41-3), procyanidin A4 (CAS: 111466-29-6), procyanidin C1 (CAS: 37064-30-5), procyanidin C2 (CAS: 37064-31-6), cinnamon tannin B1 (CAS: 88082-60-4), cinnamon tannin B2 (CAS: 88038-12-4), theaflavin (CAS: 4670-05-7), tea polyphenols (CAS: 84650-60-2), tannins (CAS: 1401-55-4), vain (CAS: 79786-01-9), cerin (CAS: 81739-27-7), daviciin T1 (CAS: 137371-86-9), granatin (CAS: 65995-64-4), gemin A (CAS: 137371-86), sanguisorba officinalis H2 (CAS: 4630-52-35), tea polyphenols (CAS: 84650-60-35-6), tannins (CAS: 81739-35-7), davidian (CAS: 8179), davidian, and (CAS: 8234-35) Equisetum (CAS: 79786-00-8), alpha-viniferin (CAS: 62218-13-7), epsilon-viniferin (CAS: 62218-08-0), delta-viniferin, gnetin C (CAS: 84870-54-2), gnetin D (CAS: 84870-53-1), gnetin J (CAS: 152511-23-4), pallidol (CAS: 105037-88-5), uterol C (CAS: 109605-83-6), salvianolic acid B (CAS: 115939-25-8), humic acid (CAS: 1415-93-6) and salts thereof, nitro humic acid (Nitro humicic acid), huangfen, dehydrodittanoic acid, valonec acid and esters thereof, biflavanethecine, oolong tea, granin, delphinidin, and the like.
According to an embodiment of the invention, the compounds of formula I further comprise: compounds of the formula I-1 to I-13 in combination with quinic acid and/or glycosyl and/or sugar acid form, such as arbutin (CAS: 497-76-7), scutellarin (CAS: 27740-01-8), native daidzin (CAS: 155-58-8), chlorogenic acid (CAS: 327-97-9), colchicoside (CAS: 604-80-8), puerarin (CAS: 3681-99-0), hesperidin (CAS: 520-26-3), neohesperidin (CAS: 13241-33-3), diosmin (CAS: 520-27-4), aloin (CAS: 5133-19-7), forsythoside E (CAS: 93675-88-8), angoroside C (CAS: 115909-22-3), kaempferol-7-O-D-glucoside (CAS: 16290-07-6), naringin (CAS: 36-47-2), apigenin-7-glucoside (CAS: 13241-33-3), diosmin (CAS: 520-27-4), aloin (CAS: 5133-19-7), forsythin E (CAS: 93675-88-8-9), angustol C (CAS: 115909-22-3), kaempferol-7-O-D-glucoside (CAS: 16290-37-9), amycin (CAS: 35-39-4), and/or 8-10 kaempferol-3-O-glucose (1-2) rhamnoside (CAS: 142451-65-8), flubenine (CAS: 55804-74-5), isorhamnetin-3-O-D-glucoside (CAS: 5041-82-7), syringin-3-O-D-rutinoside (CAS: 53430-50-5), luteolin-4 '-glucoside (CAS: 6920-38-3), astilbin (CAS: 29838-67-3), chloroglucoside paeoniflorin (CAS: 6906-39-4), colchicine-3-O-galactoside (CAS: 30113-37-2), malvidin-3-O-arabinoside (CAS: 28500-04-1), phlorizin (CAS: 60-81-1), neohesperidin dihydrochalcone (CAS: 20702-77-6), rutin (CAS: 153-18-4), trobin II (CAS: 81571-4), catechin-7, 3' -O-beta-D-glucoside, bis-glucopyranoside-7-D-glucopyranoside-7-giucomatoside-7-D-arabinoside-7-giucomatoside, and bis-O-glucopyranoside-7-D-glucopyranoside-7-giucomatoside, quercetin-4-methoxy-3 '-D-glucoside, catechin-4' -O-beta-D-glucose, triemarin II, agrimonine, geraniin phenazine, tea gallol, shrimp flower glucoside, ma Sangyin, poly-flavanoloxy glucoside, poly-flavanolcarboside, quercetin-3-O-beta-D-glucose, 3-O- {2-O- [6-O- (p-D-glucosyl) -O-anti-coumaroyl ] -D-glucosyl } - (L-rhamnosyl) quercetin, rosacin A, rosacin B, rosacin C, rosacin D, rosacin E, rosacin F, rosacin G, luteolin 7-O-rhamnose glucoside, luteolin 7-O-glucose glucoside, genistein 7-O-rhamnose glucoside, quercetin-3-O-glucoside, lobal 7-O-rhamnose glucoside, 3-O- [2-O, 6-O-oxaziram-3-O-glucose, quercetin-3-O-2-O-glucose, oxabisporin-3 '-O-2' -O-glucopyranosyl) -2 '-D-glucopyranosyl-glucoside, quercetin-2' -O-alpha-2 '-O-glucopyranosyl-4' -glucopyranosyl-p-glucopyranoside, and the like. The glycosyl includes glucose, xylose, galactose, arabinose, rhamnose, mannose, glucuronic acid, rutinose, gentiobiose, sophorose, neohesperidose, locust disaccharide, lactose, sophorose, caffeoyl glucose, 2-acetylglucose, and combinations thereof.
Preferably, the film-forming monomer containing phenolic hydroxyl groups is selected from at least one of 1, 3-dihydroxynaphthalene, p-hydroxybenzoic acid, ferulic acid, 1, 6-dihydroxynaphthalene, shikonin, 3-methylsalicylic acid, p-coumaric acid, 4 '-dihydroxybiphenyl, bisphenol a, chlorogenic acid, 3-methoxysalicylic acid, gallic acid, 4',6, 7-trihydroxyisoflavone, geraniin, tannic acid, 3, 5-diiodosalicylic acid, gentisic acid, resveratrol, esculentin, p-aminosalicylic acid, caffeic acid, ellagic acid, pinbiflavone, anthocyanin, syringic acid, tyrosine, guaiacol, 2, 6-dihydroxytoluene, catechol, hydroxytyrosol, hesperetin, 2,4, 6-trihydroxybenzaldehyde, chrysin, tectorigenin, colchicoside, rhein, galloblue, 1,8, 9-trihydroxyanthracene, urushiol, tert-butylhydroquinone.
According to an embodiment of the present invention, the film-forming monomer containing at least two amino groups has a structure represented by formula II:
each R 2 The same or different are independently selected from H, halogen, CN, NO 2 NO, OH, SH, COOH, unsubstituted or substituted by one, two or more R a2 Substituted with the following groups: c (C) 1-40 Alkyl, C 2-40 Alkenyl, C 2-40 Alkynyl, C 3-40 Cycloalkyl, C 3-40 Cycloalkenyl, C 3-40 Cycloalkynyl radicals, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclyl, -OR 2-2 、-SR 2-3 、-NR 2-4 R 2-5 、-C(O)R 2-6 、-OC(O)R 2-7 、-S(O) 2 R 2-8 、-OS(O) 2 R 2-9 、P(O)R 2-10 R 2-11 ;
A 2 Selected from unsubstituted or substituted by one, two or more R b2 Substituted C linked to the benzoring 1-40 Alkyl, C 2-40 Alkenyl, C 2-40 Alkynyl, C 3-40 Cycloalkyl, C 3-40 Cycloalkenyl, C 3-40 Cycloalkynyl radicals, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclyl; or A 2 Selected from chemical bonds, unsubstituted or optionally substituted by one, two or more R c2 Substituted O, C (O), C (O) O, S, S (O) 2 、N、C 1-6 Alkylene, ch= N, N = N, CH =n-n=ch, ch=ch-CO-CH 2 -CO-CH=CH;
p is an integer of 0 to 12;
each R a2 、R b2 、R c2 Identical or different, independently of one another, from the group consisting of H, halogen, CN, OH, SH, oxo (=o), =nh, NO 2 、COOH、C 1-40 Alkyl, C 2-40 Alkenyl, C 2-40 Alkynyl, C 3-40 Cycloalkyl, C 3-40 Cycloalkenyl, C 3-40 Cycloalkynyl radicals, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclyl, -OR 2-2 、-SR 2-3 、-NR 2-4 R 2-5 、-C(O)R 2-6 、-OC(O)R 2-7 、-S(O) 2 R 2-8 、-OS(O) 2 R 2-9 、P(O)R 2-10 R 2-11 ;
Each R is 2-2 、R 2-3 、R 2-4 、R 2-5 、R 2-6 、R 2-7 、R 2-8 、R 2-9 、R 2-10 、R 2-11 The same or different, independently of one another, from H, halogen, NH 2 CN, OH, SH, oxo (=o), NO 2 、COOH、C 1-40 Alkyl, C 2-40 Alkenyl, C 2-40 Alkynyl, C 3-40 Cycloalkyl, C 3-40 Cycloalkenyl, C 3-40 Cycloalkynyl radicals, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclyl.
According to an embodiment of the present invention, formula II has the structure shown in formulas II-1 to II-10:
Wherein R is 2 P and R c2 Having the definition set forth above; q is an integer of 0 to 12; r is R 2 ’、R 2 "and R 2 Is the same as defined in the specification; and R is 2 、R 2 ’、R 2 "has at least two amino groups therein;
each D 2 、D 3 、D 4 Identical or different, independently of one another, from N, unsubstituted or substituted by R 2 Substituted CH, N + ;
Each E 2 、E 3 、E 4 Identical or different, independently of one another, from chemical bonds, unsubstituted or optionally substituted by one, two or more R c2 Substituted O, C (O), C (S), C (O) O, S, S (O) 2 、N、C 1-6 Alkylene, ch= N, N = N, CH =n-n=ch, C 0-6 alkylene/alkenyl-CO-C 1-6 alkylene-CO-C 0-6 Alkylene/alkenyl, C 0-6 alkylene/alkenyl-CO-NH-C 0-6 alkylene-CO-C 0-6 Alkylene/alkenyl, C 0-6 alkylene/alkenyl-NH-C 0-6 alkylene-NH-C 0-6 Alkylene/alkenyl, C 0-6 alkylene/alkenyl-C (O) O-C 0-6 alkylene-C (O) O-C 0-6 Alkylene/alkenyl groups.
Each F 2 The same or different, independently of one another, are selected from O, S.
Preferably, the compound of II-1 is selected from the group consisting of p-phenylenediamine (CAS: 106-50-3) and salts thereof, p-toluenediamine (CAS: 95-70-5), 2, 3-Dimethyl-p-phenylenediamine (2, 3-Dimethyl-1, 4-benzonediamine), 2, 6-Dimethyl-p-phenylenediamine (2, 6-Dimethyl-1, 4-benzonediamine), 2, 3-Diethyl-p-phenylenediamine (2, 3-Dimethyl-1, 4-benzonediamine), 2, 5-Dimethyl-p-phenylenediamine (CAS: 6393-01-7), 2-hydroxyethyl-p-phenylenediamine sulfate (CAS: 93841-25-9), 2-Fluoro-p-phenylenediamine (2-Fluoro-1, 4-benzonediamine), 2-Isopropyl-p-phenylenediamine (2-Isopropyl-1, 4-benzonediamine), 2-Hydroxymethyl-p-phenylenediamine (2-hydroymethyl-1, 4-benzonediamine), 2-Hydroxyethoxy-p-phenylenediamine (2-hydroyethoxy-1, 4-benzonediamine), 2-acetamido-p-phenylenediamine (2-acetamidoxy-1, 4-benzodiazinediamine), N- (4-aminobenzyl) biguanide, 2-nitro-1, 4-phenylenediamine (CAS: 5-dichloro-1, 4-phenylenediamine (CAS: 615-09), 2-dichloro-1, 4-phenylenediamine (CAS: 615-09-7), 2, 5-toluenediamine sulfate (CAS: 615-50-9), o-phenylenediamine (CAS: 95-54-5) and salts thereof, 4-chloro-1, 2-phenylenediamine (CAS: 95-83-0), amiloride hydrochloride (CAS: 2016-88-8), 4, 5-dichloro-1, 2-phenylenediamine (CAS: 5348-5), 3, 4-diaminoanisole (CAS: 496-72-0), 3-nitro-1, 2-phenylenediamine (CAS: 3694-52-8), 4-nitro-1, 2-phenylenediamine (CAS: 99-56-9), 3, 4-diaminobenzoic acid (CAS: 619-05-6), meta-phenylenediamine (CAS: 108-45-2) and salts thereof, 4-chloro-1, 3-phenylenediamine (CAS: 5131-60-2), 2, 6-diaminotoluene (CAS: 823-40-5), 2, 4-diaminoanisole (CAS: 615-05-0), 3-nitro-1, 2-phenylenediamine (CAS: 3694-52-8), 4-nitro-1, 2-diaminobenzoic acid (CAS: 99-56-9), 3, 4-diaminobenzoic acid (CAS: 619-05-6), 3, 5-diaminobenzoic acid (CAS: 108-45-2), 3-diaminobenzoic acid (CAS: 35-35), 3, 35-diaminobenzene, 3-2-diaminobenzene (CAS: 35-35), and salts thereof 2, 4-diamino-6-methyl-1, 3, 5-triazine (CAS: 542-02-9), melamine (CAS: 108-78-1), 6-phenyl-1, 3, 5-triazine-2, 4-diamine (CAS: 91-76-9), veratrine (CAS: 5355-16-8), 2,4, 5-triamino-6-hydroxypyrimidine sulfate (CAS: 35011-47-3), trimethoprim (CAS: 738-70-5), phenazopyridine hydrochloride (CAS: 136-40-3), pyrimethamine (CAS: 58-14-0), eostiradine maleate (CAS: 84504-69-8), trimethoprim (CAS: 738-70-5), 4-amino-6-chlorobenzene-1, 3-disulfonamide (CAS: 121-30-2), metanilide, and the like.
Preferably, the compound of II-2 is selected from 3, 4-diaminobenzophenone (CAS: 39070-63-8), basic orange 2 (CAS: 532-82-1), o-tolidine (CAS: 119-93-7) and salts thereof, 3 '-diaminobenzidine (CAS: 91-95-2) and salts thereof, 4' -diaminobiphenyl (CAS: 92-87-5) and salts thereof, 3', 5' -tetramethylbenzidine dihydrochloride (CAS: 54827-17-7), bis (4-amino-3-chlorophenyl) methane (CAS: 101-14-4), 4 '-diaminodiphenylmethane (CAS: 101-77-9), 4' -diaminodiphenyl ether (CAS: 101-80-4), 4 '-diaminodiphenyl sulfide (CAS: 139-65-1), 4' -diaminobenzophenone (CAS: 611-98-3), 4 '-diaminodibenzyl (CAS: 621-95-4), 4' -diaminodiphenyl sulfone (CAS: 80-08-0), 4 '-diaminodiphenylamine and salts thereof, 3-dichlorobenzidine (CAS: 91-94-1), 3' -dimethoxybenzidine (CAS: 101-80-4), 4 '-diaminodiphenyl sulfide (CAS: 139-65-1), 4' -diaminobenzidine (CAS: 611-98-3), 4 '-diaminobenzidine (CAS: 621-95-4), 4' -diaminobenzidine (CAS: 80-0) 4,5' -diaminodiphenyl sulfide, and the like.
Preferably, the compound of II-3 is selected from ethylenediamine (CAS: 107-15-3) and salts thereof, 1, 2-propanediamine (CAS: 78-90-0), 1, 3-propanediamine (CAS: 109-76-2), 1, 4-diaminobutane (CAS: 110-60-1), 1, 5-pentanediamine (CAS: 462-94-2), 1, 6-hexanediamine (CAS: 124-09-4), 1, 7-heptanediamine (CAS: 646-19-5), 1, 8-octanediamine (CAS: 373-44-4), 1, 10-decanediamine (CAS: 646-25-3), diethylenetriamine (CAS: 111-40-0), triethylenetetramine (CAS: 112-24-3), tetraethylenepentamine (CAS: 112-57-2), pentaethylenehexamine (CAS: 4067-16-7), hexamine, spermidine (CAS: 124-20-9), homospermidine (CAS: 4427-76-3), aminopropyl cadaverine (CAS: 56-19-9), norspermine (CAS: 56-18-8), spermine (CAS: 71-44-3), thermophilic spermine (CAS: 70862-2), thermophilic spermine (CAS: 13274-35-379), homophilic pentamine (CAS) Thermophilic hexylamine (CAS: 63833-74-9), thermophilic homohexylamine (CAS: 133416-04-3), 3 '-iminodipropylamine (CAS: 56-18-8), N' -bis (3-aminopropyl) -1, 3-propanediamine (CAS: 4605-14-5), urea (CAS: 57-13-6), thiosemicarbazide, biuret (CAS: 108-19-0), thiosemicarbazide (CAS: 79-19-6), acrylamide methylene urea, guanidine (CAS: 90332-86-8), biguanide nitrate (CAS: 22817-07-8), glycylglutamine (CAS: 13115-71-4), alanylglutamine (CAS: 39537-23-0), amide, N- (2-guanidine ethyl) guanidine (CAS: 44956-51-6), 2, 6-diaminopimelic acid (CAS: 583-93-7), 2, 4-diaminobutyric acid dihydrochloride, annine (CAS: 57-53-4), 2, 3-diaminopropionic acid (CAS: 58-94-35-6), amino guanidine hydrochloride, amino guanidine (Ammonine-35-60), amino guanidine hydrochloride, and the like.
Preferably, the compound of II-4 is selected from the group consisting of procyanidin (CAS: 92-62-6) and salts thereof, safranine T (CAS: 477-73-6), and the like.
Preferably, the compound of II-5 is selected from 6-hydroxy-2, 4, 5-triaminopyrimidine (CAS: 1004-75-7), 2, 4-diamino-6-hydroxypyrimidine (CAS: 1956-6-4), and the like.
Preferably, the compound of II-6 is selected from 5, 6-diamino-1, 3-dimethyluracil (CAS: 5440-00-6), 4, 5-diamino-6-hydroxy-2-mercaptopyrimidine (CAS: 1004-76-8), and the like.
Preferably, the compound of II-7 is selected from the group consisting of 2, 3-diaminonaphthalene (CAS: 771-97-1), 1, 8-diaminonaphthalene (CAS: 479-27-6), 1, 5-diaminonaphthalene (CAS: 2243-62-1), triamterene (CAS: 396-01-0), methotrexate (CAS: 59-05-2), dihydralazine sulfate (CAS: 7327-87-9), and the like.
Preferably, the compound of II-8 is selected from 1, 2-diaminocyclohexane (CAS: 694-83-7), streptavidin (CAS: 488-52-8), and the like.
Preferably, the compound of II-9 is selected from 4,4' -diaminodicyclohexylmethane (CAS: 1761-71-3), and the like.
Preferably, the compound of II-10 is selected from the group consisting of 1, 2-diaminoanthraquinone (CAS: 1758-68-5), 1, 5-diaminoanthraquinone (CAS: 129-44-2), 1, 4-diaminoanthraquinone (CAS: 128-95-0), and the like.
According to an embodiment of the present invention, the compound of formula II also includes substances in which two or more structural units represented by formulas II-1 to II-10 are present in the structure, such as 4,4 '-binaphthyl amine (CAS: 481-91-4), 3' -dimethylbinaphthyl amine (CAS: 13138-48-2), and the like.
According to an embodiment of the invention, the compounds of formula II also include polymers having a plurality of amino groups in the structure, such as: polyvinyl amine (CAS: 49553-92-6), polyethylenimine (CAS: 9002-98-6), and the like.
According to an embodiment of the invention, the compound of formula II further comprises: direct brown 44 (CAS: 6252-62-6), direct blue 1 (CAS: 2610-05-1), mecobalamin (CAS: 13422-55-4), vitamin B 12 (CAS: 68-19-9), ethidium bromide (CAS: 1239-45-8), 3, 5-diamino-1, 2, 4-triazole (CAS: 1455-77-2), neored (CAS: 3248-91-7), parared base (CAS: 467-62-9), parared and salts thereof, amitriptyline (CAS: 37691-11-5), asparagine, lysine and salts thereof, hydroxylysine, cystine and salts thereof, arginine and salts thereof, ornithine and salts thereof, selenocysteine and salts thereof, 2, 7-diaminofluorene (CAS: 525-64-4), congo red (CAS: 573-58-0), valacyclovir hydrochloride (CAS: 136489-37-7), thyme pentapeptide (CAS: 69558-55-0), 4 '(5') -diaminodibenzo-15-crown-5 (CAS: 245086-08-2), adenosylcobalamine (CAS: 70-90-1), (Z) -2- (2-aminothiazol-4-yl) -2- (hydroxyimino) acetamide (CAS: 1450758-21-0), polymyxin B (CAS: 136489-37-7), thymosin pentapeptide (CAS: 69558-55-0), 4 '(5') -diaminodibenzoxacin hydrochloride (CAS: 1404-28-35-37-8), amicin hydrochloride (CAS: 37-35-8), and salts thereof) Streptomycin sulfate (CAS: 3810-74-0), neomycin sulfate (CAS: 1405-10-3), bleomycin (CAS: 11056-06-7), kanamycin, mitomycin (CAS: 50-07-7), sisomicin sulfate (CAS: 53179-09-2), gentamycin sulfate, isopalmitin sulfate (CAS: 67814-76-0), colicin sulfate (CAS: 1405-37-4), nisin (CAS: 3930-19-6), 5, 6-diamino-2, 4-dihydroxypyrimidine sulfate dihydrate (CAS: 63981-35-1), famotidine (Famotidine), 4', 6-diamidino-2-phenylindole, and the like.
Preferably, the film forming monomer containing at least two amino groups is selected from the group consisting of arginine, polyethylenimine (PEI), kanamycin, 2-fluoro-p-phenylenediamine, 2, 3-dimethyl-p-phenylenediamine, diethylenetriamine, lysine, 3-nitro-1, 2-phenylenediamine, p-phenylenediamine, 2, 3-diaminonaphthalene, procyanidin, 2, 3-diaminopyridine, 2, 3-diethyl-p-phenylenediamine, 2, 4-diaminobenzenesulfonic acid, paramaranthrene, 1, 6-hexamethylenediamine, ethidium bromide, 2-hydroxymethyl-p-phenylenediamine, 2-hydroxyethoxy-p-phenylenediamine, 5, 6-diamino-1, 3-dimethyluracil, melamine, m-phenylenediamine, 3, 4-diaminotoluene, spermine, 4' -diaminodibenzyl, 3, 4-diaminobenzoic acid, 2, 4-diaminoanisole, o-tolidine, 4' -diaminodicyclohexylmethane, 4' -dinaphthylamine, urea, guanidine, 6-hydroxy-2, 4, 5-diaminopyrimidine, 1, 2-diaminocyclohexane, 2, 4-diamino-triazine, 1, 4-diamino-4-diphenyl sulfone, 4-diamino-1, 4-diamino-sulfone.
According to an embodiment of the present invention, when the catalyst is at least one of laccase, bilirubin oxidase and peroxidase, the combination of the film-forming monomer containing a phenolic hydroxyl group and the film-forming monomer containing at least two amino groups may be: combining: r is R 1 And/or A 1 A combination of a compound of formula I and a compound of formula II when there is at least one phenolic hydroxyl group in the structure; or two in combination: compounds of formula I-13 and when D 2 Is R is 2 Substituted CH, and R 2 、R 2 ’、R 2 "a combination of compounds of formula II-1 when there are at least two amino groups in the compound.
According to an embodiment of the present invention, when the catalyst is a monophenol monooxidase, the combination of the film-forming monomer containing a phenolic hydroxyl group and the film-forming monomer containing at least two amino groups may be: a combination of a compound of formula I and a compound of formula II.
According to an embodiment of the present invention, when the catalyst is catechol oxidase, the combination of the film-forming monomer containing a phenolic hydroxyl group and the film-forming monomer containing at least two amino groups may be: r is R 1 A combination of a compound of formula I and a compound of formula II when the compound is a phenolic hydroxyl group in an ortho position.
According to an embodiment of the present invention, the film-forming monomer containing a phenolic hydroxyl group and the film-forming monomer containing at least two amino groups may be one, two or more, respectively, in the reaction system.
According to an embodiment of the present invention, the enzymatic reaction may further incorporate at least one of an enhancer for enzymes, hydrogen peroxide, metal ions, buffer ion pairs;
Preferably, the method comprises the steps of, the enzyme enhancer comprises alpha-Raffinic acid, beta-Raffinic acid, gamma-Raffinic acid, cinnamic acid, 4-hydroxy cinnamic acid, needle alcohol, ethyl vanillin, caffeic acid, ferulic acid, 2, 4-pentanedione, 4' -dihydroxybenzophenone, benzoic acid, sodium benzoate, 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, 3-hydroxy anthranilic acid, 3-hydroxy-2-aminobenzoic acid, 4-amino-3-hydroxybenzoic acid, 2, 3-hydroxybenzoic acid, 3, 4-dihydroxybenzoic acid, dimethoxybenzoic acid, 2,4, 6-trihydroxybenzoic acid, p-hydroxyphenylacetic acid, salicylic acid, salicylate, 4-amino-salicylic acid, pyruvic acid, pyruvate, nicotinic acid, ascorbic acid ascorbate, guanidine, cyanuric acid, imidazole, 2, 6-dimethylphenol, 2,4, 6-trimethylphenol, 2-acetaminophen, p-coumaric acid, 7-hydroxycoumarin, sinapic acid, syringaldehyde, syringic acid, methyl syringate, ethyl syringate, propyl syringate, butyl syringate, hexyl syringate, octyl syringate, vanillic acid, isovanillic acid, vanillin even nitrogen, acetosyringone, acetovanillone, vanillyl alcohol, homovanillic acid, catechol, epicatechin, naringin, tyrosine, 2-thiouracil, ethyl 3- (4-hydroxy-3, 5-dimethoxyphenyl) acrylate, quercetin, 2,2' -Azino-bis- (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (2, 2' -Azino-bis (3-ethylbenzidine-6-sulfonic acid) diammonium salt, ABTS), hydroxydiphenylethanol, dimethoxybenzyl alcohol, N-hydroxyphthalimide, N-acetyl-N-phenylhydroxylamine, N-benzylidene-benzylamine, N-hydroxy-N-acetanilide, N-hydroxybutyrylanilide, 4' -dimethoxy-N-methyl-diphenylamine, 4' -diaminodiphenylamine, triphenylamine, benzidine, N-benzylidene-4-benzidine, 3' -dimethylbenzidine, 3' -dimethoxybenzidine, 3',5,5' -tetramethylbenzidine, 4' -dihydroxybiphenyl, 4' -hydroxy-4-biphenylcarboxylic acid, phenol red, 2', 6' -tetramethylpiperidine oxide, 1- (3 ' -sulfophenyl) -3-methyl-5-pyrazolone, purpuric acid, p-hydroxybenzosulfonate, 1, 5-diaminonaphthalene, 7-methoxy-2-naphthol, 6-hydroxy-2-naphthoic acid, 7-amino-2-naphthalenesulfonic acid, 5-amino-2-naphthalenesulfonic acid, 7-hydroxy-1, 2-naphthoimidazole, 1-hydroxybenzotriazole, 10-methylphenoxazine, 10- (2-hydroxyethyl) phenoxazine, 10-phenoxazine propionic acid, phenothiazine-10-propionic acid, 10- (2-pyrrolidinylethyl) phenothiazine, 10-allylphenothiazine, 10- (3-hydroxypropyl) phenothiazine, 2-acetyl-10-methylphenothiazine, 10-ethyl-4-phenothiazinecarboxylic acid, 10-ethylphenothiazine, 10-propylphenothiazine, 10-isopropylphenothiazine, methyl 10-phenothiazinpropionate, 10-methylphenothiazine, 10-phenothiazine-propionic acid, thiophenazine-10-propionic acid (phenothiazine-10-propiinicacid), PPT), N-hydroxysuccinimide-10-phenothiazine-propionic acid, 10- (3- (4-methyl-1-piperazinyl) propylphenothiazine, promazine, chlorpromazine, 3-hydroxy-1, 2, 3-benzotriazin-4 (3H) -one, N- (4-cyanophenyl) acetohydroxamic acid, iminostilbene, 4-amino-4 ' -methoxystilbene, 4' -diaminostilbene-2, 2' -disulfonic acid, 2, 7-diaminofluorene, 2- (p-aminophenyl) -6-methylbenzothiazole-7-sulfonic acid, N- (4- (dimethylamino) benzylidene) -p-anisaldehyde, 3-methyl-2-benzothiazolinone (4- (dimethylamino) benzylidene) hydrazone, N-hydroxyacetylene lactone, black liquor from hardwood, black liquor from softwood, wood organic solvents (ligno-organosolv), lignosulfonates, and mixtures thereof.
According to an embodiment of the present invention, the catalyst is used in the reaction system in an amount of 0.01U/L to 600U/L, for example, 0.5U/L to 200U/L, and exemplified by 1U/L, 2U/L, 6U/L, 12U/L, 24U/L, 40U/L, 60U/L, in terms of enzyme activity.
According to an embodiment of the present invention, the film-forming monomer may have a mass concentration in the reaction system of 0.002 to 380g/L, for example, 0.1 to 20g/L, and exemplified by 0.5g/L, 0.8g/L, 1g/L, 2g/L, 3g/L, 4g/L.
According to embodiments of the present invention, the film forming temperature may be 4 to 90 ℃, for example 10 to 60 ℃, illustratively 20 ℃, 30 ℃, 35 ℃, 37 ℃, 40 ℃, 45 ℃, 50 ℃, 55 ℃;
according to embodiments of the present invention, the film forming time may be 0.01 to 72 hours, for example, 2 to 48 hours, and exemplary are 3 hours, 5 hours, 6 hours, 8 hours, 10 hours, 12 hours, 20 hours, 24 hours, 36 hours;
according to embodiments of the invention, the pH of the aqueous phase may be 2 to 10, for example 3, 4, 5, 6, 6.5, 7, 8.
According to an embodiment of the invention, when the catalyst is laccase, bilirubin oxidase, monophenol monooxidase or catechol oxidase, the reaction requires oxygen to participate. The source of oxygen can be pure oxygen or mixed gas containing oxygen, further, the oxygen can be oxygen from air, can be oxygen dissolved in the surface of a solution, and can be slowly dissolved in a reaction system by flowing, mechanically stirring, oscillating, a blower and an air compressor to provide oxygen for the reaction. An oxygen-enriched liquid may be added to the liquid.
For reactions requiring hydrogen peroxide, the source of hydrogen peroxide in solution may be at least one of the following: (1) adding a hydrogen peroxide solution to the solution; (2) Adding to the solution an enzyme system that generates hydrogen peroxide, such as glucose oxidase and glucose, the glucose oxidase oxidizing glucose to generate hydrogen peroxide; galactose oxidase and galactose, galactose oxidase oxidizes galactose to produce hydrogen peroxide; sugar alcohol oxidase and glycerol, the sugar alcohol oxidase oxidizing glycerol to hydrogen peroxide; amino acid oxidase, flavin Adenine (FAD) and amino acid, the amino acid oxidase oxidizes amino acid with FAD as a prosthetic group to produce hydrogen peroxide; l-glutamic acid oxidase and L-glutamic acid, the L-glutamic acid oxidase oxidizing L-glutamic acid to produce hydrogen peroxide; (3) Hydrogen peroxide sources, i.e., compounds that produce hydrogen peroxide when dissolved in water or a suitable water-based medium, including, but not limited to, metal peroxides, t-butyl hydroperoxide, cumene hydroperoxide, percarbonates, persulfates, perphosphates, peracetic acid, perborates, perbenzoic acid, peroxyacids, alkyl peroxides, acyl peroxides, peroxyesters, urea peroxides, and peroxycarboxylic acids or salts thereof, optionally supplemented with catalase.
The interface of the two phases can be an oil-lower water phase (reaction solvent) interface of which the upper normal temperature is liquid, an upper water phase (reaction solvent) -oil (such as carbon tetrachloride, carbon disulfide and butyl palmitate) interface of which the lower normal temperature is liquid, an oil (such as paraffin, beeswax, shellac, spermaceti, cocoa butter, coconut oil, beef tallow, mutton tallow and the like) interface of which the lower temperature is solid at a set temperature, an upper water phase (reaction solvent) -lower liquid metal (such as gallium, mercury and low-melting-point alloy) interface, an interface between liquid drops of the water phase (reaction solvent) suspended in the oil and the oil, and an interface between oil drops suspended in the water phase (reaction solvent) and the water phase.
The invention also provides copolymer particles or copolymer films prepared by the synthesis method.
According to an embodiment of the invention, the copolymer film comprises the following types: the phases of the catalyst and the film-forming monomer can be classified into the following three types: (1) A film formed by dissolving the catalyst and the film-forming monomer in the water phase; (2) A catalyst and at least one film-forming monomer are dissolved in the aqueous phase, and another film-forming monomer or monomers form a film in the oil phase; (3) The catalyst is dissolved in the aqueous phase and the film-forming monomer is dissolved in the oil phase to form a film. The interface of the film can be classified into the following: a film of an interface of an upper normal temperature being liquid oil-lower water phase, a film of an interface of an upper water phase-lower normal temperature being liquid oil, a film of an interface of an upper water phase-lower liquid metal, a film of an interface of an aqueous phase-oil (said oil phase being solid at a set temperature such as paraffin, beeswax, shellac, spermaceti, cocoa butter, coconut oil, beef tallow, etc.), an oil-water interface film of a water-in-oil emulsion, a water-oil interface film of an oil-in-water emulsion.
The invention also provides applications of the copolymer particles or copolymer films, such as applications in preparing multilayer films, preparing vesicles, preparing conductive films and constructing supermolecule functional materials; and in reducing metals, coating applications; applications in secondary reactions, such as further modification of copolymer films;
preferably, the modification incorporates sorbitol, quaternary ammonium salt, dye molecules on the surface of the copolymer film.
The copolymer membranes of the present invention also include vesicles. Vesicles (Vesicles) of the invention are a class of assemblies with a closed structure surrounded by a copolymer membrane.
The invention also provides a preparation method of the vesicle, which comprises the following steps: (1) And (3) dissolving the catalyst and the film-forming monomer in the water phase, and adding the water phase and the film-forming monomer into the oil-in-water emulsion to obtain the vesicle with the surface of the copolymer film. (2) And (3) dissolving the catalyst and the film-forming monomer in a water phase, pouring the water phase and the film-forming monomer into oil, stirring to obtain water-in-oil emulsion, and reacting for a period of time to obtain the vesicle with the surface being the copolymer. (3) Dissolving a catalyst and a water-soluble film-forming monomer in a water phase, dissolving another oil-soluble monomer in oil, preparing emulsion, and reacting for a period of time to obtain the vesicle wall which is the copolymer film.
The selection of the film-forming monomer has a remarkable influence on the characteristics of the chemical composition, molecular structure, physicochemical properties, performance and the like of the copolymer film, so that the chemical composition, molecular structure, physicochemical properties, performance and the like of the copolymer film can be designed on a molecular level by selecting a proper film-forming monomer and the proportion thereof. Such as: the general organic polymer is a good insulator, and suitable film-forming monomers such as hydroquinone, ferulic acid, catechol, p-phenylenediamine, benzidine and the like with conjugated pi bond are selected, so that the copolymer film has pi electrons with high delocalization in the structure, can be used for preparing films with conductive performance, and can be used for organic high polymer full-color plane display materials and devices, optical limiting materials, sensing materials of sensors, electrode materials and microwave absorbing materials.
The present invention also provides a multilayer film comprising at least one layer of the copolymer film.
According to an embodiment of the invention, the preparation method can also be used for increasing the thickness of the membrane by supplementing the raw materials of the enzymatic reaction and/or replacing a fresh enzymatic reaction system.
Those skilled in the art will recognize that the reaction rate, film thickness, and film surface reactive functional groups can be easily controlled by changing the kind and addition amount of the enzyme, the kind and concentration of the film-forming monomer, pH, temperature, the kind and concentration of the ion pair in the buffer, the metal ion and its concentration, the concentration of the oxidizing agent (e.g., dissolved oxygen, hydrogen peroxide), the duration of the enzymatic reaction, the enhancer of the enzyme, the inhibitor of the enzymatic activity, whether the organic solvent and the kind and concentration of the organic solvent are contained, the composition of the liquid medium constituting the interface, whether the reaction solution is updated, whether and how the reaction is terminated, and the like. The thickness of the film, the thickness of the deposit/bond on the film, can be controlled individually on the nanometer scale.
In accordance with the principles of the present invention, any buffer, pH, ion, and any combination thereof may be used for the reaction system that can satisfy the copolymerization reaction. Other aspects of the enzymatic reaction conditions of the present invention can be optimized by routine experimentation. For example, pH and temperature are non-limiting examples of optimizable factors.
By selecting suitable film-forming monomers, it is possible to design and prepare copolymer films that expose specific reactive functional groups at the molecular level, i.e. residual reactive and affinity groups on the copolymer film obtained after polymerization of the monomers, which groups may be: halogen, unsubstituted or substituted by halogen, OH, COOH, NH 2 、CN、SH、NO 2 Alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl substituted with: OH, COOH, NH 2 SH, alkyl, alkoxy, alkenyl, alkynyl, aryl, sulfonyl, sulfonamide, acyl halide, phosphoryl, and azo. The active groups on the copolymer film can introduce functional molecules and/or atoms and/or ions into the surface of the copolymer film through secondary or repeated reactions, so that the further functionalization of the surface of the copolymer film is realized, the surface of the copolymer film has extremely strong designability, and the application range of the film is further expanded.
According to embodiments of the present invention, the copolymer film can be designed and prepared to expose specific reactive functional groups at the molecular level by varying the type and concentration of film-forming monomers, and the functional groups on the film can be chemically or enzymatically reacted. The modification and/or modification of the membrane is achieved by chemical or enzymatic reactions, such as radical reactions, grafting reactions, to attach the desired target molecules/atoms to the membrane. Such group reactions include, but are not limited to: michael-type addition reaction, schiff base reaction (Schiff base reaction), friedel-Crafts reaction, mannich reaction, substitution reaction, addition reaction, polymerization reaction, condensation reaction, oxidation reaction, reduction reaction, esterification reaction, sulfonation reaction, nitration reaction, diazotization reaction, azide reaction, amidation reaction, acylation reaction, alkylation reaction, glycosidation reaction, ether formation reaction, etherification reaction, coupling reaction, complexation reaction, displacement reaction, nucleophilic elimination reaction, surface atom transfer radical polymerization (SI-ATRP) reaction, reversible addition-fragmentation chain transfer polymerization (RAFT) reaction.
Such as: the proper monomer is selected so that the prepared copolymer film contains rich phenolic hydroxyl groups. Under certain conditions, the phenolic hydroxyl group is oxidized into a quinoid structure, so that the amino group can be combined with the thiol (-SH) and amino (-NH) 2 ) The hydrophilic or hydrophobic organic molecules of the polymer film undergo Michael addition and Schiff base reaction, and functional molecules are introduced into the surface of the polymer film, so that Self-assembled monolayer modification (Self-assembled monolayers) of the surface of the polymer film can be realized.
Such as: the phenolic hydroxyl groups in the copolymer film are capable of forming coordination bonds with the metal ions in the metal oxide. Immersing the copolymer film in ammonium hexafluorotitanate ((NH) 4 ) 2 TiF 6 ) And boric acid (H) 3 BO 3 ) Mixed solution of (NH) 4 ) 2 TiF 6 And H 3 BO 3 Titanium dioxide (TiO) produced by hydrolysis 2 ) Chelating the nano particles with the copolymer film to form uniform TiO on the surface of the copolymer film 2 A film.
Those skilled in the art will appreciate that: the surface of the copolymer film contains active groups, so that different functional substances and target molecules can be combined, such as metal atoms, metal oxide nano particles, graphene oxide, functional living cells, proteins, enzymes, polypeptides, metal binding polypeptides, fluorescent dyes, antibodies, anti-antibodies, haptens, immunogens, DNA, oligonucleotides, growth factors, drug macromolecules, ligands, amino and/or sulfhydryl and/or aldehyde and/or carboxyl terminated polyethylene glycol, carbohydrate substances, fatty amines and other substances containing amino and/or sulfhydryl and/or aldehyde and/or carboxyl in the structure, and the like.
The copolymer film and the multilayer film prepared by the invention have rich types of selectable film forming monomers, and can be designed and prepared into films with rich and various components and molecular structures, so that the composition, structure, performance and service performance of the copolymer film are determined, and the copolymer film can be selected according to the application requirements.
The copolymer film prepared by selecting proper film-forming monomers is combined with quaternary ammonium salt molecules to realize antibacterial effect.
The copolymer film can construct supermolecular functional materials, assemble two-dimensional and smaller structural materials and construct multilayer functional polymer materials; the bound or supported catalyst becomes a reactive polymer.
According to embodiments of the present invention, the copolymer membrane may be used for catalysis of biological and chemical reactions by incorporating catalysts, including biological enzymes, chemical catalysts.
The copolymer film prepared by selecting a suitable film-forming monomer can be connected with dye molecules to express corresponding colors.
According to an embodiment of the present invention, the copolymer film may deposit inorganic substances (silver, hydroxyapatite, calcium carbonate, silica, etc.) on the surface thereof to form a nanolayer, and thus an organic-inorganic derivative film may be prepared. For example, a metal modified vesicle is prepared by adding the vesicle to a metal salt solution.
According to an embodiment of the invention, the metal salt includes, but is not limited to, silver nitrate, chloroauric acid, chloroplatinic acid, or palladium nitrate.
Metal cations are reduced from the metal salt solution and deposited on the surface of the copolymer film, thereby allowing electroless metallization of the film surface.
In addition, the copolymer film is prepared, and meanwhile, copolymer particles are generated in the water phase, and the copolymer particles contain high-density amino, quinone, phenolic hydroxyl and other active groups, so that the copolymer particles have the characteristic of re-reaction, and can be added into plastics as fillers to improve the performance of the plastics.
Advantageous effects
The copolymer film and the enzymatic self-assembly synthesis method thereof provided by the invention have the advantages that the operation steps are simple, the isolation of air is not needed, the external potential is not needed, the reaction condition is mild, the preparation can be carried out at normal temperature, normal pressure, neutral or near neutral pH, and the required energy consumption is small; the reaction is carried out in liquid, the chemical uniformity is good, the multi-component uniformity can reach the molecular level, and the composition and the structure are uniform; the reaction is easy to control, the repeatability is good, and the structure can be regulated and controlled at the molecular level. The thickness of the copolymer film, the thickness of the deposit/bond on the film, can be controlled individually on the nanometer scale.
The method for preparing the copolymer film has wide selection range of film forming monomers, can use various film forming monomers, can polymerize monomers containing catechol structures, can polymerize monomers with resorcinol structures, monomers with hydroquinone structures and even compounds with high oxidation-reduction potentials such as bisphenols, biphenyls and the like. On one hand, different film-forming monomers are polymerized and crosslinked by laccase catalysis to obtain films with different molecular structures, and the films with different molecular structures have different properties, performances and applications, so that the design of the films has high degree of freedom and strong designability, and the copolymer films with corresponding functions can be selected and prepared according to the application requirements. On the other hand, the surface of the copolymer film prepared by selecting a proper film-forming monomer can be provided with a selected active group, the corresponding activity and property are displayed, and target molecules and/or atoms can be introduced into the surface of the film through secondary/repeated chemical or/and enzymatic reaction, so that the purpose of functional modification of the surface of the film is achieved, the surface of the polymer film has extremely strong designability, and the application range of the film is further expanded.
The copolymer film of the invention has higher crosslinking degree, thus having better mechanical property and good tolerance to water, acid, alkali, organic solvent and heat. Thus, the vesicles prepared by the invention have better stability than vesicles prepared with surfactants and proteins.
Based on the characteristics, the preparation method is easy to upgrade from laboratory to industrialized mass production, has short design time, is easier to start and stop production, can quickly and flexibly replace products on the same production line, is suitable for small-batch production process and distributed manufacturing, has strong adaptability, and has high flexibility of products, production plans and scheduling. It is particularly noteworthy that the base membranes of the present invention are prepared enzymatically, many of which are difficult to achieve chemically.
The invention has the outstanding beneficial effects that the characteristics of the copolymer film can be controlled manually under the condition of more degrees of freedom, and the material meeting the requirements is obtained, so that the invention has great potential in technical application.
Definition and interpretation of terms
Unless otherwise indicated, the radical and term definitions recited in the specification and claims of this application, including as examples, exemplary definitions, preferred definitions, definitions recited in tables, definitions of specific compounds in the examples, and the like, may be arbitrarily combined and coupled with each other. Such combinations and combined group definitions and structures of compounds should fall within the scope of the description herein.
The term "film-forming monomer" refers to an organic compound molecule or group of molecules that becomes a copolymer film by polymerization.
The film-forming monomer containing phenolic hydroxyl groups refers to a compound which is composed of one or more hydroxyl groups in the same molecule and is directly bonded to an aromatic ring.
The film-forming monomer containing at least two amino groups refers to a compound which consists of substances containing at least two amino groups in the same molecule.
The low-melting-point alloy is a metal alloy material which has a melting point of 1-96 ℃, is not easy to volatilize, has stable property and does not react with water phase below 120 ℃.
The artificial enzyme is an enzyme mimic with specific catalytic function synthesized by utilizing an organic chemistry and biology method according to the catalytic mechanism of the enzyme and simulating the biological catalytic function of natural enzyme, and comprises metalloenzyme.
The metalloenzyme refers to a conjugated enzyme containing one or more metal ions as prosthetic groups.
The numerical ranges recited in the specification and claims are equivalent to at least each specific integer number recited therein unless otherwise stated. For example, the numerical ranges "1 to 40" correspond to the values of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, which are each integer in the numerical ranges "1 to 10", and 11, 12, 13, 14, 15, and..the numbers of 35, 36, 37, 38, 39, 40, which are each integer in the numerical ranges "11 to 40". It is to be understood that "more" in one, two or more as used herein in describing substituents shall mean an integer of ≡3, such as 3, 4, 5, 6, 7, 8, 9 or 10. Furthermore, when certain numerical ranges are defined as "numbers," it is to be understood that both endpoints of the range, each integer within the range, and each fraction within the range are delineated. For example, a "number of 0 to 10" should be understood to describe not only each integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10, but also at least the sum of each integer with 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, respectively.
The term "halogen" means fluorine, chlorine, bromine and iodine.
The term "C 1-40 Alkyl "is understood to mean a straight-chain or branched saturated monovalent hydrocarbon radical having from 1 to 40 carbon atoms. For example, "C 1-10 Alkyl "means straight-chain and branched alkyl having 1,2, 3, 4, 5, 6, 7, 8, 9 or 10 carbon atoms," C 1-6 Alkyl "means straight and branched alkyl groups having 1,2, 3, 4, 5 or 6 carbon atoms. The alkyl group is, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, 2-methylbutyl, 1-ethylpropyl, 1, 2-dimethylpropyl, neopentyl, 1-dimethylpropyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 2-ethylbutyl, 1-ethylbutyl, 3-dimethylbutyl, 2-dimethylbutyl, 1-dimethylbutyl, 2, 3-dimethylbutyl, 1, 3-dimethylbutyl, or 1, 2-dimethylbutyl, or the like, or an isomer thereof.
The term "C 2-40 Alkenyl "is understood to mean preferably a straight-chain or branched monovalent hydrocarbon radical which contains one or more double bonds and has from 2 to 40 carbon atoms, preferably" C 2-10 Alkenyl groups). "C 2-10 Alkenyl "is understood to mean preferably a straight-chain or branched monovalent hydrocarbon radical which contains one or more double bonds and has 2,3, 4, 5, 6, 7, 8, 9 or 10 carbon atoms, for example 2,3, 4, 5 or 6 carbon atoms (i.e.C 2-6 Alkenyl) having 2 or 3 carbon atoms (i.e., C 2-3 Alkenyl). It will be appreciated that where the alkenyl group comprises more than one double bond, the double bonds may be separated from each other or conjugated. The alkenyl is, for example, vinyl, allyl, (E) -2-methylvinyl, (Z) -2-methylvinyl, (E) -but-2-enyl, (Z) -but-2-enyl, (E) -but-1-enyl, (Z) -but-1-enyl, pent-4-enyl, (E) -pent-3-enyl, (Z) -pent-3-enyl, (E) -pent-2-enyl, (E) -pent-1-enyl, (Z) -pent-1-enyl, hex-5-enyl, (E) -hex-4-enyl, (Z) -hex-4-enyl, (E) -hex-3-enyl, (Z) -hex-3-enyl, (E) -hex-2-enyl, (Z) -hex-1-enyl, isopropenyl, 2-methylprop-2-enyl, 1-methylprop-2-enyl, 2-methylprop-1-enyl, (E) -1-methylprop-1-enyl, (Z) -1-methylbut-1-enyl, 3-methylbut-3-enyl, 2-methylbut-3-enyl, 1-methylbut-3-enyl, 3-methylbut-2-enyl, (E) -2-methylbut-2-enyl, (Z) -2-methylbut-2-enyl, (E) -1-methylbut-2-enyl, (Z) -1-methylbut-2-enyl, (E) -3-methylbut-1-enyl, (Z) -3-methylbut-1-enyl, (E) -2-methylbut-1-enyl, (Z) -2-methylbut-1-enyl, (E) -1-methylbut-1-enyl, (Z) -1-methylbut-1-enyl, 1-dimethylprop-2-enyl, 1-ethylprop-1-enyl, 1-propylvinyl, 1-isopropylvinyl.
The term "C 2-40 Alkynyl "is understood to mean a monovalent hydrocarbon radical, directly or branched, containing one or more triple bonds and having from 2 to 40 carbon atoms, preferably" C 2-10 Alkynyl groups. The term "C 2-10 Alkynyl "is understood to mean preferably a straight-chain or branched monovalent hydrocarbon radical which contains one or more triple bonds and has 2, 3, 4, 5, 6, 7, 8, 9 or 10 carbon atoms,for example, having 2, 3, 4, 5 or 6 carbon atoms (i.e., "C 2-6 Alkynyl ") having 2 or 3 carbon atoms (" C 2-3 Alkynyl "). The alkynyl group is, for example, ethynyl, prop-1-ynyl, prop-2-ynyl, but-1-ynyl, but-2-ynyl, but-3-ynyl, pent-1-ynyl, pent-2-ynyl, pent-3-ynyl, pent-4-ynyl, hex-1-ynyl, hex-2-ynyl, hex-3-ynyl, hex-4-ynyl, hex-5-ynyl, 1-methylpropan-2-ynyl, 2-methylbutan-3-ynyl, 1-methylbutan-2-ynyl, 3-methylbutan-1-ynyl, 1-ethylpropan-2-ynyl 3-methylpent-4-ynyl, 2-methylpent-4-ynyl, 1-methylpent-4-ynyl, 2-methylpent-3-ynyl, 1-methylpent-3-ynyl, 4-methylpent-2-ynyl, 1-methylpent-2-ynyl, 4-methylpent-1-ynyl, 3-methylpent-1-ynyl, 2-ethylbut-3-ynyl, 1-ethylbut-2-ynyl, 1-propylprop-2-ynyl, 1-isopropylprop-2-ynyl, 2-dimethylbbut-3-ynyl, 1, 1-dimethylbut-3-ynyl, 1-dimethylbut-2-ynyl or 3, 3-dimethylbut-1-ynyl. In particular, the alkynyl group is ethynyl, prop-1-ynyl or prop-2-ynyl.
The term "C 3-40 Cycloalkyl "is understood to mean a saturated monovalent monocyclic, bicyclic hydrocarbon ring or bridged cycloalkane having 3 to 40 carbon atoms, preferably" C 3-10 Cycloalkyl groups). The term "C 3-10 Cycloalkyl "is understood to mean a saturated monovalent monocyclic, bicyclic hydrocarbon ring or bridged cycloalkane having 3,4, 5,6, 7, 8, 9 or 10 carbon atoms. The C is 3-10 Cycloalkyl may be a monocyclic hydrocarbon group such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl or cyclodecyl, or a bicyclic hydrocarbon group such as a decalin ring.
The term "3-to 20-membered heterocyclic group" means a saturated monovalent monocyclic, bicyclic hydrocarbon ring or bridged cycloalkane containing 1 to 5 non-aromatic cyclic groups having 3 to 20 (e.g., 3,4, 5,6, 7, 8, 9, 10, etc. atoms) total ring atoms independently selected from N, O and S heteroatoms, preferably "3-to 10-membered heterocyclic groups". The term "3-to 10-membered heterocyclyl" means a saturated monovalent monocyclic, bicyclic hydrocarbon ring or bridged cycloalkane comprising 1 to 5, preferably 1 to 3 heteroatoms selected from N, O and S. The heterocyclic group may be attached to the remainder of the molecule through any of the carbon atoms or a nitrogen atom, if present. In particular, the heterocyclic groups may include, but are not limited to: 4-membered rings such as azetidinyl, oxetanyl; a 5-membered ring such as tetrahydrofuranyl, dioxolyl, pyrrolidinyl, imidazolidinyl, pyrazolidinyl, pyrrolinyl; or a 6 membered ring such as tetrahydropyranyl, piperidinyl, morpholinyl, dithianyl, thiomorpholinyl, piperazinyl or trithianyl; or a 7-membered ring such as diazepanyl. Optionally, the heterocyclyl may be benzo-fused. The heterocyclyl may be bicyclic, such as, but not limited to, a 5,5 membered ring, such as hexahydrocyclopenta [ c ] pyrrol-2 (1H) -yl ring, or a 5,6 membered bicyclic ring, such as hexahydropyrrolo [1,2-a ] pyrazin-2 (1H) -yl ring. The nitrogen atom-containing ring may be partially unsaturated, i.e., it may contain one or more double bonds, such as, but not limited to, 2, 5-dihydro-1H-pyrrolyl, 4H- [1,3,4] thiadiazinyl, 4, 5-dihydro-oxazolyl, or 4H- [1,4] thiazide, or it may be benzo-fused, such as, but not limited to, dihydroisoquinolinyl. According to the invention, the heterocyclic group is non-aromatic. When the 3-20 membered heterocyclic group is linked to other groups to form the compound of the present invention, the carbon atom on the 3-20 membered heterocyclic group may be linked to other groups, or the heterocyclic atom on the 3-20 membered heterocyclic ring may be linked to other groups. For example, when the 3-to 20-membered heterocyclic group is selected from piperazinyl, it may be that the nitrogen atom on the piperazinyl group is attached to other groups. Or when the 3-to 20-membered heterocyclic group is selected from piperidyl, it may be that the nitrogen atom on the piperidyl ring and the carbon atom at the para position thereof are linked to other groups.
The term "C 6-20 Aryl "is understood to mean preferably a mono-, bi-or tricyclic hydrocarbon ring, preferably" C ", of monovalent aromatic or partly aromatic nature having from 6 to 20 carbon atoms 6-14 Aryl group). The term "C 6-14 Aryl "is understood to mean preferably a mono-, bi-or tricyclic hydrocarbon ring (" C ") having a monovalent aromatic or partially aromatic character of 6, 7, 8, 9, 10, 11, 12, 13 or 14 carbon atoms 6-14 Aryl), in particular a ring having 6 carbon atoms ("C) 6 Aryl')Such as phenyl; or biphenyl, or a ring having 9 carbon atoms ("C 9 Aryl "), e.g. indanyl or indenyl, or a ring having 10 carbon atoms (" C 10 Aryl "), such as tetralin, dihydronaphthyl or naphthyl, or a ring having 13 carbon atoms (" C " 13 Aryl "), e.g. fluorenyl, or a ring having 14 carbon atoms (" C) 14 Aryl "), such as anthracenyl. When said C 6-20 When aryl is substituted, it may be mono-substituted or poly-substituted. The substitution site is not limited, and may be, for example, ortho, para or meta substitution.
The term "5-to 20-membered heteroaryl" is understood to include such monovalent monocyclic, bicyclic or tricyclic aromatic ring systems: having 5 to 20 ring atoms and containing 1 to 5 heteroatoms independently selected from N, O and S, for example "5 to 14 membered heteroaryl". The term "5-to 14-membered heteroaryl" is understood to include such monovalent monocyclic, bicyclic or tricyclic aromatic ring systems: having 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14 ring atoms, in particular 5 or 6 or 9 or 10 carbon atoms, and which contain 1 to 5, preferably 1 to 3 heteroatoms each independently selected from N, O and S and which may additionally be benzo-fused in each case. In particular, the heteroaryl group is selected from thienyl, furyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, oxadiazolyl, triazolyl, thiadiazolyl, thia-4H-pyrazolyl and the like and their benzo derivatives, such as benzofuryl, benzothienyl, benzoxazolyl, benzisoxazolyl, benzimidazolyl, benzotriazole, indazolyl, indolyl, isoindolyl and the like; or pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, and the like, and their benzo derivatives, such as quinolinyl, quinazolinyl, isoquinolinyl, and the like; or an axcinyl group, an indolizinyl group, a purinyl group, etc., and their benzo derivatives; or cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, phenoxazinyl, and the like. When the 5-to 20-membered heteroaryl is linked to other groups to form the compounds of the invention, the carbon atom on the 5-to 20-membered heteroaryl ring may be linked to other groups, or the heteroatom on the 5-to 20-membered heteroaryl ring may be linked to other groups. When the 5-to 20-membered heteroaryl group is substituted, it may be mono-substituted or poly-substituted. And, the substitution site thereof is not limited, and for example, hydrogen attached to a carbon atom on a heteroaryl ring may be substituted, or hydrogen attached to a heteroatom on a heteroaryl ring may be substituted.
As used herein, the term "derivative" refers to a chemical substance that is structurally related to another, which is a "native" substance, and may also be referred to as a "parent" compound. The "derivatives" may be manufactured in one or more steps from a structurally related parent compound.
Unless otherwise indicated, heterocyclyl, heteroaryl or heteroarylene include all possible isomeric forms thereof, e.g. positional isomers thereof. Thus, for some illustrative non-limiting examples, forms that may include substitution at one, two, or more of its 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9-, 10-, 11-, 12-positions, etc. (if present) or bonding to other groups include pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, and pyridin-4-yl; thienyl or thienylene include thiophen-2-yl, thienylene-2-yl, thiophen-3-yl and thienylene-3-yl; pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, and pyrazol-5-yl.
The term "oxo" refers to the substitution of a carbon atom, nitrogen atom or sulfur atom in a substituent with an oxo group (=o) formed after oxidation.
By polyphenol is meant a natural, synthetic and semisynthetic organic compound characterized by the presence of a large number of repeating phenolic building blocks. Polyphenols are generally compounds having a molecular weight of 400-4000 Da, greater than or equal to 5 phenolic hydroxyl groups.
The term "enhancer of enzymes" refers to diffusible molecules activated by oxidase and diffusing from active sites on the enzyme to sensitive structures, which are small organic compounds of low redox potential that act as carriers for electron transfer during laccase catalytic oxidation.
The multilayer film is a film composed of at least one layer of copolymer film. In order to distinguish the film that is initially formed from a film that is prepared by continuing the reaction two or more times on its basis, the copolymer film that is initially formed is referred to as a "base film" in the present invention. The base film is a copolymer film prepared by two or more chemical or/and enzymatic reactions, referred to as a "derivative film". The new film layer can be generated on one side or two sides of the basic film through enzymatic polymerization, the chemical composition and structure of the new film layer can be different from those of the basic film, and the new film layer can be continuously generated. The base film and the new film layer together form a "multilayer film". The derivative film continues to form a new polymer film, known as a "derivative multilayer film".
Detailed Description
The technical scheme of the invention will be further described in detail below with reference to specific embodiments. It is to be understood that the following examples are illustrative only and are not to be construed as limiting the scope of the invention. All techniques implemented based on the above description of the invention are intended to be included within the scope of the invention.
The Polyethyleneimine (PEI) in the present invention has an average relative molecular weight (average relative molecular) of 600, manufactured by Shanghai microphone Biochemical technology Co., ltd. The paraffin is refined paraffin with a melting point of 58-60 ℃ and is manufactured by Jiangsu Shitai laboratory instruments Co. Unless otherwise indicated, the starting materials and reagents used in the following examples were either commercially available or may be prepared by known methods.
Definition of laccase enzyme activity: the amount of enzyme required to oxidize 1. Mu. Mol of 2,2' -Azino-bis- (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) per minute was 1 enzyme activity unit (U).
Definition of manganese peroxidase enzyme activity: the amount of enzyme required to oxidize 1. Mu. Mol of ABTS per minute was 1 enzyme activity unit (U).
Definition of horseradish peroxidase enzymatic activity: the amount of enzyme required to oxidize 1. Mu. Mol of ABTS per minute was 1 enzyme activity unit (U).
Definition of lignin peroxidase enzyme activity: the amount of enzyme required to oxidize 1. Mu. Mol of ABTS per minute was 1 enzyme activity unit (U).
Definition of soybean peroxidase enzymatic activity: the amount of enzyme required to oxidize 1. Mu. Mol of ABTS per minute was 1 enzyme activity unit (U).
Definition of chloroperoxidase enzyme activity: the amount of enzyme required for oxidizing 1. Mu. Mol of 2-chloro-5, 5-dimethyl-1, 3-cyclohexanedione per minute to produce 2, 2-dichloro-5, 5-dimethyl-1, 3-cyclohexanedione was 1 enzyme activity unit (U).
Definition of monophenol monooxidase enzyme activity: the amount of enzyme required to oxidize 1. Mu. Mol of L-DOPA (L-DOPA) per minute was 1 enzyme activity unit (U).
Definition of catechol oxidase enzyme activity: the amount of enzyme required to oxidize 1. Mu. Mol of catechol per minute was 1 enzyme activity unit (U).
Definition of bilirubin oxidase enzyme activity: the amount of enzyme required to oxidize 1. Mu. Mol of ABTS per minute was 1 enzyme activity unit (U).
Example 1: preparation of laccase
(1) Liquid seed medium: 30g/L corn flour, 15g/L bean cake flour, 54U/L alpha-amylase and NaH 2 PO 4 2.6g/L,KCl 2.25g/L,MgSO 4 ·7H 2 O1.5 g/L, water in balance, pH 6.0,0.1MPa for 25min.
Fermentation medium: 48g/L fructose, 12g/L corn meal, 9g/L soybean peptone, (NH) 4 ) 2 SO 4 0.5g/L,KCl 1g/L,NaH 2 PO 4 1.8g/L,MgSO 4 ·7H 2 O 0.25g/L,CuSO 4 ·5H 2 O 1mmol/L,VB 1 0.03g/L Tween-80.5 g/L, vanillin 1mmol/L, water balance, pH 6.5,0.1MPa sterilization 25min.
(2) Culturing liquid seeds: taking inclined plane lawn of winter-growing porous fungus (Polyporus brumalis) (strain with preservation number CCTCC NO: M2020809) about 3cm 2 Inoculating to 500mL triangular flask, and culturing in 150mL liquid seed culture medium at 30deg.C and 150rpm for 4 days to obtain seed solution.
Shake flask fermentation culture: inoculating the seed solution to a fermentation culture medium according to the inoculum size of 6% of the volume ratio, wherein the liquid loading amount of the fermentation culture medium in a 500mL triangular flask is 150mL, carrying out shake culture at 30 ℃, and the rotation speed of a shaking table after fermentation for 1-3 days is 150rpm and the rotation speed of the shaking table after fermentation for 3 days is 200rpm.
(3) Preparation of crude enzyme solution: the fermentation broth is centrifuged for 10min at 10000 Xg at 4 ℃, and the supernatant is the crude enzyme solution of laccase.
(4) Purification of laccase:
taking 100mL of coarse enzyme solution of laccase, slowly adding ammonium sulfate in stages while stirring to ensure that the concentration of the ammonium sulfate solution gradually reaches 60%, centrifuging at 12000 Xg for 10min at 4 ℃ after full precipitation, collecting precipitate, and dissolving the precipitate in a proper volume of pH 7.0 and 0.02mol/L citric acid-disodium hydrogen phosphate buffer solution to obtain salting-out solution. And (3) placing the salting-out solution in the same buffer solution for dialysis overnight, and replacing the dialysis solution every 10 hours until the conductivity and the pH value of the liquid inside and outside the dialysis bag are the same, so as to obtain the dialysis solution of laccase.
The column packed with DEAE-Sepharose Fast Flow ion exchange medium was equilibrated with citric acid-disodium hydrogen phosphate buffer solution (solution A) at pH 7.0,0.02 mol/L. The enzyme solution obtained by dialysis was filtered through a filter membrane having a pore size of 0.22. Mu.m, and then was applied at a flow rate of 2mL/min in an amount of 10mL. After sample loading, the sample is balanced by the solution A to be at the base line zero, then continuous gradient elution is carried out by the buffer solution (solution B) of citric acid and disodium hydrogen phosphate containing NaCl of 0-0.5 mol/L respectively, the flow rate is 1mL/min, the absorbance at the wavelength of 280nm is recorded, active components are collected for standby, and each tube is collected for 2mL. And (3) measuring laccase activity and protein concentration of the collected sample, combining eluents with laccase activity to obtain laccase purified by a chromatographic column (called pure enzyme solution in the invention), and storing at-20 ℃ for later use.
Example 2: preparation of copolymer film by enzymatic polymerization at liquid paraffin-water solution interface
(1) Laccase catalyzed preparation of a cocaine-arginine copolymer film:
0.050g of caffeine, 0.050g of arginine and 5.0mg of vanillin are dissolved in 35mL of a mixed solvent of 0.05mol/L sodium succinate-succinic acid buffer solution (pH 2.0) and 15mL of acetone, 7.5U of laccase is added, and the mixture is fully and uniformly mixed to obtain a laccase catalytic system (aqueous phase). The aqueous phase was covered with 3mm thick liquid paraffin, and left to stand in an incubator (ZSD-1090, china) at 30℃for 3 hours, whereby a "cocaine-arginine copolymer film" was formed at the interface between the liquid paraffin and the aqueous phase. The transfer process of the "corin-arginine copolymer membrane" is as follows: sucking out most liquid paraffin on the upper side of the 'corin-arginine copolymer membrane' and water phase on the lower side of the 'corin-arginine copolymer membrane' by using a syringe, and injecting distilled water on the lower side of the 'corin-arginine copolymer membrane', so that the liquid suction-liquid injection-liquid suction operation is repeated for a plurality of times; the coverslip was inserted into the water phase under the membrane, carefully moved under the "corin-arginine copolymer membrane" and gently fished out, and the residual liquid paraffin on the membrane surface was sucked off with filter paper and dried at room temperature.
(2) tectorigenin-PEI copolymer membrane prepared by laccase catalysis:
A laccase catalytic system (aqueous phase) was obtained by dissolving 0.250g tectorigenin, 0.250g PEI, 12.5mg ABTS in 175mL of a mixed solvent of 0.05mol/L potassium hydrogen phthalate-sodium hydroxide buffer solution (pH 5.0) and 75mL of ethanol, adding laccase 50U, and mixing uniformly. The aqueous phase was covered with 5mm thick liquid paraffin, and left to stand in an oven (Zhiyeng, ZFD-5090, china) at 60℃for 8 hours, whereby an "tectorigenin-PEI copolymer film" was formed at the interface between the liquid paraffin and the aqueous phase.
The transfer method of the film comprises the following steps: the bottom aqueous phase was slowly drained, allowing the film to fall onto the substrate surface at the bottom of the container, removing the upper liquid wax layer.
(3) Preparation of rhein-2, 4-diamino-6-methyl-1, 3, 5-triazine copolymer film catalyzed by laccase:
0.125g rhein, 0.125g 2, 4-diamino-6-methyl-1, 3, 5-triazine and 20mg syringaldehyde are dissolved in 175mL mixed solvent of 0.05mol/L sodium acetate-acetic acid buffer solution (pH 4.0) and 75mL methanol, laccase 5U is added, and the mixture is uniformly mixed to obtain a laccase catalytic system (water phase). Liquid paraffin with the thickness of 5mm is covered on the water phase, and the mixture is placed in an oven (Zhiyeng, ZFD-5090, china) at the temperature of 50 ℃ for reaction for 10 hours. The interface between the liquid paraffin and the aqueous phase forms a 'rhein-2, 4-diamino-6-methyl-1, 3, 5-triazine copolymer film'.
(4) Preparation of 1, 6-dihydroxynaphthalene-diethylenetriamine copolymer film by manganese peroxidase catalysis:
dissolving 0.125g of 1, 6-dihydroxynaphthalene and 0.250g of diethylenetriamine in 200mL of a mixed solvent of 0.05mol/L disodium hydrogen phosphate-citric acid buffer solution (pH 4.0) and 50mL of acetone, adding 12U of manganese peroxidase, 40 mu L of 5% hydrogen peroxide and 0.1mol/L MnSO 4 3.5mL, and mixing to obtain a manganese peroxidase catalytic system (water phase). Liquid paraffin of 5mm thickness was covered on the surface of the aqueous phase with a pipette, and left to stand in an incubator (zhiyeng, ZSD-1090, china) at 37 ℃ for 10 hours, during which 5% hydrogen peroxide was added to the reaction system several times, 40 μl each time. The interface between the liquid paraffin and the aqueous phase forms a "1, 6-dihydroxynaphthalene-diethylenetriamine copolymer film".
(5) Manganese peroxidase catalysis is used for preparing shikonin-lysine copolymer film:
0.125g shikonin and 0.125g lysine are dissolved in 175mL of mixed solvent of 0.05mol/L disodium hydrogen phosphate-citric acid buffer solution (pH 3.0) and 75mL of ethanol, and manganese peroxidase 10U, 5% hydrogen peroxide 40 mu L and 0.1mol/L MnSO are added 4 3.5mL, and mixing to obtain a manganese peroxidase catalytic system (water phase). The surface of the manganese peroxidase catalytic system is covered with liquid paraffin with the thickness of 5mm by using a straw, and the liquid paraffin is placed in a baking oven (Zhiyeng, ZFD-5090, china) at the temperature of 45 ℃ for 6 hours, and 5% hydrogen peroxide is added to the reaction system for multiple times, and 40 mu L of hydrogen peroxide is added each time. The interface between the liquid paraffin and the aqueous phase forms a "shikonin-lysine copolymer film".
(6) Preparation of 3-methyl salicylic acid-3-nitro-1, 2-phenylenediamine copolymer film catalyzed by manganese peroxidase:
0.010g of 3-methyl salicylic acid, 0.010g of 3-nitro-1, 2-phenylenediamine was dissolved in 50mL of 0.05mol/L sodium succinate-succinic acid buffer solution (pH 5.0), and manganese peroxidase 0.05U, 5% hydrogen peroxide 8. Mu.L and 0.1mol/L MnSO were added 4 0.7mL, and the manganese peroxidase catalytic system (water phase) is obtained after uniform mixing. The surface of the manganese peroxidase catalytic system is covered with liquid paraffin with the thickness of 5mm by using a straw, and the liquid paraffin is placed in an incubator (ZSD-1090, china) at the temperature of 20 ℃ for reaction for 12 hours, and 5% hydrogen peroxide is added to the reaction system for multiple times during the reaction, and 8 mu L of the liquid paraffin is added each time. Formation of "3-methyl salicylic acid-3-nitro-1, 2-phenylenediamine copolymer film" at the interface of liquid paraffin and aqueous phase”。
(7) Preparation of a galloblue-2, 4, 6-triaminopyrimidine copolymer membrane by manganese peroxidase catalysis:
0.250g of galloblue and 0.250g of 2,4, 6-triaminopyrimidine were dissolved in 250mL of 0.05mol/L potassium hydrogen phthalate-sodium hydroxide buffer solution (pH 5.0), and manganese peroxidase 10U, 5% hydrogen peroxide 40. Mu.L and 0.1mol/L MnSO were added 4 3.5mL, and mixing to obtain a manganese peroxidase catalytic system (water phase). The surface of the manganese peroxidase catalytic system is covered with liquid paraffin with the thickness of 5mm by using a straw, and the liquid paraffin is placed in a baking oven (Zhiyeng, ZFD-5090, china) at the temperature of 40 ℃ for reaction for 15 hours, and 5 percent of hydrogen peroxide is added into the reaction system for multiple times, and 40 mu L of hydrogen peroxide is added each time. The interface between the liquid paraffin and the aqueous phase forms a "galloblue-2, 4, 6-triaminopyrimidine copolymer film".
(8) Preparing a 4,4' -dihydroxybiphenyl-2, 3-diaminonaphthalene copolymer film by horseradish peroxidase catalysis:
0.125g of 4,4' -dihydroxybiphenyl, 0.125g of 2, 3-diaminonaphthalene are dissolved in 215mL of a mixed solvent of 0.05mol/L glycine-sodium hydroxide buffer solution (pH 10.0) and 35mL of acetone, 6U of horseradish peroxidase and 40 mu L of 5% hydrogen peroxide are added, and the mixture is uniformly mixed to obtain a horseradish peroxidase catalytic system (water phase). Liquid paraffin with the thickness of 10mm is covered on the surface of a horseradish peroxidase catalytic system by a straw, and the mixture is kept stand for 24 hours in a baking oven (Zhiyeng, ZFD-5090, china) at the temperature of 40 ℃, and 5% hydrogen peroxide is added to the reaction system for multiple times, and 40 mu L of hydrogen peroxide is added each time. The interface between the liquid paraffin and the aqueous phase forms a "4,4' -dihydroxybiphenyl-2, 3-diaminonaphthalene copolymer film".
(9) Preparing bisphenol A-proflavone copolymer membrane by horseradish peroxidase catalysis:
0.250g bisphenol A, 0.250g pre-flavin are dissolved in 175mL mixed solvent of 0.1mol/L Tris-hydrochloric acid buffer solution (pH 8.0) and 75mL ethanol, and a proper amount of horseradish peroxidase 3U and 5% hydrogen peroxide 40 mu L are added and uniformly mixed to obtain a horseradish peroxidase catalytic system (water phase). Liquid paraffin with the thickness of 5mm is covered on the surface of a horseradish peroxidase catalytic system by a straw, and the mixture is kept stand for 5 hours in a baking oven (Zhiyeng, ZFD-5090, china) at the temperature of 45 ℃, and 5% hydrogen peroxide is added to the reaction system for multiple times, and 40 mu L of hydrogen peroxide is added each time. The interface between the liquid paraffin and the aqueous phase forms a bisphenol A-procxanthin copolymer film.
(10) Preparation of 1,8, 9-trihydroxy anthracene-4, 4' -diaminodiphenyl sulfone copolymer membrane catalyzed by horseradish peroxidase:
0.040g of 1,8, 9-trihydroxyanthracene, 0.060g of 4,4' -diaminodiphenyl sulfone are dissolved in 140mL of a mixed solvent of 0.05mol/L disodium hydrogen phosphate-citric acid buffer solution (pH 6.0) and 60mL of ethanol, 12U of horseradish peroxidase and 40 mu L of 5% hydrogen peroxide are added, and the mixture is uniformly mixed to obtain a horseradish peroxidase catalytic system (water phase). Liquid paraffin with the thickness of 5mm is covered on the surface of a horseradish peroxidase catalytic system by a straw, and the mixture is kept stand for 17 hours in a baking oven (Zhiyeng, ZFD-5090, china) at the temperature of 45 ℃, and 5% hydrogen peroxide is added to the reaction system for multiple times, and 40 mu L of hydrogen peroxide is added each time. The interface between the liquid paraffin and the aqueous phase forms a "1,8, 9-trihydroxyanthracene-4, 4' -diaminodiphenyl sulfone copolymer film".
(11) Preparation of 4',6, 7-dihydroxyisoflavone-auxiliary product red copolymer film by lignin peroxidase catalysis:
0.750g of 4',6, 7-trihydroxyisoflavone, 1.500g of parafuchsin are dissolved in 175mL of a mixed solvent of 0.05mol/L sodium citrate-citric acid buffer solution (pH 5.0) and 75mL of ethanol, 1.5U of lignin peroxidase and 40 mu L of 5% hydrogen peroxide are added, and the mixture is uniformly mixed to obtain a lignin peroxide catalytic system (water phase). The lignin peroxide catalytic system surface is covered with liquid paraffin with the thickness of 5mm by a straw, and the liquid paraffin is kept stand in a 45 ℃ oven (Zhiyeng, ZFD-5090, china) for reaction for 12 hours, and 5% hydrogen peroxide is added to the reaction system for multiple times, and 40 mu L of hydrogen peroxide is added each time. The interface between the liquid paraffin and the aqueous phase forms a "4',6, 7-trihydroxyisoflavone-subsidiary red copolymer film".
(12) Catalytic preparation of a geraniin-1, 6-hexamethylenediamine copolymer membrane with lignin peroxidase:
0.025g of geraniin, 0.050g of 1, 6-hexamethylenediamine are dissolved in 225mL of mixed solvent of trisodium phosphate-phosphate buffer solution (pH 4.0) and 25mL of dimethyl sulfoxide, 6U of lignin peroxidase and 40 mu L of 5% hydrogen peroxide are added, and the mixture is uniformly mixed to obtain a lignin peroxide catalytic system (water phase). The surface of lignin peroxide catalytic system is covered with liquid paraffin with the thickness of 5mm by using a straw, and the liquid paraffin is placed in a incubator (Zhiyeng, ZSD-1090, china) at the temperature of 30 ℃ for reaction for 8 hours, and 5% hydrogen peroxide is added into the reaction system for multiple times, and 40 mu L of hydrogen peroxide is added each time. The interface between the liquid paraffin and the aqueous phase forms a 'geraniin-1, 6-hexamethylenediamine copolymer film'.
(13) Preparation of resveratrol-5, 6-diamino-1, 3-dimethyluracil copolymer membrane by soybean peroxidase catalysis:
0.025g of resveratrol, 0.025g of 5, 6-diamino-1, 3-dimethyluracil is dissolved in 35mL of a mixed solvent of 0.05mol/L trisodium phosphate-phosphoric acid buffer solution (pH 6.0) and 15mL of ethanol, and 0.6U of soybean peroxidase and 8 mu L of 5% hydrogen peroxide are added and uniformly mixed to obtain a soybean peroxidase catalytic system (water phase). The surface of the soybean peroxidase catalytic system is covered with liquid paraffin with the thickness of 5mm by using a suction pipe, and the liquid paraffin is placed in a baking oven (Zhiyeng, ZFD-5090, china) at 65 ℃ for reaction for 5 hours, and 5% hydrogen peroxide is added to the reaction system for multiple times, and 8 mu L of the liquid paraffin is added each time. The interface between the liquid paraffin and the water phase forms a resveratrol-5, 6-diamino-1, 3-dimethyluracil copolymer film.
(14) Preparation of esculetin-melamine-1, 4-diaminoanthraquinone copolymer film catalyzed by soybean peroxidase:
0.075g esculetin, 0.125g melamine, 0.075g 1, 4-diaminoanthraquinone are dissolved in 175mL mixed solvent of 0.05mol/L trisodium phosphate-phosphate buffer solution (pH 5.0) and 75mL ethanol, 15U of soybean peroxidase and 40 mu L of 5% hydrogen peroxide are added, and the mixture is uniformly mixed to obtain a soybean peroxidase catalytic system (water phase). The surface of the soybean peroxidase catalytic system is covered with liquid paraffin with the thickness of 5mm by using a suction pipe, and the mixture is placed in a baking oven (Zhiyeng, ZFD-5090, china) at the temperature of 75 ℃ for reaction for 4 hours, and 5% hydrogen peroxide is added to the reaction system for multiple times, and 40 mu L of hydrogen peroxide is added each time. The interface between the liquid paraffin and the aqueous phase forms a "esculetin-melamine-1, 4-diaminoanthraquinone copolymer film".
(15) Preparation of ellagic acid-PEI copolymer film catalyzed by chloroperoxidase:
0.025g ellagic acid, 0.050g PEI were dissolved in 250mL of 0.05mol/L sodium citrate-citric acid buffer (pH 3.0), 11.25U of chloroperoxidase and 40. Mu.L of 5% hydrogen peroxide were added and mixed well to give a chloroperoxidase catalytic system (aqueous phase). Liquid paraffin with the thickness of 5mm is covered on the surface of a chloroperoxidase catalytic system by a suction pipe, and the liquid paraffin is placed in an incubator (ZSD-1090, china) at 35 ℃ for reaction for 4 hours, and 5% hydrogen peroxide is added to the reaction system for multiple times during the reaction, and 40 mu L of the liquid paraffin is added each time. An "ellagic acid-PEI copolymer film" is formed at the interface of the liquid paraffin and the aqueous phase.
(16) Preparing a Jinsong biflavone-spermine copolymer membrane by using chloroperoxidase as a catalyst:
0.050g of pinus koraiensis biflavone and 0.100g of spermine are dissolved in 70mL of a mixed solvent of 0.05mol/L trisodium phosphate-phosphoric acid buffer solution (pH 3.0) and 30mL of ethanol, 3U of chloroperoxidase and 16 mu L of 5% hydrogen peroxide are added, and the mixture is uniformly mixed to obtain a chloroperoxidase catalytic system (water phase). Liquid paraffin with the thickness of 5mm is covered on the surface of a chloroperoxidase catalytic system by a suction pipe, and the liquid paraffin is kept stand in a baking oven (Zhiyeng, ZFD-5090, china) at the temperature of 40 ℃ for reaction for 6 hours, and 5% hydrogen peroxide is added to the reaction system for multiple times, and 16 mu L of hydrogen peroxide is added each time. The interface between the liquid paraffin and the aqueous phase forms a 'Jinsong biflavone-spermine copolymer film'.
(17) Preparing a colchicoside-2, 4-diaminoanisole copolymer membrane by using chloroperoxidase as a catalyst:
0.075g of Narcin, 0.125g of 2, 4-diaminoanisole are dissolved in 200mL of a mixed solvent of 0.05mol/L sodium malonate-malonic acid buffer solution (pH 4.0) and 50mL of ethanol, 0.75U of chloroperoxidase and 40 mu L of 5% hydrogen peroxide are added, and the mixture is uniformly mixed to obtain a chloroperoxidase catalytic system (water phase). Liquid paraffin with the thickness of 5mm is covered on the surface of a chloroperoxidase catalytic system by a suction pipe, and the liquid paraffin is placed in an incubator (ZSD-1090, china) at the temperature of 10 ℃ for reaction for 5 hours, and 5% hydrogen peroxide is added into the reaction system for multiple times during the reaction, and 40 mu L of the liquid paraffin is added each time. The interface between the liquid paraffin and the aqueous phase forms a "colchicoside-2, 4-diaminoanisole copolymer film".
(18) Preparing a tyrosine-o-tolidine copolymer membrane by catalysis of monophenol monooxidase:
0.075g of tyrosine and 0.050g of o-tolidine are dissolved in 250mL of 0.05mol/L disodium hydrogen phosphate-potassium dihydrogen phosphate buffer solution (pH 6.5), 150U of monophenol monooxidase is added, and the mixture is uniformly mixed to obtain a monophenol monooxidase catalytic system (water phase). Liquid paraffin with the thickness of 5mm is covered on the surface of a monophenol monooxidase catalytic system by a straw, and the liquid paraffin is placed in an incubator (Zhiyeng, ZSD-1090, china) at the temperature of 20 ℃ for reaction for 36h. The interface between the liquid paraffin and the aqueous phase forms a 'tyrosine-o-tolidine copolymer film'.
(19) Catechol-urea copolymer membranes are prepared catalytically with catechol oxidase:
7.500g catechol and 5.000g urea were dissolved in 250mL of a 0.05mol/L sodium succinate-succinic acid buffer solution (pH 4.0), and catechol oxidase 0.75U was added and mixed well to obtain a catechol oxidase catalyst system (aqueous phase). Covering liquid paraffin with 5mm thickness on the surface of catechol oxidase catalytic system with a straw, standing in oven (ZFD-5090, china) at 50deg.C for reaction for 8 hr. The "catechol-urea copolymer film" is formed at the interface of the liquid paraffin and the aqueous phase.
(20) Preparation of hesperetin-6-hydroxy-2, 4, 5-triaminopyrimidine copolymer membrane catalyzed by bilirubin oxidase:
0.020g of hesperetin, 0.020g of 6-hydroxy-2, 4, 5-triaminopyrimidine are dissolved in 140mL of a mixed solvent of 0.05mol/L trisodium phosphate-phosphate buffer solution (pH 5.0) and 60mL of ethanol, and 100U of bilirubin oxidase is added and uniformly mixed to obtain a bilirubin oxidase catalytic system (water phase). Liquid paraffin with the thickness of 5mm is covered on the surface of a bilirubin oxidase catalytic system by a straw, and the liquid paraffin is placed in a 55 ℃ oven (Zhiyeng, ZFD-5090, china) for reaction for 8 hours. The interface between the liquid paraffin and the aqueous phase forms a 'hesperetin-6-hydroxy-2, 4, 5-triaminopyrimidine copolymer film'.
Example 3: preparation of copolymer film by enzymatic polymerization at aqueous solution-carbon tetrachloride interface
(1) Preparation of 1, 3-dihydroxynaphthalene-kanamycin copolymer film catalyzed by laccase:
0.25g of 1, 3-dihydroxynaphthalene and 0.25g of kanamycin are dissolved in 50mL of 0.05mol/L sodium acetate-acetic acid buffer solution (pH 4.0), 0.6U of laccase is added, and the mixture is uniformly mixed to obtain a laccase catalytic system (aqueous phase). Firstly, adding CCl with the thickness of 55mm into a container 4 (liquid phase which is mutually insoluble in water) and then to the containerSlowly adding water phase, and floating in CCl 4 On the two phases, a liquid-liquid interface is formed between the two phases. Standing in 35℃incubator (ZSD-1090, china) for reaction for 12h. A "1, 3-dihydroxynaphthalene-kanamycin copolymer film" (gas-liquid interfacial film) was formed on the upper surface of the aqueous phase (gas-liquid interface of aqueous phase and air), while at the same time, in the aqueous phase and CCl 4 The liquid-liquid interface of (a) forms a "1, 3-dihydroxynaphthalene-kanamycin copolymer film" (liquid-liquid interface film). The transfer of two interfacial films to coverslips: (1) the cover glass is first inserted into the water phase, carefully moved to the lower part of the 1, 3-dihydroxynaphthalene-kanamycin of the gas-liquid interface, and gently fished out to complete the transfer of the gas-liquid interface film. (2) Sucking out the solution on the upper side of the "1, 3-dihydroxynaphthalene-kanamycin copolymer film" of the liquid-liquid interface by a syringe, re-injecting distilled water on the upper side of the film, repeating the pipetting-liquid-pipetting operation multiple times, and inserting another coverslip into the CCl 4 In the process, the liquid-liquid interface film is gently fished up after being carefully moved below the liquid-liquid interface film, the liquid-liquid interface film is spread on a cover glass in a flat manner, and residual CCl on the lower side of the film is sucked by filter paper 4 And (5) airing at room temperature.
(2) Laccase catalyzed preparation of ferulic acid-2, 3-dimethyl-p-phenylenediamine copolymer film:
0.125g of ferulic acid and 0.125g of 2, 3-dimethyl-p-phenylenediamine are dissolved in 250mL of 0.05mol/L phthalic acid-hydrochloric acid buffer solution (pH 3.0), 0.5U of laccase is added, and the mixture is uniformly mixed to obtain a laccase catalytic system (water phase). Firstly, adding CCl with the thickness of 5mm into a container 4 (liquid phase which is mutually insoluble with water), then slowly adding an aqueous phase to the vessel, the aqueous phase floating in CCl 4 On, aqueous phase and CCl 4 Forming a liquid-liquid interface therebetween. The reaction was allowed to stand at room temperature for 2 hours. Forming a 'ferulic acid-2, 3-dimethyl-p-phenylenediamine copolymer film' on the upper surface of the aqueous phase (gas-liquid interface of the aqueous phase and air), and simultaneously in water, CCl 4 The liquid-liquid interface of the two phases forms a "ferulic acid-2, 3-dimethyl-p-phenylenediamine copolymer film".
(3) Preparation of p-coumaric acid-p-phenylenediamine copolymer membranes catalyzed by manganese peroxidase:
0.125g p-coumaric acid, 0.25g p-phenylenediamine were dissolved in 250mL of 0.05 mol-L tartaric acid-sodium tartrate buffer solution (pH 5.0), manganese peroxidase 0.125U, 5% hydrogen peroxide 40 μL and 0.1mol/LMnSO 4 3.5mL, and mixing to obtain a manganese peroxidase catalytic system (water phase). Firstly, adding CCl with the thickness of 35mm into a container 4 (liquid phase which is mutually insoluble with water) then slowly add the aqueous phase to the vessel, the aqueous phase floating in the CCl 4 On, aqueous phase and CCl 4 Forming a liquid-liquid interface therebetween. The reaction mixture was allowed to stand in an incubator (ZSD-1090, china) at 10℃for 36 hours, during which time 5% hydrogen peroxide was added to the aqueous system 40. Mu.L each time. The upper surface of the aqueous phase (the gas-liquid interface of the aqueous phase and air) forms a 'p-coumaric acid-p-phenylenediamine film' on water, CCl simultaneously 4 Form a "p-coumaric acid-p-phenylenediamine copolymer film".
(4) Preparing a 3-methoxy salicylic acid-2, 3-diethyl-p-phenylenediamine copolymer film by horseradish peroxidase catalysis:
0.125g of 3-methoxysalicylic acid and 0.125g of 2, 3-diethyl-p-phenylenediamine are dissolved in 250mL of 0.05mol/L dipotassium hydrogen phosphate-sodium hydroxide buffer solution (pH 6.5), 1.5U of horseradish peroxidase and 40 mu L of 5% hydrogen peroxide are added, and the mixture is uniformly mixed to obtain a horseradish peroxidase catalytic system (water phase). Firstly, adding CCl with the thickness of 25mm into a container 4 (liquid phase which is mutually insoluble with water) then slowly add the aqueous phase to the vessel, the aqueous phase floating in the CCl 4 On, aqueous phase and CCl 4 Forming a liquid-liquid interface therebetween. The reaction was allowed to stand in an oven (ZFD-5090, china) at 55deg.C for 8 hours, during which time 5% hydrogen peroxide was added to the aqueous phase 40. Mu.L each time. The upper surface of the aqueous phase (gas-liquid interface of the aqueous phase and air) forms "3-methoxy salicylic acid-2, 3-diethyl-p-phenylenediamine" while in water, CCl 4 Form the 3-methoxy salicylic acid-2, 3-diethyl-p-phenylenediamine.
(5) Preparing a 3, 5-diiodosalicylic acid-2-hydroxymethyl-p-phenylenediamine copolymer membrane by lignin peroxidase catalysis:
0.050g of 3, 5-diiodosalicylic acid, 0.100g of 2-hydroxymethyl-p-phenylenediamine were dissolved in 250mL of 0.05mol/L tartaric acid-sodium tartrate buffer solution (pH 3.0), and lignin peroxidase 0.2 was added5U and 40. Mu.L of 5% hydrogen peroxide were mixed to obtain a lignin peroxide catalyst system (aqueous phase). Firstly, adding CCl with the thickness of 25mm into a container 4 (liquid phase which is mutually insoluble with water) then slowly add the aqueous phase to the vessel, the aqueous phase floating in the CCl 4 On the water phase and CCl 4 Forming a liquid-liquid interface therebetween. The reaction mixture was allowed to stand in an incubator (ZSD-1090, china) at 37℃for 3 hours, during which time 5% hydrogen peroxide was added to the aqueous phase 40. Mu.L each time. The upper surface of the aqueous phase (gas-liquid interface of the aqueous phase and air) forms a '3, 5-diiodosalicylic acid-2-hydroxymethyl-p-phenylenediamine copolymer film', and simultaneously, the copolymer film is formed on water and CCl 4 The liquid-liquid interface of (a) forms a '3, 5-diiodosalicylic acid-2-hydroxymethyl-p-phenylenediamine copolymer film'.
(6) Preparing gentisic acid-2-hydroxyethoxy-p-phenylenediamine copolymer membrane by lignin peroxidase catalysis:
0.250g gentisic acid and 0.250g 2-hydroxy ethoxy-p-phenylenediamine are dissolved in 250mL of 0.2mol/L disodium hydrogen phosphate-sodium dihydrogen phosphate buffer solution (pH 6.5), 0.5U of lignin peroxidase and 40 mu L of 5% hydrogen peroxide are added, and the mixture is uniformly mixed to obtain a lignin peroxide catalytic system (water phase). Firstly, adding CCl with the thickness of 25mm into a container 4 (liquid phase which is mutually insoluble with water) then slowly add the aqueous phase to the vessel, the aqueous phase floating in the CCl 4 On the water phase and CCl 4 Form a liquid-liquid interface between the liquid phases of (a). The reaction was allowed to stand in an oven (ZFD-5090, china) at 40℃for 36h, during which time 5% hydrogen peroxide was added to the aqueous phase 40. Mu.L each time. The upper surface of the aqueous phase (the gas-liquid interface of the aqueous phase and air) forms a "gentisic acid-2-hydroxyethoxy-p-phenylenediamine copolymer film" with water, CCl 4 Form a "gentisic acid-2-hydroxyethoxy-p-phenylenediamine copolymer film".
(7) Preparation of para-aminosalicylic acid-m-phenylenediamine copolymer film by soybean peroxidase catalysis:
dissolving 0.250g of p-aminosalicylic acid and 0.250g of m-phenylenediamine in 250mL of 0.05mol/L disodium hydrogen phosphate-citric acid buffer solution (pH 7.0), adding 0.25U of soybean peroxidase and 40 mu L of 5% hydrogen peroxide, and uniformly mixing to obtain the soybean peroxidase catalystSystem (aqueous phase). Firstly, adding CCl with the thickness of 25mm into a container 4 (liquid phase which is mutually insoluble with water) then slowly add the aqueous phase to the vessel, the aqueous phase floating in the CCl 4 On the water phase and CCl 4 Forming a liquid-liquid interface therebetween. The reaction was allowed to stand in an incubator (ZSD-1090, china) at 10℃for 24 hours, during which time 5% hydrogen peroxide was added to the aqueous phase 40. Mu.L each time. The upper surface of the aqueous phase (gas-liquid interface of the aqueous phase and air) forms a 'p-aminosalicylic acid-m-phenylenediamine copolymer film', and simultaneously, the p-aminosalicylic acid-m-phenylenediamine copolymer film is formed on water and CCl 4 Form a "para-aminosalicylic acid-meta-phenylenediamine copolymer film".
(8) Preparation of catechol-caffeic acid-3, 4-diaminotoluene copolymer membranes with soybean peroxidase catalysis:
0.025g catechol, 0.025g caffeic acid and 0.050g 3, 4-diaminotoluene were dissolved in 50mL of 0.05mol/L tartaric acid-sodium tartrate buffer solution (pH 4.0), and soybean peroxidase 0.15U and 5% hydrogen peroxide 8. Mu.L were added and mixed to obtain a soybean peroxidase catalyst system (aqueous phase). Firstly, adding CCl with the thickness of 25mm into a container 4 (liquid phase which is mutually insoluble with water) then slowly add the aqueous phase to the vessel, the aqueous phase floating in the CCl 4 On the water phase and CCl 4 Forming a liquid-liquid interface therebetween. The reaction mixture was allowed to stand in an incubator (ZSD-1090, china) at 20℃for 6 hours, during which time 5% hydrogen peroxide was added to the aqueous phase 8. Mu.L each time. The upper surface of the aqueous phase (gas-liquid interface of the aqueous phase and air) forms a "catechol-caffeic acid-3, 4-diaminotoluene copolymer film" while in water, CCl 4 Form a "catechol-caffeic acid-3, 4-diaminotoluene copolymer film".
(9) Preparation of syringic acid-3, 4-diaminobenzoic acid copolymer membrane catalyzed by chloroperoxidase:
0.375g of syringic acid and 0.200g of 3, 4-diaminobenzoic acid are dissolved in 250mL of 0.05mol/L sodium acetate-acetic acid buffer solution (pH 3.5), 1.25U of chloroperoxidase and 40 mu L of 5% hydrogen peroxide are added and uniformly mixed to obtain a chloroperoxidase catalytic system (water phase). Firstly, adding CCl with the thickness of 25mm into a container 4 (liquid phase which is mutually insoluble in water) and then to the containerSlowly adding water phase, and floating in CCl 4 On the water phase and CCl 4 Forming a liquid-liquid interface therebetween. The reaction mixture was allowed to stand in an incubator (ZSD-1090, china) at 20℃for 7 hours, during which time 5% hydrogen peroxide was added to the aqueous phase 40. Mu.L each time. The upper surface of the aqueous phase (the gas-liquid interface of the aqueous phase and air) forms a "syringic acid-3, 4-diaminobenzoic acid copolymer film", at the same time in water and CCl 4 Form a "syringic acid-3, 4-diaminobenzoic acid copolymer film".
(10) Preparation of anthocyanin-4, 4' -diaminodibenzyl copolymer membrane by chloroperoxidase catalysis:
0.020g anthocyanin and 0.010g 4,4' -diamino dibenzyl are dissolved in 100mL 0.05mol/L sodium citrate-citric acid buffer solution (pH 4.0), 1U of chloroperoxidase and 16 mu L of 5% hydrogen peroxide are added, and the mixture is uniformly mixed to obtain a chloroperoxidase catalytic system (water phase). Firstly, adding CCl with the thickness of 25mm into a container 4 (liquid phase which is mutually insoluble with water) then slowly add the aqueous phase to the vessel, the aqueous phase floating in the CCl 4 On the water phase and CCl 4 Forming a liquid-liquid interface therebetween. The reaction mixture was allowed to stand in an incubator (ZSD-1090, china) at 25℃for 8 hours, during which time 5% hydrogen peroxide was added to the aqueous phase 16. Mu.L each time. The upper surface of the aqueous phase (gas-liquid interface of the aqueous phase and air) forms an 'anthocyanin-4, 4' -diaminodibenzyl copolymer film ', and the anthocyanin-4, 4' -diaminodibenzyl copolymer film is formed on water and CCl simultaneously 4 The liquid-liquid interface of the two phases forms a "anthocyanin-4, 4' -diaminodibenzyl copolymer film".
(11) Preparation of 2, 6-dihydroxytoluene-4, 4' -binaphthyl amine copolymer film catalyzed by monophenol monooxidase:
0.050g of 2, 6-dihydroxytoluene and 0.025g of 4,4' -binaphthyl amine are dissolved in 250mL of 0.05mol/L potassium hydrogen phthalate-sodium hydroxide buffer solution (pH 5.5), 2.5U of monophenol monooxidase is added, and the mixture is uniformly mixed to obtain a monophenol monooxidase catalytic system (water phase). Firstly, adding CCl with the thickness of 25mm into a container 4 (liquid phase which is mutually insoluble with water) then slowly add the aqueous phase to the vessel, the aqueous phase floating in the CCl 4 On the water phase and CCl 4 Forming a liquid-liquid interface therebetween. Standing in 30 deg.C incubator (ZSD-1090, china) for reaction 1 And 0h. The upper surface of the aqueous phase (gas-liquid interface of aqueous phase and air) forms a "2, 6-dihydroxytoluene-4, 4' -binaphthyl amine copolymer film", while water, CCl 4 The liquid-liquid interface of the two phases forms a "2, 6-dihydroxytoluene-4, 4' -binaphthyl amine copolymer film".
(12) Preparation of hydroxytyrosol-guanidine copolymer membranes catalyzed by catechol oxidase:
1.000g of hydroxytyrosol and 1.250g of guanidine are dissolved in 250mL of 0.05mol/L disodium hydrogen phosphate-citric acid buffer solution (pH 5.0), and 0.005U of catechol oxidase is added and uniformly mixed to obtain a catechol oxidase catalytic system (water phase). Firstly, adding CCl with the thickness of 25mm into a container 4 (liquid phase which is mutually insoluble with water) then slowly add the aqueous phase to the vessel, the aqueous phase floating in the CCl 4 On the water phase and CCl 4 Forming a liquid-liquid interface therebetween. Standing in incubator (ZSD-1090, china) at 30deg.C for 30 hr. The upper surface of the aqueous phase (the gas-liquid interface of the aqueous phase and air) forms a "hydroxytyrosol-guanidine copolymer film", while water, CCl 4 The liquid-liquid interface of the two phases forms a "hydroxytyrosol-guanidine copolymer film".
(13) Preparation of 2,4, 6-trihydroxybenzaldehyde-1, 2-diaminocyclohexane copolymer membranes catalyzed by bilirubin oxidase:
0.400g of 2,4, 6-trihydroxybenzaldehyde and 0.400g of 1, 2-diaminocyclohexane are dissolved in 200mL of 0.05mol/L boric acid-borax buffer solution (pH 8.0), and bilirubin oxidase 120U is added and mixed uniformly to obtain a bilirubin oxidase catalytic system (aqueous phase). Firstly, adding CCl with the thickness of 25mm into a container 4 (liquid phase which is mutually insoluble with water) then slowly add the aqueous phase to the vessel, the aqueous phase floating in the CCl 4 On the water phase and CCl 4 Forming a liquid-liquid interface therebetween. Standing in oven (ZFD-5090, china) at 60deg.C for 14 hr. The upper surface of the aqueous phase (gas-liquid interface of the aqueous phase and air) forms a "2,4, 6-trihydroxybenzaldehyde-1, 2-diaminocyclohexane copolymer film", while in water, CCl 4 The liquid-liquid interface of the two phases forms a "2,4, 6-trihydroxybenzaldehyde-1, 2-diaminocyclohexane copolymer film".
Example 4: preparation of copolymer film by upper water phase-lower liquid gallium interface enzymatic polymerization
0.125g of parahydroxybenzoic acid and 0.250g of 2-fluoro-p-phenylenediamine are dissolved in 125mL of distilled water, the pH is adjusted to 6.0 by phosphoric acid, 0.125U of laccase is added, and the mixture is uniformly mixed to obtain a laccase catalytic system (water phase). A layer of liquid gallium is put into a plastic container, then a laccase catalytic system (aqueous phase) is slowly added into the container, the aqueous phase floats on the liquid gallium, and an upper aqueous phase-lower liquid gallium interface is formed between the aqueous phase and the liquid gallium. Standing in oven (ZFD-5090, china) at 40deg.C for 48 hr. The p-hydroxybenzoic acid-2-fluoro-p-phenylenediamine copolymer film is formed at the aqueous solution-liquid gallium interface.
Example 5: preparation of copolymer film by upper water phase-lower paraffin wax interface enzymatic polymerization
0.250g chlorogenic acid, 0.125g 2, 3-diaminopyridine are dissolved in 125mL of 0.05mol/L disodium hydrogen phosphate-potassium dihydrogen phosphate buffer solution (pH 7.0), and 0.125U of horseradish peroxidase and 20 mu L of 5% hydrogen peroxide are added and uniformly mixed to obtain a horseradish peroxidase catalytic system (water phase). And placing the paraffin into a container, heating to melt and level the paraffin, and standing at room temperature to cool and solidify the paraffin into a solid. To the solid paraffin in the vessel was added a horseradish peroxidase catalytic system (aqueous phase) which was located above the solidified paraffin. The reaction was carried out at 25℃with shaking at 100rpm with a constant temperature shaker (Crystal, IS-RDV3, co., ltd.) for 12 hours, during which 5% hydrogen peroxide was added to the aqueous phase several times, 20. Mu.L each. A "chlorogenic acid-2, 3-diaminopyridine copolymer film" was formed on the upper surface of the solid paraffin. At the same time, a granular "chlorogenic acid-2, 3-diaminopyridine copolymer" is produced in the aqueous phase, suspended in the aqueous phase. The aqueous phase above the membrane was decanted and the copolymer membrane was rinsed with distilled water. The vessel was placed at 70 ℃ and paraffin melted to liquid, the PE plate was inserted into the liquid paraffin, carefully moved under the "chlorogenic acid-2, 3-diaminopyridine copolymer film" and the film was gently fished out and spread flat on the PE plate.
Example 6: preparation of copolymer film by upper water phase-lower butter interface enzymatic polymerization
0.300g of tannic acid and 0.300g of ethidium bromide are dissolved in 100mL of 0.05mol/L sodium malonate-malonic acid buffer solution (pH 6.0), 0.05U of lignin peroxidase and 15 mu L of 5% hydrogen peroxide are added, and the mixture is uniformly mixed to obtain a lignin peroxide catalytic system (water phase). Placing beef tallow in a container, heating to melt and level, and standing at room temperature to cool and solidify the beef tallow into solid. To this vessel was added a lignin peroxide catalytic system (aqueous phase) which was located above the coagulated tallow. The reaction was carried out at 25℃with shaking at 100rpm with a constant temperature shaker (Crystal, IS-RDV3, co., ltd.) for 20 hours, during which 5% hydrogen peroxide was added to the aqueous phase several times, 15. Mu.L each time. A "tannic acid-ethidium bromide copolymer film" was formed on the upper surface of the solid tallow. At the same time, a particulate "tannic acid-ethidium bromide copolymer" is produced in the aqueous phase, suspended in the aqueous phase. The aqueous phase above the membrane was decanted and the copolymer membrane was rinsed with distilled water. The vessel was placed at 65 ℃ and the tallow melted into a liquid, the PE plate was inserted into the liquid tallow, carefully moved under the "tannic acid-ethidium bromide copolymer film" and the film was gently fished out and spread flat over the PE plate.
Example 7: preparation of copolymer film by enzymatic polymerization at water-oil phase interface
0.02g of lysine is dissolved in 50mL of 0.05mol/L trisodium phosphate-phosphate buffer solution (pH 5.0), laccase 2U is added, and the mixture is uniformly mixed to obtain an aqueous phase part of a laccase catalytic system. 0.02g of tert-butyl hydroquinone is dissolved in 50mL of soybean oil, and is uniformly mixed to obtain an oil phase part of a laccase catalytic system, the oil phase part is covered on a water phase, and the mixture is subjected to standing reaction for 5h in a 30 ℃ incubator (Zhiyeng, ZSD-1090, china). A "terbutylhydroquinone-lysine copolymer film" formed at the interface of the aqueous phase and the oil phase.
Example 8: preparation of copolymer film by enzymatic polymerization at water-oil phase interface
0.05g of diethylenetriamine is dissolved in 50mL of 0.05mol/L trisodium phosphate-phosphoric acid buffer solution (pH 6.0), 5U of soybean peroxidase and 8 mu L of 5% hydrogen peroxide are added, and the mixture is uniformly mixed to obtain an aqueous phase part of the soybean peroxidase catalytic system. Gradually covering a layer of urushiol with a thickness of more than 1mm on the water phase, standing in an oven (Zhiyeng, ZFD-5090, china) at 40 ℃ for reaction for 5h, and adding 8 mu L of 5% hydrogen peroxide to the water phase every 1 h. A "urushiol-diethylenetriamine copolymer film" is formed at the interface of urushiol and the aqueous phase.
Example 9: preparation of multilayer films
0.040g of guaiacol and 0.025g of 4,4' -diamino dicyclohexylmethane are dissolved in 50mL of 0.05mol/L tartaric acid-sodium tartrate buffer solution (pH 7.0), and then 20U of monophenol monooxidase is added and uniformly mixed to obtain a monophenol monooxidase catalytic system (water phase). Firstly, adding CCl with the thickness of 55mm into a container 4 (liquid phase which is mutually insoluble with water), then slowly adding an aqueous phase to the vessel, the aqueous phase floating in CCl 4 And (3) upper part. Standing in 25 deg.C incubator (ZSD-1090, china) for 48 hr to form "guaiacol-4, 4' -diaminodicyclohexylmethane copolymer film" (gas-liquid interfacial film) on the upper surface of water phase (gas-liquid interface of water phase and air), and simultaneously in water phase and CCl 4 The "guaiacol-4, 4' -diaminodicyclohexylmethane copolymer film" (liquid-liquid interfacial film) was formed. The gas-liquid interface film was removed, and the solution on the upper side of the liquid-liquid interface "guaiacol-4, 4' -diaminodicyclohexylmethane copolymer film" was sucked out by a syringe, and another aqueous phase (0.125 g of gallic acid, 0.125g of 2, 4-diaminobenzenesulfonic acid, dissolved in 250mL of a 0.2mol/L disodium hydrogen phosphate-sodium dihydrogen phosphate buffer solution (pH 7.0), and 0.5U of horseradish peroxidase and 40. Mu.L of 5% hydrogen peroxide were added and mixed well) was poured again on the upper side of the film, whereby the pipetting-pouring-pipetting operation was repeated a plurality of times. Placing in a 40 ℃ oven (zhicheng, ZFD-5090, china) again for standing reaction for 20h, adding 5% hydrogen peroxide to the water phase for multiple times, and forming a gallic acid-2, 4-diaminobenzenesulfonic acid copolymer film (gas-liquid interface film) on the upper surface of the water phase (gas-liquid interface film) each time by 40 mu L, wherein the original guaiacol-4, 4' -diaminodicyclohexylmethane copolymer film forms a gallic acid-2, 4-diaminobenzenesulfonic acid copolymer layer on the upper side of the liquid-liquid interface film, and the gallic acid-2, 4' -diaminodicyclohexylmethane copolymer film is combined with the original guaiacol-4, 4' -diaminodicyclohexylmethane copolymer film to form a double-layer film.
Example 10: enzyme-catalyzed secondary reactions (introduction of sorbitol)
Dissolving 0.1g bisphenol A, 0.1g PEI, 10mg ABTS in 70mL trisodium phosphate-phosphate buffer solution (pH 4.0) 0.05mol/L and 30mL ethanol, adding laccase0.6U, and mixing uniformly to obtain a laccase catalytic system (aqueous phase). Firstly, adding CCl with the thickness of 55mm into a container 4 (oil phase) then slowly add the aqueous phase to the vessel, the aqueous phase floating in the CCl 4 On the two phases, a liquid-liquid interface is formed between the two phases. Standing in 40 deg.C oven (ZFD-5090, china) for 10 hr to form bisphenol A-PEI copolymer film (gas-liquid interfacial film) on the upper surface of water phase (gas-liquid interface of water phase and air), and simultaneously mixing with water and CCl 4 The "bisphenol A-PEI copolymer film" (liquid-liquid interfacial film) is formed at the liquid-liquid interface of (C). Removing the gas-liquid interfacial film. The solution on the upper side of the "bisphenol A-PEI copolymer film" of the liquid-liquid interface was sucked out by syringe, another solution (0.3 g sorbitol was dissolved in 150mL of 0.05mol/L trisodium phosphate-phosphate buffer solution (pH 5.0), 175mg of laccase 10U, 2, 6-tetramethylpiperidine oxide (TEMPO) was added, and the mixture was homogenized), and the pipetting-pouring-pipetting operation was repeated several times. Standing in oven (ZFD-5090, china) at 40deg.C for 24 hr. Liquid-liquid (CCl) was injected with a syringe 4 ) The solution on the upper side of the interfacial film was sucked out and re-deposited in the liquid-liquid (CCl 4 ) Distilled water is injected into the upper side of the interface film, and the operations of liquid suction, liquid injection and liquid suction are repeated for a plurality of times. Inserting coverslips into CCl 4 In the middle, carefully move to liquid-liquid (CCl 4 ) Gently picking up the membrane below the interface membrane, spreading the membrane on a cover glass, and sucking residual CCl on the lower side of the membrane with filter paper 4 And (5) airing at room temperature.
The elemental composition of the film surface was measured using an X-ray photoelectron spectrometer (X-ray Photoelectron Spectroscopy, XPS, thermo Fisher Scientific, escalab 250xi, USA) and the N/O ratio of the film surface was reduced from 0.695 to 0.527 after reaction with sorbitol. The surface of the bisphenol A-PEI copolymer film which is not combined with sorbitol contains C, H, O, N elements; the sorbitol structure contains C, H, O elements, and no N element exists; thus, a decrease in the N/O ratio at the membrane surface demonstrates that the membrane incorporates sorbitol, i.e., the liquid-liquid interfacial membrane surface can undergo an enzyme-catalyzed secondary reaction.
Example 11: vesicle and enzymatic polymerization preparation method thereof
To the centrifuge tube, 100. Mu.L of oleic acid, 2mg/mL of cetyltrimethylammonium bromide (Hexadecyl trimethyl ammonium bromide, CTAB) solution (1 mL) were sequentially added, vortexed for 5min and then sonicated for 15min to prepare an oil-in-water emulsion. Centrifuging the emulsion 6000 Xg for 5min, removing the supernatant by a syringe, adding the supernatant into 1mL of 0.05mol/L trisodium phosphate-phosphoric acid buffer solution (pH 5.0) dissolved with 0.05U laccase, 2mg hydroquinone and 2mg PEI, vibrating and reacting for 24h at room temperature and in a dark place, and wrapping the hydroquinone-PEI copolymer film on the outer surface of the oil drop to obtain the hydroquinone-PEI copolymer vesicle with oleic acid wrapped inside, wherein the stability of the emulsion is greatly improved.
Soaking the prepared vesicle in ethanol, dissolving oleic acid and CTAB in the vesicle by using ethanol, centrifuging 10000 Xg for 10min, collecting the vesicle, dissolving residual oleic acid and CTAB in the ethanol again, centrifuging, and collecting the vesicle for multiple times. Evaporating the vesicle into solvent under negative pressure to obtain hollow vesicle.
Hydrophilic, hydrophobic vesicle outer walls can be prepared as desired, and target molecules/atoms can be bonded/deposited on the outer walls of the capsule.
The copolymer vesicles can be used to encapsulate cells, organelles, antigens, antibodies, functional polymers, proteins, enzymes, DNA, RNA, polysaccharides, drugs, nutrients, fragrances, pesticides, fertilizers, chemicals, fuels, explosives, and the like.
Copolymer vesicles may also provide a suitable microenvironment for some chemical or biochemical reactions.
Example 12: copolymer film reduction metal
hydroquinone-PEI vesicles were prepared as in example 11, and the vesicles were immersed in 0.05mol/L AgNO 3 Placing in a solution in a dark place for 30min, and AgNO 3 Ag in solution + The simple substance reduced into Ag nano particles is deposited on the outer surface of the vesicle wall. Centrifuging at 5000rpm for 5min, and washing with ultrapure water twice to obtain vesicles with Ag nano-particle simple substances deposited on the outer surfaces.
Those skilled in the art will appreciate that not only Ag + For other oxidizability higher than Ag + The film may also reduce and deposit it on the surface of the film,for example, noble metal ions such as gold ions, foil ions, palladium ions and the like are reduced to generate corresponding simple substances, so that the surface metallization of the electroless plating material is realized. The silver particle-covered material has excellent antibacterial performance. Palladium, platinum, silver, etc. are important chemical catalysts, and thus, the copolymer film deposited with the metal can be used for chemical catalysis. This method can also be used to remove, enrich, and recover these metals from water.
Example 13: preparation of films with conductive properties
0.25g of ferulic acid and 0.25g of p-phenylenediamine are dissolved in 125mL of 0.05mol/L trisodium phosphate-phosphoric acid buffer solution (pH 5.0), 7.5U of laccase is added, and the mixture is uniformly mixed to obtain a laccase catalytic system (water phase). Firstly, adding CCl with the thickness of 15mm into a container 4 (oil phase) then slowly add the aqueous phase to the vessel, the aqueous phase floating in the CCl 4 On water, CCl 4 A liquid-liquid interface is formed between the two phases. Standing in oven (ZFD-5090, china) at 50deg.C for 13 hr. Forming a 'ferulic acid-p-phenylenediamine copolymer film' on the upper surface of the aqueous phase (gas-liquid interface of the aqueous phase and air) while simultaneously forming a 'ferulic acid-p-phenylenediamine copolymer film' on the upper surface of the aqueous phase in water, CCl 4 The liquid-liquid interface of the two phases forms a "ferulic acid-p-phenylenediamine copolymer film". Removing the gas-liquid interfacial film. Sucking out the solution on the upper side of the liquid-liquid interface film with a syringe, and re-mixing the solution with the liquid-liquid (CCl 4 ) Distilled water is injected into the upper side of the interface film, the operations of liquid suction, liquid injection and liquid suction are repeated for a plurality of times, and a cover glass is inserted into the CCl 4 In the middle, carefully move to liquid-liquid (CCl 4 ) Gently picking up the membrane below the interface membrane, spreading the membrane on a cover glass, and sucking residual CCl on the lower side of the membrane with filter paper 4 And (5) airing at room temperature. Determination of liquid-liquid (CCl) on coverslip by four-probe method using resistance tester (lattice, ST2722, china) 4 ) The conductivity of the interfacial film surface was 1.67S/m.
The copolymer conductive film can be used in the fields of electroluminescence, electrochromic, light conduction, electronic switches, all-solid-state batteries, nonlinear optical devices, high-density memory materials, flat panel displays, organic semiconductor devices, molecular wires, light-emitting diodes, antistatic materials, electromagnetic shielding materials, photovoltaic cell materials and the like.
By selecting different film-forming monomers, copolymer films with different conductivities within a certain range can be prepared.
The conductive copolymer film can improve the conductivity of the conductive copolymer film by doping and composite deposition of metal particle simple substances.
The metal ions can be reduced on the surface of the conductive copolymer film, so that the metal simple substance is deposited on the surface of the film, and the conductivity is improved.
Comparative example 1:
(1) 0.250g bisphenol A, 0.250g pre-flavin were dissolved in 175mL of a mixed solvent of 0.1mol/L Tris-hydrochloric acid buffer solution (pH 8.5) and 75mL ethanol, and mixed well. Liquid paraffin of 5mm thickness was covered on the surface of the above solution (aqueous phase) with a pipette, and left to stand in an oven (Zhiyeng, ZFD-5090, china) at 45℃for 48 hours. No film forms at the interface between the liquid paraffin and the aqueous phase, and no particulate matter forms in the aqueous phase.
(2) 0.250g bisphenol A, 0.250g pre-flavin were dissolved in 175mL of a mixed solvent of 0.1 mol/L10 g/L NaOH solution (pH 13.4) and 75mL ethanol and mixed well. Liquid paraffin of 5mm thickness was covered on the surface of the above solution (aqueous phase) with a pipette, and left to stand in an oven (Zhiyeng, ZFD-5090, china) at 45℃for 24 hours. No film forms at the interface between the liquid paraffin and the aqueous phase, and no particulate matter forms in the aqueous phase.
Comparative example 2:
(1) 0.125g of 4,4' -dihydroxybiphenyl, 0.125g of 2, 3-diaminonaphthalene were dissolved in 215mL of a mixed solvent of 0.05mol/L glycine-sodium hydroxide buffer solution (pH 8.5) and 35mL of acetone, and mixed well. Liquid paraffin of 10mm thickness was covered on the surface of the above solution (aqueous phase) with a pipette, and left to stand in an oven (Zhiyeng, ZFD-5090, china) at 40 ℃ for 48 hours. No film forms at the interface between the liquid paraffin and the aqueous phase, and no particulate matter forms in the aqueous phase.
(2) 0.125g of 4,4' -dihydroxybiphenyl and 0.125g of 2, 3-diaminonaphthalene were dissolved in 215mL of a 10g/L NaOH solution (pH 13.4) and 35mL of acetone in a mixed solvent, and mixed well. Liquid paraffin of 10mm thickness was covered on the surface of the above solution (aqueous phase) with a pipette, and left to stand in an oven (Zhiyeng, ZFD-5090, china) at 40 ℃ for 24 hours. No film forms at the interface between the liquid paraffin and the aqueous phase, and no particulate matter forms in the aqueous phase.
The embodiments of the present invention have been described above. However, the present invention is not limited to the above embodiment. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (22)
1. A method for synthesizing a copolymer film, comprising the steps of:
dissolving a film-forming monomer containing phenolic hydroxyl groups, a film-forming monomer containing at least two amino groups and a catalyst in an aqueous phase and/or a liquid phase which is mutually insoluble in water, and polymerizing at the interface of the two phases to form a film to obtain the copolymer film;
the catalyst is at least one of peroxidase and/or oxidoreductase with laccase activity and/or artificial enzyme with catalytic activity;
The structure of the film forming monomer containing phenolic hydroxyl is shown as a formula I:
wherein each R 1 The same or different are independently selected from H, halogen, CN, NO 2 OH, SH, COOH, unsubstituted or substituted by one, two or more R a1 Substituted with the following groups: c (C) 1-10 Alkyl, C 2-10 Alkenyl, C 2-10 Alkynyl, C 3-10 Cycloalkyl, C 3-10 Cycloalkenyl, C 3-10 Cycloalkynyl radicals, C 6-14 Aryl, 5-14 membered heteroaryl, 3-10 membered heterocyclyl, -OR 1-2 、-SR 1-3 、-NR 1-4 R 1-5 、-OC(O)R 1-7 、-S(O) 2 R 1-8 、-OS(O) 2 R 1-9 、-P(O)R 1-10 R 1-11 、-N=NR 1-12 ;
A 1 Presence or absence; when A is 1 When present, is selected from unsubstituted or substituted by one, two or more R b1 Substituted C linked to the benzoring 6-14 Aryl, 5-14 membered heteroaryl, 5-10 membered heterocyclyl;
each R a1 、R b1 The same or different, independently of one another, from H, halogen, CN, OH, SH, NO 2 、COOH、-OR 1-2 、-SR 1-3 、-NR 1-4 R 1-5 、-OC(O)R 1-7 、-S(O) 2 R 1-8 、-OS(O) 2 R 1-9 、P(O)R 1-10 R 1-11 Unsubstituted or optionally substituted by one, two or more R 1-12 Substituted C 1-10 Alkyl, C 2-10 Alkenyl, C 2-10 Alkynyl, C 3-10 Cycloalkyl, C 3-10 Cycloalkenyl, C 3-10 Cycloalkynyl radicals, C 6-14 Aryl, 5-14 membered heteroaryl, 3-10 membered heterocyclyl;
each R is 1-2 、R 1-3 、R 1-4 、R 1-5 、R 1-6 、R 1-7 、R 1-8 、R 1-9 、R 1-10 、R 1-11 、R 1-12 The same or different, independently of one another, from H, halogen, CN, OH, SH, NO 2 、COOH、C 1-10 Alkyl, C 2-10 Alkenyl, C 2-10 Alkynyl, C 3-10 Cycloalkyl, C 3-10 Cycloalkenyl, C 3-10 Cycloalkynyl radicals, C 6-14 Aryl, 5-14 membered heteroaryl, 3-10 membered heterocyclyl;
the film-forming monomer containing at least two amino groups has a structure shown in a formula II:
Each R 2 The same or different are independently selected from H, halogen, CN, NO 2 NO, OH, SH, COOH, unsubstituted or substituted by one, two or more R a2 Substituted with the following groups: c (C) 1-10 Alkyl, C 2-10 Alkenyl, C 2-10 Alkynyl, C 3-10 Cycloalkyl, C 3-10 Cycloalkenyl, C 3-10 Cycloalkynyl and 3-14 membered heterogeniesCyclic group, -OR 2-2 、-SR 2-3 、-NR 2-4 R 2-5 、-C(O)R 2-6 、-OC(O)R 2-7 、-S(O) 2 R 2-8 、-OS(O) 2 R 2-9 、P(O)R 2-10 R 2-11 ;
A 2 Selected from unsubstituted or optionally substituted by one, two or more R c2 Substituted C 1-6 Alkylene, ch=n-n=ch, ch=ch-CO-CH 2 -CO-CH=CH;
p is an integer of 0 to 12;
each R a2 、R c2 Identical or different, independently of one another, from the group consisting of H, halogen, CN, OH, SH, oxo (=o), =nh, NO 2 、COOH、C 1-10 Alkyl, C 2-10 Alkenyl, C 2-10 Alkynyl, C 3-10 Cycloalkyl, C 3-10 Cycloalkenyl, C 3-10 Cycloalkynyl, 3-to 10-membered heterocyclyl, -OR 2-2 、-SR 2-3 、-NR 2-4 R 2-5 、-C(O)R 2-6 、-OC(O)R 2-7 、-S(O) 2 R 2-8 、-OS(O) 2 R 2-9 、P(O)R 2-10 R 2-11 ;
Each R is 2-2 、R 2-3 、R 2-4 、R 2-5 、R 2-6 、R 2-7 、R 2-8 、R 2-9 、R 2-10 、R 2-11 The same or different, independently of one another, from H, halogen, NH 2 CN, OH, SH, oxo (=o), NO 2 、COOH、C 1-10 Alkyl, C 2-10 Alkenyl, C 2-10 Alkynyl, C 3-10 Cycloalkyl, C 3-10 Cycloalkenyl, C 3-10 Cycloalkynyl, 3-10 membered heterocyclyl.
2. A method for synthesizing a copolymer film, comprising the steps of:
dissolving a film-forming monomer containing phenolic hydroxyl groups, a film-forming monomer containing at least two amino groups and a catalyst in an aqueous phase and/or a liquid phase which is mutually insoluble in water, and polymerizing at the interface of the two phases to form a film to obtain the copolymer film;
The catalyst is at least one of peroxidase and/or oxidoreductase with laccase activity and/or artificial enzyme with catalytic activity;
the film-forming monomer containing phenolic hydroxyl groups has a structure shown in formulas I-1 to I-8 or I-10 to I-13:
wherein R is 1 M and R c1 Having the same definition as in claim 1; b is selected from quilt R 1 Substituted N; D. d (D) 1 、D 2 And D 3 Identical or different, independently of one another, from chemical bonds, unsubstituted or optionally substituted by one or two R c1 Substituted CH 2 The method comprises the steps of carrying out a first treatment on the surface of the E and E 1 The same or different, independently of one another, are selected from the group consisting of chemical bonds, C 1-6 Alkylene, ch=ch, ch= N, N =n or ch=n-n=ch; n is an integer of 0 to 5; f (F) 1 And F 2 The same or different, independently of one another, are selected from N, CH or O + ;R 1 ’、R 1 "and R 1 Is the same as defined in the specification;
the film-forming monomer containing at least two amino groups has a structure shown in formula II-3, II-8 or II-9:
H 2 N-E 3 -NH 2
II-3、
wherein R is 2 And p has the same definition as in claim 1; q is an integer of 0 to 12; r is R 2 ' and R 2 Is the same as defined in the specification; and R is 2 、R 2 At least two of the' are amino groups;
each E 3 、E 4 Identical or different, independently of one another, from chemical bonds, unsubstituted or optionally substituted by one, two or more R c2 Substituted C 1-6 Alkylene, ch= N, CH =n-n= CH. Alkylene or alkenyl radicals having up to 6 carbon atoms-CO-C 1-6 alkylene-CO-alkylene or alkenyl having up to 6 carbon atoms, alkylene or alkenyl-CO-NH-alkylene or alkenyl having up to 6 carbon atoms, alkylene or alkenyl-NH-alkylene having up to 6 carbon atoms, alkylene or alkenyl-C (O) O-alkylene having up to 6 carbon atoms, alkylene or alkenyl having up to 6 carbon atoms.
3. A method for synthesizing a copolymer film, comprising the steps of:
dissolving a film-forming monomer containing phenolic hydroxyl groups, a film-forming monomer containing at least two amino groups and a catalyst in an aqueous phase and/or a liquid phase which is mutually insoluble in water, and polymerizing at the interface of the two phases to form a film to obtain the copolymer film;
the catalyst is at least one of peroxidase and/or oxidoreductase with laccase activity and/or artificial enzyme with catalytic activity;
the film forming monomer containing phenolic hydroxyl groups is selected from at least one of 1, 3-dihydroxynaphthalene, p-hydroxybenzoic acid, ferulic acid, 1, 6-dihydroxynaphthalene, 3-methyl salicylic acid, p-coumaric acid, 4' -dihydroxybiphenyl, bisphenol A, chlorogenic acid, 3-methoxy salicylic acid, gallic acid, tannic acid, 3, 5-diiodosalicylic acid, gentisic acid, resveratrol, esculin, p-amino salicylic acid, caffeic acid, ellagic acid, anthocyanin, syringic acid, tyrosine, guaiacol, 2, 6-dihydroxytoluene, catechol, hydroxytyrosol, galloblue, 1,8, 9-trihydroxy anthracene, urushiol and tert-butylhydroquinone;
The film forming monomer containing at least two amino groups is at least one selected from arginine, polyethyleneimine (PEI), kanamycin, diethylenetriamine, lysine, 1, 6-hexamethylenediamine, spermine, 4' -diamino dicyclohexylmethane, urea, guanidine and 1, 2-diamino cyclohexane.
4. A synthetic method according to any one of claims 1 to 3, wherein the copolymer film is obtained by dissolving a film-forming monomer containing a phenolic hydroxyl group and a film-forming monomer containing at least two amino groups in a solvent, adding a catalyst and mixing to obtain an aqueous phase, contacting the aqueous phase with a liquid phase which is insoluble in water, and polymerizing at the interface of the two phases to form a film.
5. A synthetic method according to any one of claims 1 to 3, characterized in that a film-forming monomer containing a phenolic hydroxyl group is dissolved in a solvent, a catalyst is added and mixed to obtain an aqueous phase, the film-forming monomer containing at least two amino groups is dissolved in a liquid phase which is mutually insoluble in water, the aqueous phase is contacted with the liquid phase which is mutually insoluble in water, and the copolymer film is polymerized at the interface of the two phases.
6. A synthetic method according to any one of claims 1 to 3, characterized in that a film-forming monomer containing at least two amino groups is dissolved in a solvent, a catalyst is added and mixed to obtain an aqueous phase, a film-forming monomer containing a phenolic hydroxyl group is dissolved in a liquid phase which is mutually insoluble in water, the aqueous phase is contacted with a liquid phase which is mutually insoluble in water, and the copolymer film is polymerized at the interface of the two phases.
7. A synthetic method according to any one of claims 1 to 3, characterized in that a catalyst is dissolved in an aqueous phase, a film-forming monomer containing a phenolic hydroxyl group, a film-forming monomer containing at least two amino groups are dissolved in a liquid phase which is mutually insoluble in water, the aqueous phase is brought into contact with the liquid phase which is mutually insoluble in water to undergo an enzymatic reaction, and the copolymer film is polymerized at the interface of the two phases to form a film.
8. The synthetic method according to any one of claims 1 to 7, wherein the peroxidase is selected from at least one of manganese peroxidase, lignin peroxidase, chloroperoxidase and plant peroxidase; the plant peroxidase is at least one of horseradish peroxidase, soybean peroxidase, rice peroxidase, cotton peroxidase, safflower bean peroxidase, chickpea peroxidase, guar peroxidase and pea peroxidase;
the oxidoreductase with laccase activity is selected from at least one of catechol oxidase, monophenol monooxidase and bilirubin oxidase;
the artificial enzyme is an enzyme mimic with specific catalytic function synthesized by utilizing an organic chemistry and biology method according to the catalytic mechanism of the enzyme and simulating the biological catalytic function of natural enzyme.
9. The method of claim 8, wherein the laccase is a fungal laccase.
10. The method of claim 9, wherein the fungal laccase is a polyporus winter laccase.
11. The method of claim 1, wherein when the catalyst is at least one of laccase, bilirubin oxidase, and peroxidase, the combination of the phenolic hydroxyl group-containing film-forming monomer and the film-forming monomer containing at least two amino groups is: r is R 1 And/or A 1 A combination of a compound of formula I and a compound of formula II when there is at least one phenolic hydroxyl group in the structure;
when the catalyst is a monophenol monooxidase, the combination of the film-forming monomer containing a phenolic hydroxyl group and the film-forming monomer containing two amino groups is: a combination of a compound of formula I and a compound of formula II;
when the catalyst is catechol oxidase, the combination of the film-forming monomer containing a phenolic hydroxyl group and the film-forming monomer containing at least two amino groups is: r is R 1 A combination of a compound of formula I and a compound of formula II when the compound is a phenolic hydroxyl group in an ortho position;
the film-forming monomer containing phenolic hydroxyl and the film-forming monomer containing at least two amino groups are respectively one or more than two in a reaction system.
12. A method according to any one of claims 1 to 3, wherein the aqueous phase is an aqueous solution having a water content of not less than 50% by total mass.
13. The method of claim 12, wherein the aqueous phase is dissolved with a film-forming monomer and contains a water-soluble organic solvent, the organic solvent being at least one of methanol, ethanol, isopropanol, acetone, methyl formate, ethyl acetate, acetonitrile, tetrahydrofuran, N-dimethylformamide, 1, 4-dioxane, dimethyl sulfoxide, diethylene glycol butyl ether, diethylene glycol.
14. The method of claim 7, wherein the enzymatic reaction further incorporates at least one of an enhancer for the enzyme, hydrogen peroxide, metal ions, buffer ion pairs.
15. The method of claim 7, wherein the water-immiscible liquid phase is selected from the group consisting of an oil that is a liquid at ambient temperature, an oil that is a solid at a set temperature, and a liquid metal.
16. The method of claim 4, wherein the solvent is selected from the group consisting of water and buffer solutions, wherein the buffer solution is a sodium acetate-acetic acid buffer solution, a disodium hydrogen phosphate-citric acid buffer solution, a potassium hydrogen phthalate-sodium hydroxide buffer solution, a tartaric acid-sodium tartrate buffer solution, a sodium citrate-citric acid buffer solution, a trisodium phosphate-phosphoric acid buffer solution, a sodium malonate-malonic acid buffer solution, a sodium succinate-succinic acid buffer solution, a phthalic acid-hydrochloric acid buffer solution, a disodium hydrogen phosphate-sodium dihydrogen phosphate buffer solution, a disodium hydrogen phosphate-potassium dihydrogen phosphate buffer solution, a dipotassium hydrogen phosphate-sodium hydroxide buffer solution, a Tris-hydrochloric acid buffer solution, a boric acid-borax buffer solution, and a glycine-sodium hydroxide buffer solution.
17. A process according to any one of claims 1 to 3, wherein the catalyst is used in the reaction system in an amount of from 0.01 to 600U/L in terms of enzyme activity.
18. A process according to any one of claims 1 to 3, wherein the catalyst is used in the reaction system in an amount of from 0.5U/L to 200U/L in terms of enzyme activity.
19. A method according to any one of claims 1 to 3, wherein the film-forming monomer is present in the reaction system at a mass concentration of 0.002 to 380g/L.
20. A method according to any one of claims 1 to 3, wherein the temperature of the film forming reaction is 4 to 90 ℃.
21. A method according to any one of claims 1 to 3, wherein the film forming reaction is carried out for a period of 0.01 to 72 hours.
22. A process according to any one of claims 1 to 3, wherein the pH of the aqueous phase is from 2 to 10.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110797790.0A CN115612114B (en) | 2021-07-14 | 2021-07-14 | Copolymer membrane and method for enzymatic self-assembly synthesis and application thereof |
PCT/CN2022/105417 WO2023284777A1 (en) | 2021-07-14 | 2022-07-13 | Copolymer film, enzyme catalysis self-assembly synthesis method therefor, and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110797790.0A CN115612114B (en) | 2021-07-14 | 2021-07-14 | Copolymer membrane and method for enzymatic self-assembly synthesis and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115612114A CN115612114A (en) | 2023-01-17 |
CN115612114B true CN115612114B (en) | 2024-02-20 |
Family
ID=84855595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110797790.0A Active CN115612114B (en) | 2021-07-14 | 2021-07-14 | Copolymer membrane and method for enzymatic self-assembly synthesis and application thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115612114B (en) |
WO (1) | WO2023284777A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117070119A (en) * | 2023-06-06 | 2023-11-17 | 杭州日耀涂料有限公司 | Steel drum inner wall paint and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5143828A (en) * | 1991-12-31 | 1992-09-01 | The United States Of America As Represented By The Secretary Of The Army | Method for synthesizing an enzyme-catalyzed polymerized monolayer |
CN1091141A (en) * | 1993-10-14 | 1994-08-24 | 吉林大学 | The enzymatic that tensio-active agent is used for phenol and aromatic amines polymer synthesizes |
CN107158980A (en) * | 2017-06-07 | 2017-09-15 | 浙江大学 | Utilized thin film composite membranes reacted based on air liquid interface and its preparation method and application |
CN108889139A (en) * | 2018-07-31 | 2018-11-27 | 南京工业大学 | Method for preparing high-flux covalent organic framework nanofiltration membrane based on interfacial polymerization |
CN109293957A (en) * | 2018-09-11 | 2019-02-01 | 北京理工大学 | One kind has the COFs thin-film material of ultralow dielectric |
CN109906248A (en) * | 2016-09-28 | 2019-06-18 | 可隆工业株式会社 | Quinone curable compositions and adhesive compositions comprising the same |
CN111944144A (en) * | 2020-08-18 | 2020-11-17 | 齐鲁工业大学 | Self-supporting catecholamine film and preparation method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6444450B2 (en) * | 1998-01-28 | 2002-09-03 | The United States Of America As Represented By The Secretary Of The Army | Large-scale production of polyphenols or polyaromatic amines using enzyme-mediated reactions |
US6362315B2 (en) * | 1999-02-04 | 2002-03-26 | The United States Of America As Represented By The Secretary Of The Army | Process to control the molecular weight and polydispersity of substituted polyphenols and polyaromatic amines by enzymatic synthesis in organic solvents, microemulsions, and biphasic systems |
KR101791241B1 (en) * | 2014-06-17 | 2017-10-30 | 한국과학기술원 | Catecholamine-based versatility film and a preparation method thereof |
KR101743278B1 (en) * | 2014-06-17 | 2017-06-07 | 한국과학기술원 | Method of Preparing Biocatalytic Films Using Phenol containing polymer and Tyrosinase Expressing Bacterial cell |
-
2021
- 2021-07-14 CN CN202110797790.0A patent/CN115612114B/en active Active
-
2022
- 2022-07-13 WO PCT/CN2022/105417 patent/WO2023284777A1/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5143828A (en) * | 1991-12-31 | 1992-09-01 | The United States Of America As Represented By The Secretary Of The Army | Method for synthesizing an enzyme-catalyzed polymerized monolayer |
CN1091141A (en) * | 1993-10-14 | 1994-08-24 | 吉林大学 | The enzymatic that tensio-active agent is used for phenol and aromatic amines polymer synthesizes |
CN109906248A (en) * | 2016-09-28 | 2019-06-18 | 可隆工业株式会社 | Quinone curable compositions and adhesive compositions comprising the same |
CN107158980A (en) * | 2017-06-07 | 2017-09-15 | 浙江大学 | Utilized thin film composite membranes reacted based on air liquid interface and its preparation method and application |
CN108889139A (en) * | 2018-07-31 | 2018-11-27 | 南京工业大学 | Method for preparing high-flux covalent organic framework nanofiltration membrane based on interfacial polymerization |
CN109293957A (en) * | 2018-09-11 | 2019-02-01 | 北京理工大学 | One kind has the COFs thin-film material of ultralow dielectric |
CN111944144A (en) * | 2020-08-18 | 2020-11-17 | 齐鲁工业大学 | Self-supporting catecholamine film and preparation method and application thereof |
Non-Patent Citations (3)
Title |
---|
"Air/Water Interfacial Formation of Freestanding, Stimuli-Responsive, Self-Healing Catecholamine Janus-Faced Microfi lms";Seonki Hong等;《ADVANCED MATERIALS》;第26卷;第7581–7587页 * |
侯海云等.《表面活性剂物理化学基础》.西安交通大学出版社,2014,第104页. * |
古练权.《生物化学》.高等教育出版社,2020,第29段. * |
Also Published As
Publication number | Publication date |
---|---|
WO2023284777A1 (en) | 2023-01-19 |
CN115612114A (en) | 2023-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yi et al. | Preparation of strong antioxidative, therapeutic nanoparticles based on amino acid-induced ultrafast assembly of tea polyphenols | |
Zhu et al. | Non‐conjugated polymer dots with crosslink‐enhanced emission in the absence of fluorophore units | |
Munin et al. | Encapsulation of natural polyphenolic compounds; a review | |
Nune et al. | Green nanotechnology from tea: phytochemicals in tea as building blocks for production of biocompatible gold nanoparticles | |
Wang et al. | Co‐encapsulation of biodegradable nanoparticles with silicon quantum dots and quercetin for monitored delivery | |
Fei et al. | One-pot ultrafast self-assembly of autofluorescent polyphenol-based core@ shell nanostructures and their selective antibacterial applications | |
CN115612403B (en) | Self-assembled strong-adhesion copolymer film, coating method and application | |
Han et al. | pH‐Responsive Nanoscale Coordination Polymer for Efficient Drug Delivery and Real‐Time Release Monitoring | |
Zhang et al. | Proanthocyanidin encapsulated in ferritin enhances its cellular absorption and antioxidant activity | |
CN115612114B (en) | Copolymer membrane and method for enzymatic self-assembly synthesis and application thereof | |
Chen et al. | Acidity and Glutathione Dual‐Responsive Polydopamine‐Coated Organic‐Inorganic Hybrid Hollow Mesoporous Silica Nanoparticles for Controlled Drug Delivery | |
Wang et al. | Improvement of the stabilities and antioxidant activities of polyphenols from the leaves of Chinese star anise (Illicium verum Hook. f.) using β‐cyclodextrin‐based metal–organic frameworks | |
Chu et al. | NIR Responsive Doxorubicin‐Loaded Hollow Copper Ferrite@ Polydopamine for Synergistic Chemodynamic/Photothermal/Chemo‐Therapy | |
CN112646197B (en) | Aminated lignin and preparation method and application thereof | |
CN101618021B (en) | Chitosan coating medicine slow release microsphere and preparation method thereof | |
Wang et al. | Self‐A ssembly of Near‐M onodisperse Redox‐S ensitive Micelles from Cholesterol‐C onjugated Biomimetic Copolymers | |
Varshosaz et al. | Retinoic Acid Decorated Albumin‐Chitosan Nanoparticles for Targeted Delivery of Doxorubicin Hydrochloride in Hepatocellular Carcinoma | |
CN111420064B (en) | protein-EGCG composite nanoparticle and antioxidant Pickering high internal phase emulsion | |
Zhao et al. | The delivery of doxorubicin of multifunctional β‐cyclodextrin‐modified CdSe/ZnS quantum dots for bioactivity and nano‐probing | |
Yi et al. | Gelatin/tannin complex nanospheres via molecular assembly | |
Xie et al. | Engineering metal‐phenolic networks for enhancing cancer therapy by tumor microenvironment modulation | |
Jiang et al. | Preparation of hypocrellin B nanocages in self-assembled apoferritin for enhanced intracellular uptake and photodynamic activity | |
CN111603568A (en) | Charge reversal type polypeptide composite nano-drug and preparation method and application thereof | |
Chen et al. | Curcumin-loaded high internal phase emulsions stabilized with lysine modified lignin: a biological agent with high photothermal protection and antibacterial properties | |
Sun et al. | Natural deep eutectic solvent supported targeted solid–liquid polymer carrier for breast cancer therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |